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Airborne infectious diseases, such as tuberculosis (TB), are spread by airborne infectious parti-
cles (viable particles with potential for TB infection) in exhaled air from infectious individuals
in enclosed spaces, which have a high probability of deposition in the terminal airways. Exhaled
air is the carrier of airborne infectious particles and carbon dioxide is used as a surrogate of
this exhaled air. Respiratory activities such as talking, coughing, sneezing and singing could
contribute to respiratory particle production. When susceptible individuals become exposed to
the expelled airborne infectious particles by infectors, they may become infected, depending
on the infectivity of the strains in the infectious particles, proximity to infectors, duration of
exposure and the immune response of the host.
Using carbon dioxide as a surrogate for exhaled air, we modified the Wells-Riley model and prior
modified versions of the model, and obtained a flexible but sensitive mathematical model that
predicts the risks of airborne infectious diseases, such as TB under steady and non-steady state
conditions, without assumptions of well mixed airspace and equilibrium conditions. In reality,
airspace can never be well mixed because regions of high and low contaminant concentrations
exist simultaneously within the same airspace. Furthermore, equilibrium conditions cannot
be achieved consistently as the climate changes. From a biological point of view, not all
airborne infectious particles reach the target infection site of the host to establish infection,
some deposit in the upper airways without inducing infection. In our model, we take into
consideration that alveolar deposition fraction determines the number and concentration of
surviving airborne infectious particles that reach the alveolar to induce infection.
Applying experimental data from in vivo studies to the mathematical model developed in
this study, we explored the probability of exposed guinea pigs acquiring infection in these
in vivo studies and quantified the number of surviving airborne infectious particles (infective
organisms) required to reach the alveolar to establish infection. Our study shows that the
number of infective organisms demonstrated in the in vivo studies might have been markedly
underestimated. We note that for a susceptible individual to be infected, the average number
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of inhaled airborne infectious particles should attain a threshold level, which is the minimum
number of airborne infectious particles required to deposit in the alveolar to induce infection,
and infection cannot occur from a single infective organism as reported previously.
In this study, we investigated TB transmission in congregate settings, such as schools, house-
holds, public transport, prisons and health care settings and suggested preventive measures for
TB control. TB transmission in these locations is attributable to numerous factors, including
overcrowding and air pollution, which acts as a carrier of airborne infectious particles. Further-
more, high TB prevalence in these locations fosters the force of infection and a large number
of susceptible individuals get infected as they share expired air with infectious individuals.
Though human immunodeficiency virus (HIV) may be regarded as a key contributing factor to
TB transmission, TB prevalence in high TB burden settings is influenced by many other fac-
tors, including poor diagnostic tools, incomplete doses of therapy, overcrowding in townships,
ineffective air disinfection tools in congregate settings and poverty-induced malnutrition.
We explored the population impact of effective contact rate (β ) on TB epidemiology by
comparing the number of newly infected and reinfected individuals at stability point of a TB
epidemic with increasing effective contact rate (ranging from 5 to 30 yr−1). Furthermore, we
examined the impact of post-treatment immune status by comparing the number of active TB
cases when all treated individuals move to either a susceptible, newly infected or reinfected
state at stability point of a TB epidemic. We found that the number of newly infected cases
increases when β = 5 to β = 10 yr−1 then decreases with increasing effective contact rate,
while that of reinfected individuals increases in all values of effective contact rate, implying that
TB prevalence might be driven by reinfection, especially in high burden settings. Furthermore,
we noted that the number of active TB becomes higher when all treated individuals move to a
susceptible state than when they move to either a newly infected or reinfected state, probably
because of immunological factors. Results show that post-treatment immunological memory
reduces the risk of active disease by 7−16% compared to susceptible individuals.
Using an age-structured mathematical model developed in this study that incorporates vacci-
nation for the age groups [0 - 5) and [5 - 15) years, we explored TB disease progression in
different age groups (from [0−5) to ≥ 75 years). We found that TB disease progression is age
dependent. High TB notification was detected for the age groups [0−5), [15−25), [45−55)
and [55−65) years, and the lowest TB notification rate was detected in the age group [5−15)
years. Furthermore, we noted that vaccination decreases active disease progression for the age
groups [0−5) to [15−25) years, while TB notification rates remain high for the age groups
[25− 35) to ≥ 75 years. The findings in this study suggest that active disease progression
depends on age and average duration of the waning of the vaccine effect.
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This chapter reviews tuberculosis (TB) transmission scenarios from the historical background
of Mycobacterium tuberculosis discovery, TB global status and TB prevalence in South Africa.
It describes TB transmission mechanisms, TB transmission from adults to children, factors
associated with TB transmission, TB diagnosis and tools used for TB diagnosis. It provides
an overview of TB infection progression to disease and factors attributable to infection and
disease, including environmental, socio-economic conditions, biological and immunological fac-
tors. Furthermore, it explores factors attributable to TB transmission in congregate settings,
such as schools, households, public transport, health care settings and prisons. Finally it
explores the motivation for this project.
1.1 Tuberculosis historical trends
In 1882, a medical scientist in Germany, Robert Koch, discovered airborne infectious particles
viable with potential for TB infection, known as tubercle bacilli (Mycobacterium tuberculosis),
in his seminal line of thinking for the proof of tubercle bacilli as the main cause of TB [12].
He observed that infection began in the respiratory tract and concluded that tubercle bacilli
were mostly spread through the air [12]. Subsequently, work done by William Firth Wells,
in the 1930s, at the Harvard School of Public Health provided additional knowledge about
airborne transmission by suggesting that for the infectious agent to be transmissible, it should
remain buoyant in the air. Collaborating with Wells on a project conducted in the hospital
using a guinea pig model, Riley and colleagues provided more information to enhance our
understanding of the TB transmission scenario than any other prior project [59].
1
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Historically, it is believed that Mycobacterium tuberculosis, which causes TB, probably origi-
nated in Africa because the earliest branches of its phylogenetic tree (Mycobacterium africanum
and Mycobacterium bovis) are organisms that are found in Africa, and the earliest fossil records
of TB in human are from the continent. Additionally, it was noted that TB was highly estab-
lished in Africa and started to spread globally about 9000 years ago as people started to move
into different regions around the world, including America and Europe [8].
However, there is empirical evidence that TB was present in Europe during the middle ages
and during the 18th century, when a TB epidemic erupted in Western Europe. In 1740, the TB
morbidity rate was very high in London with approximately 900 deaths per 100,000 individuals
in the population [12, 13]. Furthermore, in 1882, Robert Koch, who discovered the tubercle
bacilli, reported that 1 in 7 deaths in Berlin was caused by TB.
In the 19th century the burden of TB in European cities began to diminish. This was demon-
strated by Davies and colleagues after obtaining British data from the General’s annual report
register. These data noted that in the mid-19th century there were approximately 300 deaths
per 100,000 population with a decline of 1.7% per year throughout the remaining period of
the century. Additionally, the same declining statistics were observed in the United States.
However, according to TB historical data, Europe and North America might still have had
a TB burden even though the prevalence was not well documented [13]. The TB burden in
Europe and North America started to diminish after the industrial revolution, associated with
improvement of social and economic conditions. Some scientists concluded that TB started
to diminish in Europe and North America due to the presence of a new generation with strong
immune systems which resisted TB. This hypothesis was opposed by other scientists who
claimed that TB diminished rapidly, while the new generation took a long time to be estab-
lished. On the other hand, McKeown postulated that TB diminished in Europe and North
America because nutrition was improved. According to the TB transmission environment, it’s
commonly believed that the disease is associated with poverty, for example, in 1988, Brudney
and Dobkin classified 224 patients who were discharged after 9 months from one of the hos-
pitals in New York City [8]. Of these patients, 82% were unemployed, 68% were homeless,
53% were alcoholic and 40% were HIV-positive.
According to TB historical data and statistics, whatever reason could be given for the TB
epidemic and decline, there is a contradictory debate in terms of empirical evidence, but TB
has remained a burden thought history in Europe and North America. TB remains one of the
most prevalent infectious diseases globally, which kills millions of people each year, especially
in Sub-Saharan Africa and South-East Asia as discussed in Section 1.2. This is briefly how TB
was discovered and started to spread globally while destroying the lives of millions of people
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worldwide. Knowledge of TB history is crucial in TB epidemiological studies because it helps
us to understand how TB infectious particles where discovered, how TB started to spread
globally and how it started to decline in some areas. Additionally, knowing the TB burden
globally is very important as it provides the big picture of the TB status worldwide and factors
potentially influencing TB prevalence, as discussed in the following section.
1.2 Tuberculosis global status
Tuberculosis is the major global health airborne infectious disease epidemic, which causes mor-
bidity and mortality for millions of people annually [84, 85]. While human immunodeficiency
virus (HIV) was the leading cause of mortality from infectious disease with 1.2 million deaths in
2014, TB was the second worst with 1.1 million deaths globally [84]. According to the World
Health Organization (WHO) statistics in 2014, there were approximately 9.6 million incident
TB cases and 1.5 million deaths, of which 1.1 million were HIV-negative and 0.39 million HIV-
positive co-infected with TB [84]. The latest estimate in 2015 shows that there were 10.4
million incident TB cases and 1.4 million TB deaths among HIV-negative and additional of
0.4 million TB deaths among HIV co-infected, showing that TB caused more deaths than HIV
in 2015 [85]. Though most of this TB morbidity and mortality occurred among men, perhaps
because of higher exposure, TB morbidity and mortality among women and children has also
been noted to be high [84, 85]. The degree of involvement in social and public activities differs
by gender in different countries and societies, which is why exposure probability to infectious
individuals differs for men and women [12]. Of 9.6 million incident TB cases in 2014, there
were approximately 5.4 million among men, 3.2 million among women and 1.0 million among
children [84]. In 2015, of the estimated 10.4 million incident TB cases globally, there were
5.9 million among men, 3.5 million among women and 1.0 million among children [85].
The TB burden can be measured in terms of the number of new and relapsed cases of TB
disease arising in a given period of time (incidence), the number of cases of TB in a given
population over time (prevalence rate) and the number of deaths caused by TB in a given
period of time (mortality rate). It can also be measured in terms of incidence of ill-health in a
given period of time such as per year (morbidity rate) [85]. According to the WHO statistics
in 2015, there were about 10.4 million incident TB cases (range, 8.7−12.2 million) globally
which equates to approximately 142 cases per 100,000 population [85]. This was distributed
as follows: 61% in Asia, 26% Africa, 7% Eastern Mediterranean Region, 3% European Region
and 3% in the Americas [85].
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The three countries with the highest number of incident cases worldwide in 2014, were India
with 2.2 million, followed by Indonesia with 1.0 million and the third country was China with
0.93 million [84]. In 2015, India was still leading with 2.84 million of incident cases followed
by Indonesia (1.02 million) and the third position was occupied by China (0.918 million)
[85]. India, Indonesia and China are the leading TB burden countries and together accounted
for 45% of the total number of incidence cases globally in 2015 [85]. In 2015, countries
with the highest TB mortality rate globally were India (0.48 million), Nigeria (0.18 million)
and Indonesia (0.1 million). The fourth position was taken by Bangladesh with 0.073 million
deaths, while China seemed to be out of top four in terms of mortality rate (0.035 million) [85].
According to WHO statistics, the burden of TB infection is very high globally and it is endemic
in developing countries, especially in South-East Asia and Sub-Saharan Africa [84, 85]. The
estimated annual incidence rate in Sub-Saharan Africa was over 255 per 100,000 population
in 2014, which shows that the TB burden is still high, though recent data demonstrates that
the incidence has declined [84]. Efforts to reduce TB infection rates could be a critical to
decrease the TB morbidity and mortality rates in regions with high rates of TB cases. Figure
1.1 shows estimated TB incidence rates globally in 2015.
Figure 1.1: Estimated TB incidence rates in 2015 (WHO global TB report 2016) [85].
HIV infection is a big challenge and has been significantly associated with TB [58], it has
increased the individual level risk of active TB incidence rate within the past few decades
[70, 80]. Numerous studies have reported that the risk of active TB among HIV-positive
individuals is higher than for HIV-negative individuals, due to high viral loads and low CD4
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counts in the former. However, the correlation between HIV and TB strains is not clearly
known and more research is needed. Currently it is estimated that the TB incidence rate
is approximately 20% higher among HIV-positive than HIV-negative individuals [70]. This
implies that the increase in HIV prevalence is highly associated with rapid increase in TB
documentation rates, especially in high burden settings, including Sub-Saharan Africa and
South-East Asia. The WHO estimated that 32% of TB cases were HIV co-infected in African
countries in 2014 [84] and 31% in 2015 [85]. More than 50% of TB cases with HIV co-infection
were from Southern Africa [83, 84, 85]. Overall, statistics show that the number of TB cases
with HIV co-infection is extremely high in African regions. There is empirical evidence that
patients with HIV-TB contribute to TB transmission in high burden settings, though they are
less often sputum-positive. According to WHO data, in most of the countries with high TB
prevalence, the high mortality rate is due to HIV associated with TB [80, 85]. The three main
impacts of HIV on the TB burden, is that it is highly associated with endogenous reactivation
if infected with MTB, it catalyses the progression from latent to active TB, and it acts as a
reservoir for TB transmission in the community.
Multi-drug resistant tuberculosis (MDR-TB) is a great challenge that fosters the spread of TB
and hampers the TB control effort globally [69, 78, 79]. Endemic transmission of MDR-TB is
attributed to several factors, including: prolonged period of infectiousness due to delay in MDR-
TB treatment, poor diagnosis and chemotherapy leading to improper MDR-TB treatment and
a large number of MDR-TB patients are not yet identified due to insufficient chemotherapy
susceptibility testing tools, which accelerates extensive drug resistance TB (XDR-TB) explo-
sion. Additionally, MDR-TB increases the risk of morbidity and mortality globally especially
for people living with HIV, due to compromised immune responses [79]. By definition, MDR-
TB is resistant to the first line drugs Isoniazid and rifampicin while XDR-TB is resistance to
Isoniazid, refampicin, and to any fluoroquinolone, as well as to at least one of the second line
injectable drugs, including kanamycin, amikacin and kapreomycin. Countries with high preva-
lence of MDR-TB include India and China, which together account for about 50% of MDR-TB
patients globally [69]. In 2015, it was estimated that there were 580,000 (520,000−640,000)
incident cases of MDR-TB globally [85]. Furthermore, the WHO statistics show that there
were 250,000 (160,000− 340,000) deaths from MDR-TB in 2015 [85]. Generally, it shows
that MDR-TB and HIV co-infection are among the barriers hindering TB control strategies
towards the WHO target of eliminating TB [80, 82, 83, 84, 85].
Section 1.3. TB transmission in Cape Town and South Africa in general Page 6
1.3 TB transmission in Cape Town and South Africa in
general
1.3.1 Cape Town
Cape Town is one of the major South African cities with a population of about 3.2 million
residents in 2006, of which 27,000 were TB cases [97]. Additionally, in 2006, TB annual
notification rates where documented to exceed 1,500 per 100,000 population in urban high
density settlements [55, 101]. In 2009, the city of Cape Town had approximately 3.4 million
people, of which about 30,000 were new TB cases as documented by the national TB control
programme [102]. The TB notification rates in Cape Town are extremely high between the
ages of 20 and 40 years, which might be fuelled by high prevalence of HIV in those age groups
[29]. However, new TB cases among HIV-negative individuals were also found to be very high,
at 386 per 100,000 population. Children and young adults were found to be infected with
the ratio 511 per 100,000 population and 553 per 100,000 population, respectively. Latent
TB prevalence for children and adolescents in Cape Town is high at a prevalence of 20% for
children of school going age. The annual rate of infection increases from approximately 4%
per year in childhood to 7% per year in adolescence, and TB infection prevalence rises to
80% during the young adult age [103]. Childhood (0−15 years) TB notification rates in high
burden Cape Townships have been noted to be 3.5 times the adult rate, where childhood TB
accounts for 39% of the total prevalence [97]. Thus a large proportion of the population in
Cape Town acquire TB infection and develop active TB before reaching adulthood [100]. It
is not well understood in which specific locations TB transmission occurs, though empirical
evidence shows that infections mostly occur in congregate locations outside of households
[72, 111].
It has been noted that rebreathed air volume (RAV) that is associated with the transmission of
airborne infectious diseases is very high in township adolescents [100]. A number of TB cases
have been identified in townships with a high concentration of carbon dioxide as a surrogate for
expired air, which reflects the dispersal of airborne infectious particles [98, 92]. According to a
study conducted by the Desmond Tutu HIV Centre in Cape Town, when the concentration of
carbon dioxide is high, the risk of acquiring airborne infectious disease, such as TB, increases
[100]. The annual risk of children and adolescents in townships is remarkably high. Currently,
it is estimated that 5% to 8% of adolescents become infected in townships annually [98, 100].
Since the concentration of exhaled air is reasonably high in townships, some of which is derived
from infectious sources, it might be one of the key factors that accelerate TB transmission in
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these areas [92].
Since Cape Town has high HIV and TB prevalence, the national programme launched an-
tiretroviral therapy (ART) in the city for all HIV-infected individuals with CD4 counts below
200 cells/µl in 2004 [107]. ART reduces TB risk by two-third, depending on time and CD4
counts with the fact that the risk becomes high for individuals with low CD4 counts [28]. In
2013 ART became available for individuals with 350 cells/µl and 2015 for those with 500
cells/µl and currently, more than 130,000 people in Cape Town have been initiated on ART
[107]. Over the last 10 years, HIV control programme in the city of Cape Town has substan-
tially advanced with identified HIV and TB co-infection notification rates. Furthermore, ART
coverage has increased from 0 to 63% in nine years and TB notification rates continue to be
high. Over the last three years, TB notification rates in Cape Town declined for approximately
16% in both the HIV-positive and the HIV-negative individuals after ART initialisation [107].
1.3.2 South Africa
South Africa has one of the highest TB notification rates in the world with approximately 1%
of the population developing active TB annually [80, 100]. In 2011, WHO data demonstrated
that South Africa had an incidence of 500,000 cases of active TB. Hence, about 1% of the
population of approximately 50 million people develop active TB disease each year, implying
that the incidence has increased by 400% over the past 15 years [80]. Fuelled by high HIV
prevalence, the TB notifications in South Africa have increased 6-fold over the last two decades
[82]. It is estimated that South Africa accounts for 25% of HIV associated TB globally [80].
Of 500,000 incident cases in South Africa, WHO estimated that about 330,000 (66%) people
have both HIV and TB infection. TB is the leading cause of death from infectious diseases
in South Africa. In 2011, WHO estimated that there were 25,000 deaths from TB in South
Africa, excluding the death of people with both TB and HIV. This is because people who die of
both TB and HIV, internationally are regarded as HIV deaths. One of the facts which identifies
South Africa as among the countries with the highest burden of TB globally is that in 2007,
there were 461,000 new cases of TB infection while the total incidence rate was approximately
948 per 100,000 population, of which the prevalence of HIV-positive associated TB infection
was approximately 73% [98]. This implies that much of the burden of TB in South Africa can
be attributed to HIV infection, which weakens the immune system, enabling airborne infectious
particles to penetrate easily to the lungs, causing TB infection and active TB disease.
Though TB diagnosis and treatment have been improved, South Africa had an incidence
greater than 1,000 per 100,000 people in 2012, which is highly associated with HIV prevalence
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[113]. Besides the HIV epidemic in South Africa, TB transmission is highly associated with
overcrowding, as the urban areas in the country, including the city of Cape Town, are extremely
overcrowded. In this environment, many of the susceptible individuals become exposed and
acquire TB infection easily [49]. In rural areas, most of the houses are poorly designed with
inadequate natural ventilation, which creates a good environment for TB transmission [68].
Tobacco smoking is undoubtedly one of the risk factors influencing TB prevalence, and there
is empirical evidence that smokers have a higher risk of developing and dying from TB than
non-smokers [25, 30, 43, 70, 115]. Nicotine, carbon monoxide, tar and cyanide are some of
the harmful chemicals contained in tobacco cigarettes, which cause TB susceptibility and lung
cancer. These chemicals, especially nicotine in tobacco cigarettes, are drugs which mainly
affect the brain and nerves, and cause addiction. The WHO and the International Union
Against Tuberculosis and Lung Disease joint report demonstrated that exposure to tobacco
smoke is significantly associated with TB infection and disease. Several studies have noted
that the rates of TB infection, disease and mortality were significantly higher among smokers
than non-smokers, thus confirming this [70]. For example, a study conducted in Rio de Janeiro,
Brazil, observed that TB mortality among smokers was about twice that of non-smokers [25].
Statistically, there are approximately 1.3 billion smokers and more than 5 million deaths per
year attributable to tobacco smoking globally. In South Africa, there are approximately 7
million smokers, with a reasonably high prevalence of 20% [115]. Since South Africa has one
of the highest burdens of TB, tobacco smoking might be one of the risk factors attributable
to TB infection and disease, though HIV is still the major risk factor. Currently, the mortality
among smokers in South Africa is approximately twice that of non-smokers. Almost a third of
all male deaths in South African adults over the age of 35 years have recently been attributed
to tobacco smoking [115]. It has been documented that the group classified as Coloured
has the highest smoking prevalence in South Africa. The estimated smoking-related mortality
among Coloured individuals is 50% higher than for black or white smokers and ex-smokers
[115]. Tobacco smoking is also associated with the world’s top five causes of death, which are
lung cancer, pneumonia, stroke, ischaemic heart disease and chronic obstructive pulmonary
disease (COPD) [25, 43, 70, 115].
Alcohol is yet another factor contributing to TB transmission in households for those who abuse
it [54]. In 2004, it was documented that 3.8% of TB deaths globally were associated with
alcohol abuse [54, 70]. Furthermore, it has been noted that TB among heavy alcohol drinkers
is about 3 to 4 times higher than in non-drinkers or controls. For example, studies conducted
in Australia, Canada, Russia, Switzerland and the USA, demonstrate that the prevalence of
alcohol abuse among TB cases ranged from 10% to 50% for persons who consume more than
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40 g or 50 ml of alcohol per day [54]. The actual causes of TB for alcohol abusers include
social mixing with other alcoholics as well as the alcohol itself, which weakens the immune
system and influences TB susceptibility, leading to a high risk of TB infection and disease.
Furthermore, there is empirical evidence that alcohol is highly correlated with tobacco smoking
and sometimes drug abuse, which are undoubtedly associated with TB infection and disease
susceptibility for users and people with second hand exposure [30, 43]. Hence, it is plausible
to conclude that alcoholics, smokers and drug addicts, are some of the sources contributing to
the explosion of TB infection and disease in South African communities. However, there are
some groups in the community which are more vulnerable to TB acquisition, such as children
and adolescents due to factors discussed in the following section.
1.4 Age distribution, children and adolescents
TB transmission mostly occurs among individuals who spend long periods of time in the same
enclosed space or dwelling with a TB infectious individual [68], for instance inmates in prisons
and students in schools. Usually, TB infectious individuals will behave in a similar manner to
uninfected individuals in the community and thus they cannot be identified easily by physical
appearance. Since it is commonly known that people are used to socializing with others of
their own age, this implies that the risk of TB infection varies considerably with age and TB
prevalence [11]. From findings in recent years, it has been noted that the risk of infection in
children and adolescents underestimates the actual risk of infection in the community because
public health has not yet concentrated on these age groups [44]. In industrialized countries,
the prevalence of TB infection has been observed to be high among the adults, while in other
countries such as Latin America, Sub-Saharan Africa and South-East Asia, the prevalence of
TB infection is high among young economically productive people of reproductive age. This
implies that TB is becoming less of a public health problem in industrialized countries due to
rapid decrease in prevalence of TB infection among children and adolescents, while in other
parts of the world TB is still a critical problem with high prevalence among children and young
adults [12].
The WHO statistics in 2011, demonstrated that every year there are approximately 0.5 million
TB cases and 64,000 deaths among children globally [80]. However, WHO also noted that
estimating the burden of TB in children (aged < 15) is difficult and might be underestimated.
Some of the reasons for underestimation include: childhood treatment for TB outside of
national TB programs (NTPs), lack of routine recording and reporting of childhood TB cases
by some NTPs, difficulties with access to health care for TB diagnosis and clinical similarities
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with other common childhood diseases. Most of the NTPs focus on reporting the number of
adults who have been identified or treated, who have smear-positive TB, and who are mostly
considered as a source for TB transmission to children. They keep in mind that even if children
are diagnosed, they are often smear-negative, and are not included in reports. But in reality,
children are at high risk of acquiring TB infection because their social contacts, interaction
and social mixing are extremely high in the community. Social interactions are key to the
transmission dynamics of TB in the community [11].
TB control programs demonstrate that adolescence is the period in which TB incidence in-
creases, though there is little investigation into prevalence of TB infection in this age group.
TB transmission mostly occurs in crowded areas, such as schools, where students stay in
enclosed rooms for a long period of time. This implies that most of the children and adoles-
cents become infected in the school environment and they may develop TB disease while still
at school [44, 92]. Thus, children and adolescents are at high risk of TB infection and the
probability of infecting others is extremely high due to social contacts, interactions and social
mixing in the community [11, 55].
Of all available immunological tests, the tuberculin skin test (TST) has been widely used
for TB diagnosis in the community, especially in low TB prevalence settings. A recent study
conducted in Cape Town using a cut-off of ≥ 10 mm diameter of induration as epidemiological
evidence of latent TB, found that a fifth of children at school entry were already infected [98].
This implies that approximately 50% of adolescents in the community were infected by an
average age of 15 years, and about 75% of individuals had epidemiological evidence of latent
TB by the age of 25 years, which is when the prevalence of HIV peaks in South Africa [98].
Childhood TB notification declines rapidly after the age of 5 years until the childhood stage
between 10 and 14 years, despite the continuation of a high annual TB infection rate. This
scenario has been widely recognised in epidemiological studies but it is not well understood,
and further research is needed to clarify this, though immunological response might be a major
factor [55, 98]. After 10-14 years of age, TB notification rates increase rapidly to a second
peak at age 20−24 years. These two peaks occurred throughout 100 years of TB notification
in Cape Town data [108]. The second peak represents the continuation of the TB epidemic as
measured by the number of notified cases. It has been documented that most of the children
become infected by elders either in their households, schools or public transport as discussed
below.
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1.5 TB transmission from adults to children
Childhood is one of the age groups in the community which is highly vulnerable to TB infection
and disease due to high exposure in social mixing and weak immune response [78]. It is
estimated that of 9 million people who develop TB disease annually, 11% are children of < 15
years, and 75% of these childhood TB cases occur in 22 countries of high TB burden, which
account for 82% of the world’s estimated incidence cases annually.
Most of the children in the community acquire TB infection from adults with active TB disease
either in households, public transport, schools or social mixing [97]. Therefore, TB infection
risk for children mainly depends on the infectious adults in the community [20]. Children have
prolonged contact in poorly ventilated dwellings and share sleeping quarters with adults who
are assumed to be a source of TB transmission among children [57]. From a physiological point
of view, children breathe heavily, inhaling amounts equivalent to the weight of the body. Since
children are highly exposed during social mixing, they inhale a large quantity of rebreathed air
from adults that contains airborne infectious particles, and develop active TB 12 months from
the period of exposure [49], or even earlier, depending on the immune system. In addition,
WHO reported that the probability of children of < 10 years of age progressing to disease after
exposure is extremely high, especially in children of 0− 4 years of age, due to an immature
immune system [78].
WHO reported that the End TB Strategy that builds on the directly observed treatment short-
course strategy (DOTS) has a critical role to play in reducing the burden of TB globally in
order to save the lives of children. Quantitative TB infection in children is highly related to the
adult TB prevalence in the community. Since infectious adults are a source of TB transmission
to children, if TB can be reduced among adults then children might be safer. Children who
are at a higher risk of getting TB include those living in the same household with infectious
individuals, children less than 5 years old, children with HIV infection and children with severe
malnutrition. TB transmission is a big problem that needs to be solved by applying alternative
scientific approaches. In the following section we introduce TB transmission mechanisms and
properties of airborne infectious particles, which cause airborne infectious diseases.
1.6 TB transmission mechanisms
Droplets produced by TB patients either by talking, coughing, sneezing or singing may con-
tain airborne infectious particles, which cause TB infection in other susceptible individuals
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who become exposed [33]. Droplets may evaporate to the size of infectious droplet nuclei
by containing either one or more airborne infectious particles which become suspended in a
confined space for a long period of time. However, there is a critical diameter of droplet nuclei
containing airborne infectious particles which maximizes the probability of inhaling infectious
particles and which create the TB infection environment. An experiment conducted by Sonkin,
demonstrates that many particles with diameter greater than 5µm are trapped in the nose,
whereas those smaller than 5µm become suspended in air and can reach the alveoli and cause
TB infection [12]. Thus, he drew the conclusion that the critical diameter of the droplet nuclei
containing airborne infectious particles with high probability of causing TB infection ranges
from 1µm to 5µm in order to penetrate and reach the target infection site of the person
and cause TB infection. The infectious droplet nuclei which are the critical size for reaching
the target infection site are the primary source of Mycobacterium tuberculosis transmission.
However, even if airborne infectious particles do manage to reach the target infection site, they
must overwhelm the immune defenses of the person to commence infection [74]. Hence, when
a susceptible individual becomes exposed to airborne infectious particles, that person may
be infected or not depending on the threshold level and infectivity strength of the airborne
infectious particles to dominate the immune defenses of the person.
The main factors which determine the probability of TB transmission particles include the
number of incident infectious individuals, duration of exposure and proximity to infectors or
modes of interaction between infectious and susceptible individuals in the community. If the
proximity of a susceptible to an infector is ignored, then the probability of an individual to
acquire TB infection is primarily dependent on the duration of exposure to the infector [24]. If
the concentration of airborne infectious particles in the room is high, the duration of exposure
before infection occurs will be short. If airborne infectious particles concentrations are low,
the safe exposure duration will be much longer. This is because TB infection depends on the
threshold concentration and number of airborne infectious particles required to dominate the
immunological state of the host [74].
As discussed earlier, the number of people who might be infected with airborne infectious
particles that cause TB, given that there are a number of infectious individuals in the commu-
nity, will depend on the duration of exposure, number of infectious droplet nuclei that contain
airborne infectious particles per air volume and manner of interaction between infectious and
susceptible individuals [12, 49]. Duration of exposure is defined as the time individuals spend in
a confined space with the probability of being infected if there is an infectious individual. The
word exposure can be defined as contact interaction between two or more individuals within
confined spaces where the environment of the given space can trigger infection for susceptible
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individuals [80]. Extensively high exposure mostly occurs among persons who share the same
dwelling or who spend long periods of time in enclosed spaces with an infectious individual.
In overcrowded areas such as townships, prisons and schools, where duration of exposure is
long, the number of TB transmission particles is also extremely high, so the number of people
who could be exposed to a single infectious individual is high [109]. However, in rural areas
the situation is not as critical because the number of people who become exposed to a single
infectious individual is smaller than urban areas as rural areas have low population density. In
addition, regardless of rural areas or urban areas, TB transmission depends on the population
density in the household, nature of the dwelling and interactions which trigger the risk of
exposure, provided that there is an infectious individual in the given household. Therefore,
population density plays a big role in the transmission of tuberculosis in the community.
Duration of exposure sometimes depends on the weather and climatic conditions, for instance,
during winter the duration of exposure is very high because most people prefer indoor activities
and stay in confined spaces to maintain body temperature. In some countries, such as northern
Europe, which have long, cold winters, outdoor social activities are scarcer than in warm
climates [12]. Airborne infectious particles expelled indoors by an infected person in a confined
space are retained and evenly distributed anywhere in poorly ventilated spaces, which causes
infection over a long period of exposure [12]. Thus, if individuals enter that confined space,
they may become infected even if an infectious individual has left, depending on the duration
of exposure and their immune system. However, airborne infectious particles disperse rapidly if
expelled outdoors and die quickly because they become exposed to high air flow and ultraviolet
irradiation from the sun [11]. This implies that TB transmission particles spread more rapidly
in cold climates than warm climates because outdoor social activities are reduced due to the
cold, and indoor ventilation becomes poor since windows are kept closed for a long period of
time. This affects duration of exposure. TB infection and disease progression are discussed in
the following section.
1.7 TB infection and progression to disease
There are two major clinical states of TB, latent TB and active TB disease. Latent TB can
be categorised into early, late and reinfection latent TB, whilst active TB can be divided into
drug susceptible, drug resistant and extensively drug resistant. When a susceptible individual
is infected by airborne infectious particles, they usually cause latent TB and if that infected
individual does not receive medication, he/she may develop active TB disease. However,
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some susceptible individuals become infected and develop active TB very quickly, depending
on the virulence of infecting pathogen strains and immunological state of the host. Both
clinical states of TB can be treated if medication is taken immediately after TB diagnosis
[12]. Additionally, a person with latent TB usually does not feel sick and cannot spread TB to
others, while someone who has developed active TB disease is sick and spreads TB to others
who are exposed for a prolonged period of time in a confined space.
It is very easy for susceptible individuals with a weak immune system to be infected and develop
active TB disease, while those with an effective response and active immune system can be
infected but not progress to active TB disease because the immune system will fight off the
pathogen. If a person becomes infected and doesn’t develop active TB disease then they
can remain latently infected whereby TB infectious particles become dormant in the body but
rapidly replicative and therefore cannot cause infection to other people as mentioned above.
The lifetime probability of a person with latent TB developing TB disease is about 5−10%,
depending on the host immune system and the virulence of the infecting pathogen strains
[33]. However, both latent TB and active TB disease may progress to critical illness or death
if preventative medication is not taken.
In addition, a person with latent TB can develop active TB disease if he/she didn’t take
medication to prevent accumulation of pathogens in the body. A person with active TB is
contagious and can cause infection to other people especially in overcrowded locations with
low per person ventilation, such as public transport, prisons and schools [44]. However, since
TB spreads through air, it can infect any person who lives in proximity to infectious individuals
regardless of age, sex or socio-economic status.
TB symptoms may include coughing that may last for a minimum of three weeks, fever, night
sweats, haemoptysis, chest pain, weakness, and weight loss. A person with latent TB will be
advised to take 1 medication for 6 to 9 months while those with active TB disease should take
3 to 4 medicines for at least 6 months in order to recover and avoid infecting others.
1.8 TB diagnosis
There are numerous TB diagnostic tools which are currently used as tests for TB. Some of
these tests can be used to determine if someone has a latent infection, while others are used to
identify if an infected person has progressed to active TB. Some TB tests can also determine
if someone is infected with drug susceptible or drug resistant TB [14]. These are known as
drug susceptibility tests. Though several types of TB tests exist, TB diagnosis is still difficult
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even if someone has TB symptoms, as some of the tests are not sensitive or specific, resulting
in a delay in obtaining results. These can lead to false positive results, where the test suggests
someone has been infected while he/she is not, and false negative results, in which the test
indicates that a person is not infected while in reality he/she is.
Latent TB diagnostic tools include the Tuberculin skin test, Interferon Gamma Release Assays,
Sputum smear microscopy, Fluorescent microscopy and Culture TB test. The most accurate
TB test is the TB culture test. Culturing is a method of studying Mycobacterium tuberculosis
(MTB) by growing them on media containing nutrients [14]. Culture can provide drug sus-
ceptibility and multi-drug resistance testing by indicating which TB drugs are susceptible and
which are resistant to observed MTB in a particular TB patient. However, TB diagnosis by
using culture can take long time (approximately 2 to 6 weeks) because of the slow growth of
TB bacilli [114]. Furthermore, some of these TB diagnostic tools, including TB culture test are
complex and expensive with highly advanced technology, which require advanced laboratory
tools and well trained operators [14].
The Expert MTB/RIF assay is a new test that seem to bring hope and revolution in TB
control by detecting both MTB and drug resistance to rifampin (RIF) simultaneously in a
short time (less than 2 hours) [14, 114]. The Xpert MTB/RIF assay is an automated nucleic
acid amplification test that uses a disposable cartridge with the GeneXpert instrument system.
A sputum sample collected from an infected individual is mixed with the reagent provided
with the assay and a cartridge containing this mixture is placed in the GeneXpert machine for
detection [114]. The advantage of Expert MTB/RIF assay over other diagnostic tools, such
as culture is that it provides results quickly and it requires minimum training to run the test
[14, 114]. Since 2010, Xpert MTB/RI assay is the only rapid diagnostic test for detection
of TB and rifampicin resistance recommended by WHO, particularly in high TB settings with
burdens of HIV and MDR-TB [84, 85].
Active TB can be detected by a chest x-ray, though these are expensive in some countries with
limited resources. TB diagnosis has remained a big challenge since there is no 100% specific
TB diagnostic tool that can provide significant results, and there is no a specific diagnostic
tool that can be used for both latent TB and active TB diagnosis simultaneously [14, 84].
1.9 TB transmission in schools and attributable factors
School is one of the identified settings with high TB transmission in South Africa [44, 92, 97].
It is estimated that 39% of children (0− 15 years) in South Africa have been infected [97].
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A large number of children have been infected and some developed active disease at a young
age due to factors correlated with their daily life and a TB transmission environment. Since
children and adolescents are at a high risk of acquiring TB infection and disease, TB incidence
in South Africa continues to increase annually despite the fact that TB treatment completion
improved from 40− 74% between 1995 and 2011 [82]. With a TB prevalence of 427 per
100,000 in schools and the large amount of time they spend indoors, adolescent students are
at a high risk of acquiring TB infection and disease [82, 113]. Since students spend 30% of
their daytime in schools, exposed to this infectious environment, it means that the likelihood
of acquiring infectious disease, such as TB, is remarkably high.
Out of 30% of daytime they spend in schools, students and teachers spend about 97% of
the time in confined spaces, with 80.2% of the time indoors used for interaction and social
contacts. Since many schools are overcrowded with low per person ventilation and students
spend long time periods in confined spaces with a high concentration of polluted air, they are
at a high risk of acquiring TB infection in school. Furthermore, since 50% of TB transmission
for children and adolescents occurs in schools [113], this implies that the effective contact rate
that influences the force of infection is very high in schools.
Apart from school, a large number of students spend 1% of their time each day in public
transport, such as minibus taxis, buses and trains to commute between school and home.
These students become exposed to indoor air pollution by inhaling rebreathed air from elders,
which could contain airborne infectious particles. As discussed earlier, it is estimated that
80% of the population, particularly elders in South Africa, have already been infected, thus,
if students share re-breathed air with elders in confined spaces, the probability of acquiring
TB infection is very high [90]. Furthermore, students spend 4% of their daytime in other
social mixing environments, such as churches, visiting friends in their houses, or work places,
where TB transmission probability may be high, depending on social contacts, interaction and
environmental exposure [87, 95]. Through all these locations, and interaction with classmates
at school, students may get infected by inhaling droplet nuclei, which contains MTB, and
develop active disease. Statistically, it shows that a large number of students get TB infection
and develop TB disease in the school environment because of high interaction and duration of
exposure in confined spaces. Here, we explore some factors correlated with TB transmission
in school transport as discussed in the following section.
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1.9.1 TB transmission in school transport
School transport seems to be among the problematic areas attributed to TB transmission in
schools. Some schools in South Africa, especially private schools, provide transport, such as
minibus taxis and buses, which take students from home to school and back again. However,
often drivers in these vehicles are randomly employed, provided that they have valid driving
licences and experience, they are not required to pass a health test (medical check up), such
as tuberculin skin test (TST) or chest radiography screening to examine whether they have
latent TB or active disease. If at least one or all school transport drivers is infectious, it
means that most of the students can be infected because they become frequently exposed to
the infectious individual in a confined space [90, 104]. Hence, TB transmission is assumed to
be remarkably high during school transport due to exposure to infectors [90, 104, 113]. For
example, in New York, it has been reported that approximately 60% to 80% of students who
were exposed to 5 infectious school bus drivers for a period of 6 months had positive TSTs
[104]. This implies that school transport drivers are one of the sources of TB transmission in
schools because if at least one of the students is infected in the vehicle, it means that other
students also become exposed [72, 104].
Since South Africa has one of the highest TB prevalences, a large number of the school
transport drivers have probably been infected, so students are at a high risk of acquiring TB
infection and disease [90, 113]. TB transmission from school transport drivers to students is
estimated to be extremely high, especially during winter, when windows remain closed and
concentration of exhaled air that contains airborne infectious particles becomes very high
indoors.
1.10 TB transmission in households
TB transmission occurs in different locations in the community, including the household, where
members of the family spend up to 68% of their time in the same dwelling after outdoor social
activities and during the night. Thus, if there is an infectious individual among the household
members, it means that the duration of exposure is extremely high and the probability of being
infected for susceptible individuals in the household is high.
Natural ventilation is a problem in most buildings either in urban or rural areas, which leads
to creation of an effective TB transmission environment. This is because most of the houses,
especially in rural areas are poorly designed and constructed so that natural ventilation is
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insufficient [37]. For example, some houses commonly known as shacks in the Western Cape,
South Africa rural areas, have been poorly designed and constructed so that air circulation
is limited, which fosters indoor air pollution that is associated with the spread of airborne
infectious disease [68]. Though ventilation is not one of the most effective interventions for
TB control, when air change per hour (ACH) decreases in the room, the probability of being
infected becomes significantly high due to accumulation of carbon dioxide, which reflects
dispersal of airborne infectious particles [66].
Poverty is another factor that contributes to TB transmission in households, particularly in
developing countries. When some members of the household get infected, they cannot always
access health care centres due to socio-economic problems, for example, lack of money for
TB diagnosis and chemotherapy or transport to reach the hospital [61]. Thus, if one person
in the household has been infected and cannot access health care, that person develops TB
disease due to lack of treatment and other members of the household become exposed and
may get infected. Additionally, poverty is highly associated with malnutrition due to lack of
a balanced diet with nutrients that improve and strengthen the immune system to combat
pathogens [70]. For persons with malnutrition, the immune system is weak and if they acquire
TB infection, they develop active disease in a short period of time.
Overcrowding is also a key contributor to TB transmission in households [58, 61]. For example,
it was found that TB transmission in New Zealand was highly associated with overcrowding
in households [61]. In this scenario, a large number of people sleep in a single confined
room, sharing re-breathed air, where susceptible members of the family become exposed and
infected if there is an infectious individual among them. Baker et al (2007) [61] suggested
that in order to reduce TB transmission in households, TB control programmes should include
strategies to reduce crowding in the home. Generally, extensive exposure to infector(s), high
population density and low income communities lead to a greater likelihood of TB transmission
in households [79]. However, some studies found that people living in the same household
do not always have the same infective strain of MTB. For example, in one of the studies it
was noted that 55% of those from the same household had different infective strains [72]
and another study found that only 19% of TB transmission occurs in households [111]. This
implies that TB transmission occurs from both outside and inside households.
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1.11 TB transmission in public transport
Public transport, including buses, minibuses and trains, is another problematic system that is
associated with TB transmission, especially in countries with high TB prevalence, such as South
Africa [90]. For example, Two studies conducted in Lima, Peru, demonstrated that people
who commute by public transport have a 4.09−4.9 fold higher risk of acquiring TB infection
and disease compared to private forms of transport [35] and concluded that there is a high risk
of getting TB when commuting for ≥ 1 hour in public transport. TB transmission in public
transport is mainly attributable to social contact, interaction, poor ventilation and proximity
to an infector. The number of people and duration of exposure are linearly distributed with
the risk of TB transmission by the fact that the concentration of exhaled air becomes higher
as the number of occupants and duration of exposure increase in the space [7, 46]. Given
the presence of infectious individuals in this polluted environment with high concentration of
exhaled breath, high duration of exposure and proximity to infectors, TB transmission risk is
high in public transport.
In South Africa, the basic means of transport are minibuses, buses, trains and private forms
of transportation. About 43% of South Africans, including adults and children, use public
transport as a basic means of transport. However, these modes of public transport tend to
become extremely overcrowded [48], particularly in the mornings and evenings when workers
and students commute to and from jobs and schools. With the high prevalence of TB in
South Africa, there is a high probability of presence of at least one infectious individual on
every route for each mode of public transport.
Minibuses accommodate a small number of passengers (about 18), but susceptible individuals
are at a very high risk of TB infection given the presence of an infectious individual. This
is because the concentration of re-breathed air that may contain airborne infectious particles
becomes very high in a small confined space, with insufficient ventilation. Buses have a
larger space and carry a larger number of passengers than minibuses, but due to a large
number of commuters at certain peak times, the buses often carry as many as twice the
recommended number of passengers. Overcrowding, poor ventilation per person, interaction
and reasonable proximity to infectious individuals in the buses create a conducive environment
for TB transmission.
In South Africa, some areas have neither buses nor minibuses and the community depend only
on trains for daily commuting. Furthermore, some people prefer trains to buses or minibuses
even if the routes exist, believing that the train is safer and cheaper than any other means of
transport. Though trains have many large carriages, overcrowding is a critical problem due to
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the large number of people who use this mode of transport in South Africa, especially during
peak hours. Long periods of cold weather in South Africa are a challenge, particularly during
winter where trains act as enclosed spaces, since all windows are kept closed to conserve the
heat. The vehicle acts as an enclosed space if windows are kept closed and the passengers
breathe heavily depending on the body mass, respiratory quotient and oxygen consumption,
leading to a high accumulation of carbon dioxide [7]. This accelerates TB transmission proba-
bility due to high accumulation of re-breathed air, some of which is derived from an infectious
source.
Carbon dioxide is among the most diffusible tracer gases that is used to measure the indoor
air quality [7, 46]. According to a study conducted in South African cities, particularly in Cape
Town in 2011, it was noted that the lowest level of carbon dioxide was 1,000 ppm in trains,
1,150 ppm in buses and 1,800 ppm in minibuses [90]. These values demonstrate that minibuses
have the highest risk environment to foster TB transmission due to high accumulation of carbon
dioxide. This might be attributed to the small space of the vehicle and large number of routes
conducted by the minibuses per day compared to other modes of public transport.
The high prevalence of TB in South Africa increases the already high risk of acquiring TB
infection and disease for susceptible individuals who commute twice a day, 5 days a week,
due to high exposure, contacts, interactions and social mixing in confined spaces. Drivers
and fare-collectors are highly exposed individuals as they commute daily for a long period of
time, interacting and mixing with many different infectious individuals [48]. Furthermore, this
group is unlikely to go for diagnosis and they only seek care after the disease has progressed,
perhaps because they don’t have adequate education about infectious diseases, have limited
time available, or they can’t see the importance of getting tested for TB. This might be one of
unidentified sources that led to the eruption of MDR-TB and a high rate of TB transmission
in the community.
1.12 TB transmission in health care settings
TB transmission has been noted in different health care sections, including autopsy rooms
and hospital wards [4, 58]. Health care workers, including nurses, doctors and pharmacists
are at a high risk of acquiring TB infection and disease, because of frequent interaction and
contact with infectious individuals during provision of health care services and facilities. Several
studies have demonstrated the spread of TB infection and disease among nurses and medical
students. For example, a study conducted in 1924 in Oslo, Norway, by Heimbeck, noted
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that from 220 tuberculin-negative tests from 420 nursing students on entry into the degree,
210 (95%) became tuberculin-positive by graduation [2, 4]. Furthermore, in his 1946 work,
Heimbeck demonstrated that 105 (37%) of 284 nurses who were initially tuberculin-negative
became infected and developed TB disease [4]. Based on these findings, he concluded that
nurses are at excessively high risk of acquiring TB infection and disease.
Apart from Heimbeck’s work, numerous other studies have reported higher rates of TB trans-
mission risk among nurses than the general population, and one of the studies concluded that
the risk of developing TB among nurses was 500 times higher than the general population.
Another study in 1953, noted that the risk of developing TB for hospital workers in contact
with patients, including nurses and technical workers, such as doctors is 8 to 10 times higher
than other workers in the same institution without such contact [4]. Numerous studies since
then, including empirical evidence demonstrated by Myers et al (1930) [2] also show that
health care workers, such as nurses and doctors are at a high risk of acquiring TB infection
and developing clinical disease in their working environments. The main reservoir and spread
of TB strains among health care workers is not clearly understood, however, several factors
and conditions are attributable to TB transmission in heath care settings as discussed in the
following section.
1.12.1 Factors associated with TB transmission in health care set-
tings
The risk of TB transmission among health care workers is attributable to numerous factors,
including interaction with active TB patients seeking treatment, some of whom are multi-drug
and extensive-drug resistant TB individuals. Because of a prolonged period of unsuccessful
treatment, multi-drug and extensive-drug resistant TB strains are among the key factors ac-
celerating TB infection and disease in health care settings. The source of multi-drug and
extensive-drug resistant strains is unknown but an increasing number of drug resistant TB
patients in health care settings is attributable to poor diagnostic tools in some centres, late
identification of TB cases and insufficient treatment or incomplete doses.
Furthermore, unidentified TB cases and HIV co-infection in TB individuals are additional
factors that drive TB transmission in health care settings. In these scenarios, the probability
of acquiring TB for health care workers is often higher because excessive precautions are not
taken before exposure to infectious individuals. However, even if these cases are identified,
some health care centres cannot afford protective devices, so health care workers provide
services and interact with TB cases without wearing respiratory protective devices, such as
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surgical masks and particulate respirators. Since TB transmission mostly occurs through
talking, coughing, sneezing or singing by infectious individuals who expel airborne infectious
particles into the air [40, 47], health care workers become exposed and inhale these airborne
infectious particles, which can commence with infection. Furthermore, since the concentration
of airborne infectious particles increases dramatically in the given space with increasing duration
of exposure, health care workers may become infected depending on the proximity of staff
offices to TB wards, exposure frequency, interaction with TB patients and strains of airborne
infectious particles. TB transmission probability in ambulances during transportation of TB
infectious individual is also reasonably high for health care workers [58]. This is exacerbated
if engineering controls are not working properly in the ambulance and if personal protective
devices used are not effective enough. Therefore, health care workers can have a high risk of
TB infection and disease in different locations related to their working environments.
Apart from health care workers, susceptible patients, such as HIV infected individuals and
children, are at high risk of acquiring TB infection and disease in the hospitals because of
sharing environments and thus expired air with TB patients. Due to either overpopulation
or limited ward rooms in some health care settings, particularly in developing countries, HIV
infected and TB cases are admitted to the same ward and share exhaled air, some of which is
derived from infective sources. This is one of the factors fostering the spread of TB co-infection
with HIV in health care settings and the community at large. As mentioned earlier, since they
don’t receive treatment, unidentified HIV-negative TB patients are an additional threat in
health care settings and in the general population [105]. Since they are not yet identified as
cases for treatment and interact with people in different locations in the community, this group
may also be among unidentified sources of multi-drug and extensive-drug resistant strains in
the community [5].
Poor infrastructure is a key factor fostering TB transmission in health care settings, particularly
in high TB settings, such as Sub-Saharan Africa and South-East Asia, where health care
buildings are of poor quality and can accelerate the transmission of infectious diseases. As
mentioned earlier, because of limited income and support for renovation and new building
construction, TB cases are not isolated in most of health care settings, especially in developing
countries. TB transmission in this sector is highly correlated with high concentration of air
pollution, poor air disinfection and high prevalence of TB cases in the region. Although the
WHO specified a ventilation of 12 ACH for health care settings, most are constructed with
few and small windows, which are insufficient for indoor air circulation and removal of airborne
infectious particles. However, though the WHO recommended ventilation is achieved in some
health care centres, TB prevalence is still high. The major problem is that the WHO specified
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the ventilation but not the number of patients per ward, location or room size. This ventilation
is probably insufficient for TB control because ward room size, number of patients per ward,
locations and climatic conditions are not the same for all health care settings world wide.
Therefore, ventilation cannot be the same in all health care buildings, so it should rather be
specified according to the location, climatic condition, room size and approximate number of
TB patients to be accommodated.
1.13 TB prevalence in prisons and attributable factors
Though TB control has been successfully implemented in some developed countries such as
the United State, TB remains as a public health concern that causes morbidity and mortality
in prisons in both developed and developing countries [9]. Among the factors contributing to
TB transmission in congregate and confined spaces, such as prisons, are prolonged period of
exposure, high TB prevalence, high concentration of infectious particles per air volume, over-
crowding, low ventilation per person, proximity to infectors and the virulence of the infecting
pathogen strains [9, 15]. Prisons are one of the congregate and confined settings with low
per person ventilation rate where TB transmission is noted to be high. Furthermore, pris-
ons are overcrowded due to constant movement of inmates, long waits for trials and a large
number of sentenced prisoners. Highly confined, small and contaminated communal cells with
a large number of inmates, including infectious individuals lead to a high accumulation and
retention of airborne infectious particles per air volume, which can cause infectious disease in
susceptible individuals. Some prisons accommodate more than twice the specified number of
prisoners. For example, South Africa, has the fourth highest global incarceration rate with
165,000 prisoners in 237 prisons, with those awaiting trials comprising about one-third of this
number [109]. These awaiting trial prisoners are frequently enclosed in communal cells of 40
to 60 prisoners with a small area of about 1.4 m2 per inmate for 23 hours daily [109]. This
environmental exposure to indoor air pollution containing airborne infectious particles puts the
susceptible individuals at a high risk of acquiring TB infection and disease given the presence
of infectious individuals. Thus, due to high TB prevalence, low per person ventilation, long
period of exposure to infectors, indoor air pollution and overcrowding, TB transmission in
prisons remains a world heath challenge [81].
HIV co-infection associated with TB is an important factor contributing to TB transmission
in prisons [15, 81]. Intravenous drug users are at a high risk of acquiring HIV, and individuals
with HIV are vulnerable and at a high risk of acquiring TB infection and developing active
disease due to low CD4 counts, high viral loads, and a weak immune system. As mentioned
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earlier, the risk for an individual with HIV infection to acquire TB is about 7-fold higher than
for an HIV-negative individual. HIV co-infection has a great impact on TB diagnosis and
treatment, and weakens TB control efforts, as HIV co-infected individuals usually have false
negative TSTs and chest radiography results, which delays TB diagnosis, and thus treatment.
Though TB treatment strategies have been implemented globally, as mentioned before, multi-
drug resistant TB (MDR-TB) makes the situation more complex and hampers TB control
[9, 15, 81]. MDR-TB usually takes a long time to be treated and sometimes results in
extensively drug resistant TB (XDR-TB), which is even more difficult to treat than MDR-
TB. Due to poor diagnosis strategies, inadequate health care and high population density
in prisons, TB cases are often delayed in getting treatment and can become resistant to
chemotherapy, hampering TB control in prisons. The WHO postulated that approximately
24% of TB cases in prisons are MDR-TB [81]. Health services in prisons are generally poor,
with old facilities, inadequate treatment, incomplete chemotherapy and careless health workers,
which together can trigger MDR-TB. Prisons are not usually considered by the governments
in terms of renovation and health service improvement. Furthermore, since health services in
prisons are not under the Ministry of Health for political reasons, health workers in this sector
are not motivated. Reinfection plays a key role in TB transmission probability, especially in
high TB burden settings with insufficient TB diagnosis and treatment [34]. Since prisons are
overcrowded, with high TB prevalence and inadequate treatment, reinfection might be one of
the factors driving the increasing annual TB incidence and MDR-TB [65].
Malnutrition is another factor that accelerates susceptibility to infectious diseases in prisons
and in the community at large. Apart from poor health care in prisons, malnutrition there can
lead to weak immune systems. Generally, the environmental living conditions and nutrition in
prisons are fostering infectious disease susceptibility. As mentioned earlier, tobacco smoking
and drug abuse are also key factors contributing to TB infection susceptibility and disease
[81]. A large number of prisoners are from populations at a high risk of acquiring TB infection
and disease, such as homeless people, alcoholics, intravenous drug users and illegal immigrants
[45]. Since a large number of people in these groups are highly susceptible to TB and face
malnutrition in prisons, they can acquire TB infection and develop active TB in a short period
of time, and then act as a source of TB transmission to other prisoners. In addition, though
prisoners are under surveillance in prisons, some of them continue smoking and using drugs,
which are associated with TB susceptibility. There is no empirical evidence and it is not well
understood how inmates manage to get these substances and use them, perhaps through
visitors, prison guards or prison staff.
It is estimated that the world’s prisons hold about 8-10 million prisoners on any day, and
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because of high entrance and exit rate of inmates, it is estimated that 4 to 6-times this
number pass through the prison annually [81]. Furthermore, it is estimated that TB prevalence
in prisons is very high, about 5 to 80 times that in the civilian population [15]. In fact, the
WHO postulated that the level of TB in prisons is about 100 times higher than that of the
civilian population, and these TB cases may account for up to 25% of the country’s TB burden
[81]. Furthermore, in 2012, WHO reported that TB in prisons in European countries is also
remarkably high, like other countries worldwide, and notification rates of new TB cases in
prisons in all reporting countries were multiple times higher than in civilian populations [82].
Due to high TB prevalence in prisons, a large number of susceptible inmates are at a high risk
of acquiring TB infection and developing active TB. Some prisoners are released while they are
still on treatment and interact direct with the civilian community, which is another challenge.
Furthermore, since visitors, prison staff and former prison inmates who have already developed
active TB interact directly with the community, they transmit TB to susceptible individuals
and the fuel of TB infection and disease continues. Hence, since TB is not hampered by the
prison walls, prisons act directly as a reservoir for TB transmission in the civilian community.
Thus, while prisons are reserved for criminal punishment, the civilian community is punished
indirectly in terms of disease transmission.
1.14 Project motivation and outline
Tuberculosis (TB) is a disease of endemic proportions, particularly in the Western Cape, South
Africa which has one of the highest TB incidences in the world. The progression and severity
of disease depend on a number of different factors, including the state of the host immune
system, host genetics, and the virulence of the infecting strain of Mycobacterium tuberculosis
(MTB). Transmission of TB occurs through sneezing, talking or coughing out of small droplets
into the air which contain MTB. The efficiency of transmission is dependent on a number of
factors, including proximity to infected people, length of contact, ventilation in the area, etc.,
and with enough information, can be modelled.
The Desmond Tutu HIV Centre (DTHC) is investigating the transmission of TB, particularly
in crowded communities, such as in prisons and townships. They have the capacity to measure
carbon dioxide levels in enclosed spaces in order to measure how much air we ”rebreathe”,
as an indication of the level of potential exposure in different places. DTHC clinicians are
identifying TB cases in the study community and will investigate the clinical and radiological
factors associated with infected aerosol production. Newly diagnosed TB cases are assessed
for infectiousness by direct sputum smear status, quantitative culture, and direct measurement
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of aerosols during coughing and normal activity. In addition, they have collected social mixing
data, in particular for children from a school in Cape Town. This data includes movements
of children from home to school, and interaction with others at school and in transit. Carbon
dioxide levels are being monitored in these different locations. The advantage of this group is
that the children are of similar ages and their movements have been tracked over time.
The aim of this project is to develop models of TB transmission in crowded locations including
schools, households, public transport, prisons and health care settings. These models will
use the movement, carbon dioxide as a marker of exhaled air and other data, together with
the Wells-Riley equation, to determine the risk of TB infection over time. However, since
it is somewhat difficult to monitor indoor air conditions due to climatic changes, we shall
modify the Wells-Riley equation so that it can be applied to determine the risk probability of
TB transmission in all conditions regardless of steady-state ventilation. Though Rudnick and
Milton modified the Wells-Riley model under non-steady state conditions, they applied the
same concept of quanta and well mixed airspace as postulated by Wells (1995). Infectious
quantum hides many significant parameters, such as particle size, deposition fraction, bacteria
mortality and survival, which have previously been difficult to quantify, but they may be
amenable to modern technological measurement. Thus, the Rudnick and Milton equation
can be further modified. Additionally, we aim to develop a specific mathematical model that
determines TB transmission probability in a group of people contributing rebreathed air (carbon
dioxide) equally in a confined space. Moreover, we aim to develop a general mathematical
model that determines infection risk probability of TB transmission in all manners of interaction
in the community in general mixing environments associated with TB transmission. We shall
quantify the quantity of exhaled air that can be inhaled in the buildings with high probability
of inducing infection. We shall explore factors attributable to TB transmission in each of these
five locations and demonstrate measures for TB prevention and control. Furthermore, we shall
explore the impact of effective contact rate on TB epidemiology using a compartmental model.
Using an age-structured mathematical model we shall discuss the impact of the vaccines on
TB control.
Modelling TB transmission is an important tool that provides new knowledge about the dy-
namics of TB burden and can suggest alternative methods for TB infection and disease control.
Chapter two in this study, describes our model for the transmission of TB. Here, we modi-
fied the Wells-Riley and Rudnick-Milton models to obtain a new mathematical model, which
predicts the risk of airborne infectious diseases in all conditions without the limitation of one
quanta of contagion and assumptions of well mixed airspace. By numerical simulation, we
applied the mathematical model to different real life conditions to predict the risk of TB
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transmission probability under all conditions by monitoring exhaled air by infectors in confined
spaces. Furthermore, this chapter demonstrates the quantity of rebreathed air required to
induce infection in the buildings.
Chapter three describes reanalysis of previous in vivo studies by applying the mathematical
model developed in this study to guinea pig experimental data. Since it is not clear what
number of infective organisms are required to induce TB infection, this chapter aimed to
explore the probability of exposed guinea pigs acquiring infection using in vivo experimental
data, while varying airborne infectious particles and deposition fraction. We demonstrated
the number of surviving airborne infectious particles required to attain the threshold level to
induce infection for exposed guinea pigs. Here, we dispute that TB is transmitted by a single
infective organism as reported by prior studies.
Chapter four explores TB transmission in congregate settings, including schools, households,
public transport, health care settings and prisons using mathematical modelling approach.
We demonstrate the contribution of biological, socio-economic and environmental factors to
TB prevalence in these locations, and investigate TB transmission in these locations using
mathematical models developed in this study. Additionally, this chapter describes preventive
measures for TB control in these crucial locations.
Chapter five demonstrates TB transmission using a compartmental model, where we explored
the impact of effective contact rate on TB epidemiology. Here, we used a next generation
method to explore the basic reproduction number and computed eigenvalues to predict the
stability of the disease free equilibrium. Furthermore, we simulated the model by introducing
an infectious individual with varying effective contact rate and observed the number of primary
infection, reinfected and active TB individuals, with increasing effective contact rate.
Chapter six describes the impact of vaccines on TB control using an age-structured mathe-
matical model. This chapter demonstrates conditions under which TB vaccines can be used
to have greater impacts on TB control. Furthermore it shows active disease progression in
different age groups and attributable factors. Finally, chapter seven provides the conclusions
of the study.
Chapter 2
Mathematical models for TB
transmission
Abstract
In this study we develop a flexible mathematical model that predicts the risk of airborne infec-
tious diseases, such as tuberculosis (TB) under steady state and non-steady state conditions
by monitoring exhaled air by infectious individuals in a confined space. In the development of
the model, we use rebreathed air accumulation rate concept to directly quantify the average
volume fraction of exhaled air in a given space. From a biological point of view, exhaled
air by infectious individuals contains airborne infectious particles viable with potential for TB
infection. Since not all infectious particles can reach the alveolar, we take into consideration
that the infectious particles that establish the infection are determined by alveolar deposi-
tion fraction, which is the probability of each infectious particle reaching the target infection
site of the respiratory tracts and causing infection. Furthermore, we compute the quantity
of carbon dioxide as a marker of exhaled air, which can be inhaled in the space with high
probability of causing airborne infectious disease given the presence of infectious individual(s).
We demonstrated mathematically and schematically the correlation between TB transmission
probability and airborne infectious particle generation rate, ventilation rate, average volume
fraction of exhaled air, TB prevalence and duration of exposure to infectious individuals in
confined spaces.
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2.1 Introduction
Mathematical modelling is one of the computational tools that can be used to investigate or
predict tuberculosis (TB) transmission and identify measures for infection and disease control.
Mathematical model development in epidemiological studies usually involves equations which
helps understand how the phenomena under investigation evolves over time. Additionally, in
developing the model, we make assumptions about the numerous factors that influence the
evolution of the time dependent process that we are dealing with. We obtain the model
by analysing these assumptions in terms of mathematics, and use mathematical techniques to
analyse the model. If the model takes the form of an equation, we apply mathematical tools to
solve this equation. Finally, we assess the outcome of our mathematical analysis and translate
this back into the real world situation to find out how closely the predictions from our model
agree with actual observations. Mathematical models will usually only be an approximation of
what is actually happening in the community in real life.
In this study we modified the Wells-Riley and Rudnick-Milton equations to develop another,
more flexible equation to study the transmission of infectious diseases, such as TB. In the
development of the model, we use rebreathed air accumulation rate concept to directly quantify
the average volume fraction of exhaled air in a given space. From a biological point of
view, exhaled air by infectious individuals contains airborne infectious particles, which cause
airborne infectious diseases [66, 92, 100, 113]. Since not all infectious particles can reach
the alveolar, we take into consideration that the infectious particles that reach the alveolar to
establish the infection are determined by alveolar deposition fraction, which is the probability of
each infectious particle reaching the target infection site of the respiratory tracts and causing
infection [66]. Furthermore, we compute the quantity of rebreathed air required to induce
airborne infectious diseases in confined spaces with the presence of infectious individuals, as
discussed in the following sections.
2.2 The Wells-Riley model
The Wells-Riley equation has been extensively used to model infectious diseases, such as TB
risk probability for susceptible individuals to be infected if they are exposed to an infectious
individual in a confined space [24]. Additionally, this equation has been widely used to illus-
trate how ventilation is associated with airborne infection risks in the context of the clinical
environment. For example, it has been used to demonstrate the outbreaks of measles and TB
in the USA, and it has also been used to assess the risk of contracting TB infection during
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commercial aircraft flights [24].
The Wells-Riley equation was developed by Riley and co-workers in an epidemiological study
to demonstrate the outbreak of measles in an elementary school [74]. The equation is focused
on the quanta, which is the number of droplet nuclei required to cause infection for 63.2%
of susceptible individuals in a confined space as demonstrated by Wells (1955) and this is
known as the Wells-Riley model. In the derivation of this equation, Riley et al (1978) made
two assumptions: first, that airborne infectious particles (viable particles with potential for
TB infection) are spread under steady-state conditions, implying that quanta concentration
and the rate of outdoor air supply do not vary with time, and second, that the airspace is
well mixed, which implies that infectious particles are evenly distributed in the airspace of
the room regardless of the source proximity and duration of generation [73]. Based on these
assumptions, this equation is useful in a confined space where air flow is almost constant,
since it works under steady-state conditions. The Wells-Riley equation was developed from
the concept of quanta generation rate and the average number of quanta as described below.
The average number of quanta (µ̄) inhaled by a susceptible individual in a confined space, is
given by the following equation:
µ̄ = ptN̄ (2.2.1)
where p is the breathing rate of the susceptible individual (L/s), t is the time spent in a
confined space, and N̄ is the average quantum concentration (quanta/m3).
Quanta accumulation rate in an enclosed space of volume, V (m3), is equal to quanta gener-





where q denotes quanta generation rate (quanta/s), Q is the indoor ventilation rate (L/s), I
is the number of infectious individuals and N is the number of quanta in the space.
Assuming that the infectious individual stays in the confined space in a given time interval and
there is no occurrence of new infectious individuals, the steady-state condition was assumed,
implying that dNdt = 0. Hence, the average quantum concentration (N̄) from Equation (2.2.2)





Substituting N̄ from Equation (2.2.3) into Equation (2.2.1), the average number of quanta
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Wells (1955) postulated that the number of susceptible individuals infected in a confined space
bears a Poisson distribution to the number of tubercle bacilli, which they breathe [3], such
that
P = 1− e−µ̄ (2.2.5)
Thus, the Wells-Riley equation, which predicts the risk of TB transmission probability for
susceptible individuals is written as
P(T ≤ t|I,q,Q, p) = 1− e−
Iqpt
Q (2.2.6)
where P(T ≤ t|I,q,Q, p) denotes the risk of TB transmission probability for susceptible indi-
viduals and T ≤ t is the random variable representing infection risk for susceptible individuals
up to the time spent in the confined space.
In his book entitled ”Airborne contagion and air hygiene”, Wells (1955) postulated the con-
cept of the quantum of infection, and defined a quanta as being the number of infectious
droplet nuclei required to infect 63.2% of susceptible individuals in a confined space [3]. He
demonstrated that the number of susceptible individuals who become infected follows a Pois-
son distribution to the number of infectious particles which they breathe, implying that 63.2%
(1− e−1) of a population becomes infected when, on the average, each susceptible individual
inhales one quanta of contagion [3].
However, in contrast to Wells’ (1995) postulate, the overall infectivity of any airborne infectious
particle mostly depends on the immunological state of the susceptible individuals as well as the
virulence of the infecting pathogen strains. We can’t directly measure and determine the exact
number of airborne infectious particles present in any infectious disease outbreak, however, it
is possible to indirectly determine airborne infectious particles associated with an outbreak,
if the numerous physical parameters associated with the outbreak are known [24]. When a
host organism is exposed to the airborne infectious particles, whether the organism will be
infected or not depends on the infectivity of the infectious particles and the immune response
of the host organism [74]. Different regions of the respiratory tract may have different immune
mechanisms, implying that airborne infectious particles generally have different infectivity in
these different regions. The threshold level is the minimum amount of infectious particles
required to induce infection. When the intake dose reaches or exceeds the threshold level, the
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probability of infection cannot be zero. These facts clarify that for a susceptible individual
to be infected, the number of infectious particles inhaled should attain the threshold level to
dominate the immunological state of the host to commence the infection.
In contrast to Wells’ postulate, it is not plausible that one infective organism is likely to
cause infection from each exposure. For example, Wells agreed with and emphasised Chapin’s
postulate that ”the room air is not very dangerous to breathe in a short time even if airborne
infectious particles can be found in the settled dust” [59]. This postulate suggests that Wells
was wrong in his observation, and shows that airborne infectious diseases, such as TB are not
directly caused by a single infective organism, otherwise it would be very dangerous to breathe
contaminated air in a short period of exposure. The probability of inhaling a single infective
organism is very high in any period of exposure in a contaminated space.
In reality, TB infection is a somewhat complex scenario that incorporates the immune response
of the host and the threshold level of airborne infectious particles, which is determined by
respiratory deposition fraction, duration of exposure, strains of airborne infectious particles
and proximity to infectious individual(s). Different airborne infectious particles may have
different strains with different threshold levels and it is not obvious that every infected human
or organism is infectious [5]. For example in Wells’ experiment it was noted that there were
5 different strains among 22 cultures, 12 cultures were the same strain, 7 had another strain
and different strains were detected in the remaining 3 of 22 cultures [59].
Airborne infectious particles are randomly distributed in air and any estimated exposure level
or intake dose would be an expected value rather than an exact one. Respiratory deposition
fraction of airborne infectious particles is also an expected value rather than an exact one.
This implies that when the respiratory deposition fraction of airborne infectious particles with
a particular size is θ , each infectious particle with this size would have a probability of suc-
cessful deposition equal to θ . When airborne infectious particles are inhaled by the susceptible
individual, not all, but a fraction of the inhaled infectious particles may successfully reach the
target infection site in the respiratory tract depending on the deposition fraction. In addition,
because of the dynamics of airborne infectious particles, the respiratory deposition of these
airborne infectious particles is dependent on the particle dynamic size. Because of the differ-
ence in respiratory deposition of airborne infectious particles with different sizes, the airborne
infectious particles have different deposition fractions on different regions of the respiratory
tract [74]. For example, airborne infectious particles with sizes > 5µm are trapped dramati-
cally on the upper respiratory tract [86], and those with sizes > 10µm generally do not reach
the alveolar region. However, airborne infectious particles with critical size range 1µm to 5µm
have a high probability of reaching and depositing on the alveolar region [12]. This implies that
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not all inhaled airborne infectious particles can reach or be retained in the target infection site.
Infectectivity of airborne infectious particles increases dramatically with increasing deposition
fraction, thus, when assessing the risk of airborne infectious disease, the respiratory deposition
fraction of infectious particles has to be taken into consideration as demonstrated in Section
2.4 below.
Since the Wells-Riley equation seems to have several limitations as discussed above, including
assumptions and an equilibrium condition, which cannot be achieved consistently as the climate
changes, it should therefore be modified to one which can operate under all situations. Rudnick
and Milton (2003), modified the Wells-Riley equation by monitoring carbon dioxide, though
there are some similarities, including assumptions and concepts such as well mixed air and
quanta, which are still not well understood in epidemiological studies and the community, as
discussed below.
2.3 Rudnick and Milton approach
Rudnick and Milton (2003), modified the Wells-Riley equation using exhaled air (carbon diox-
ide) volume fraction to estimate the number of quanta inhaled by susceptible individuals. In
their approach, they used the same assumptions as those used in the Wells-Riley equation, for
example, airspace should be well mixed. Biologically, this assumption is not plausible since
in reality the room cannot contain uniformly mixed air. This is because the concentration of
airborne infectious particles is higher close to the infector (source) than other parts of the
room and is why when considering TB transmission, we should take into consideration the
duration of exposure and proximity to the infector. Despite the fact that, since Wells (1955)
first used the word quanta, it has caused some confusion in understanding TB transmission,
Rudnick and Milton still used the same approach to modify the Wells-Riley equation. The
derivation of the Rudnick and Milton equation started by considering carbon dioxide volume





where C is the indoor carbon dioxide volume fraction, Co is the outdoor carbon dioxide volume
fraction and Ca is the volume fraction of carbon dioxide in exhaled air.
The quantum concentration (N), given by the product of quanta concentration in exhaled air
and the volume fraction of exhaled air by infectors in the space was introduced as follows:





where q is the quantum generation rate by infectors (quanta/s) and n is the total number of
people in the space.
Rudnick and Milton postulated that the average volume fraction ( f̄ ) of exhaled air was com-
puted by integrating f in Equation (2.3.1) over time divided by elapsed time, though it was






The average number of quanta inhaled by susceptible individuals was given by
µ̄ = ptN̄ (2.3.4)
Substituting N̄ from Equation (2.3.3) into Equation (2.3.4), the average number of quanta





As stated earlier, Wells (1955), postulated that the number of susceptible individuals infected
in a confined space bears a poisson distribution to the number of TB bacilli they breathe, such
that
p = 1− e−µ (2.3.6)
Hence, the probability of infected individuals was expressed as:
P(T ≤ t|I,q,n, f̄ ) = 1− e−
Iq f̄ t
n (2.3.7)
Equation (2.3.7) is known as the Rudnick and Milton equation, and determines the risk of TB
transmission under all conditions. However, in this equation, f̄ was not directly determined
from the volume fraction of carbon dioxide, instead the quantum concentration (N̄) was






This equation is exactly the same as Equation (2.2.2), which is used in the Wells-Riley equa-
tion to determine the quantum concentration under steady state conditions, and it has no
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relationship with monitored carbon dioxide as a marker of rebreathed air in the space. Rud-
nick and Milton used this equation to determine the average quantum concentration under


































where T is the random variable representing infection risk for susceptible individuals up to the
time spent in the confined space.



























N̄ from Equation (2.3.13) was substituted into Equation (2.3.4) to obtain the average number













Finally, µ̄ from Equation (2.3.14) was substituted into Equation (2.3.6) to obtain the modified
Wells-Riley equation as:
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Equation (2.3.15) is the modified Wells-Riley equation, by Rudnick and Milton (2003), under
non-steady state conditions. However, derivation of this equation carries the same concept
as the Wells-Riley equation under steady-state conditions since both used the same equa-
tions (Equations 2.2.2 and 2.3.8) and idea of quanta. Furthermore, this equation has no
link with monitored carbon dioxide since it only applies the concept of quanta under non-
steady-state conditions. As discussed earlier, the average volume fraction ( f̄ ) was not directly
determined from monitored carbon dioxide as a marker of rebreathed air as expected. Hence,
this demonstrates that the average volume fraction of exhaled air was not directly applied in
the modification of the Wells-Riley equation, instead the concept of quantum concentration
(N̄) was considered and extended. This implies that both the Wells-Riley and Rudnick-Milton
equations have limitations, which impact the prediction of infectious disease risks. In this
study, we modified the Wells-Riley and the Rudnick-Milton equations by monitoring carbon
dioxide as a marker of rebreathed air and used it to determine the average volume fraction of
exhaled air, f̄ , directly from the volume fraction of exhaled air as discussed below.
2.4 Modification of the Wells-Riley and Rudnick-Milton
equations
As discussed earlier, both the Wells-Riley and Rudnick-Milton equations assume completely
mixed airspace, implying that the airborne infectious agents are evenly distributed throughout
a room. In reality and from a biological point of view, this is not true, the room air can never
be completely mixed [24, 74]. This is because regions of high and low contaminant concen-
trations will exist simultaneously within the same airspace, with the highest concentrations
usually occurring close to the contaminant source. Furthermore, in the derivation of these
equations, the quanta generation rate concept, which is not well understood, was considered,
as demonstrated in Equations (2.2.2) and (2.3.8). Infectious quantum hides very important
parameters such as particle size, deposition fraction, bacterial mortality and survival, which
have previously been difficult to quantify. Now, however, they may be amenable to modern
technological measurement. Though it has been applied in different respiratory infectious dis-
ease scenarios, the Wells-Riley equation should therefore be modified to develop a new equation
which is flexible and holds for all infectious disease transmission environments. Additionally,
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since the Rudnick-Milton equation seems to follow the same concepts and assumptions as the
Wells-Riley equation, it should also be modified.
The quantity of air rebreathed from others has been estimated in a variety of indoor congre-
gate settings including households, schools and transport by use of a portable carbon dioxide
monitor with geo-positioning capacity. Rebreathed air volumes vary considerably between indi-
viduals and locations and have been proposed as a novel metric, which can identify social and
environmental factors associated with potential airborne transmission risk [100, 113]. We use
carbon dioxide concentrations in confined spaces as a marker of rebreathed air to directly com-
pute the fraction of inhaled air that has been exhaled previously by individuals in the space,
called the average volume fraction of exhaled air. Furthermore, we determine the average
number and concentration of airborne infectious particles inhaled by susceptible individuals to
induce infection. Carbon dioxide is a very diffusible natural tracer gas, which can be easily
measured within an enclosed environment [90, 100, 113]. We assume that all occupants of
the room contribute equally to the elevated indoor carbon dioxide level as a maker of exhaled
air, and susceptible individuals become infected if they inhale rebreathed air from infectors,
which contains airborne infectious particles.
Respiratory activities such as talking, coughing, sneezing and singing could contribute to
respiratory particle production [40, 47]. Since not all infectious particles can reach the target
infection site, we took into account that the infectious particles that commence the infection
are determined by respiratory deposition fraction, which is the probability of each infectious
particle reaching the target infection site of the respiratory tracts and causing infection. Hence,
in contrast to quanta, we use airborne infectious particles in exhaled air from infectors to
modify the Wells-Riley and Rudnick-Milton equations. For a susceptible individual to be
infected, the number and concentration of airborne infectious particles inhaled should attain
the threshold level to dominate the immunological state of the host [66]. Using the average
volume fraction of exhaled air, respiratory deposition fraction, breathing rate, ventilation rate,
generation, mortality and survival rates of airborne infectious particles by infectors, we modify
both the Wells-Riley and Rudnick-Milton equations and obtain a flexible mathematical model
that predicts the risk of airborne infectious diseases under non-steady state and steady state
conditions. This approach will enhance our understanding of TB transmission scenarios in the
community and improve preventive measures for TB control.
In the modification of these equations, we made three assumptions. First, ventilation rate
should not necessarily be the same for all susceptible individuals in a confined space, second,
accumulated exhaled air by infectors contains airborne infectious particles in a confined space
and third, the probability of infection for each susceptible individual in the space is independent.
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This is because for a susceptible person to be infected, the average number and concentration
of infectious particles inhaled by each susceptible individual should reach the threshold level,
which is the minimum number and concentration of infectious particles required to reach the
target infection site of the host to cause infection [74]. Additionally, since the concentration of
airborne infectious particles is higher near the source (infector) than other parts of the room,
airspace cannot be uniform as assumed in the Wells-Riley model and subsequent modified
Wells-Riley models [66].
As stated earlier, exhaled air from infectors is the carrier of airborne infectious particles that
cause airborne infectious diseases, such as TB. Since we have the ability to monitor carbon
dioxide concentration as a marker of rebreathed air in a room [100, 113], we use the exhaled
air generation rate concept to modify the Wells-Riley and Rudnick-Milton equations as follows:
Let us consider the concentration of exhaled air in a confined space of volume V (m3), which
contains n persons and let carbon dioxide fraction contained in breathed air be Ca, while the
ventilation rate is Q (L/s), and indoor carbon dioxide concentration is C (ppm). Airborne
infectious particles are generated in the accumulated exhaled air in confined spaces. Hence,
exhaled air accumulation rate in the space is equal to indoor exhaled air generation rate minus





= npCa−QC, n≥ 2 (2.4.1)
where n is the total number of persons in the space and p is the breathing rate (L/s).
From this exhaled air basic equation (Equation (2.4.1)), we can determine the average volume
fraction of exhaled air in an enclosed space at either non-steady state or steady-state conditions.
Therefore, we can develop an equation that predicts the risk of infectious disease transmission
under all conditions by monitoring carbon dioxide as a marker of rebreathed air in the given
space.
Arranging Equation (2.4.1) and assuming that exhaled air started to rise from 0 to C(T ) when
persons entered the space, and time spent is counted from 0 to T , we obtain sampled exhaled











After integrating Equation (2.4.2) by application of a substitution method and simplifying it,
we obtain:
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Simplifying Equation (2.4.4) further, by applying logarithmic and exponential rules, we obtain
sampled exhaled air concentration (C(T )) in the given space, which is the difference between
indoor exhaled air concentration and outdoor exhaled air concentration (rebreathed air removed










where QV is the rate of air change outdoors and T is the elapsed time in the given space.
Taking into account the volume fraction of exhaled air, ( f ) which is given by the sampled ex-
haled air concentration (C(T )) in the space divided by carbon dioxide concentration in breathed


















Hence, we obtain the average volume fraction of exhaled air ( f̄ ) per elapsed time by integrating













































If we further simplify Equation (2.4.9), we obtain the average volume fraction of exhaled air
for non-steady-state conditions, and if we apply the same procedure in the exhaled air basic
equation (Equation (2.4.1)) while dCdt = 0, we obtain the average volume fraction under steady
state conditions, or if QTV → ∞, Equation (2.4.9) adopts steady-state conditions:












if non− steady− state
np
Q if steady− state
(2.4.10)
Therefore, Equation (2.4.10) denotes the average volume fraction of exhaled air, f̄ (0< f̄ < 1)
under non-steady-state and steady-state conditions, where each part can be derived from
Equation (2.4.1) depending on the condition used to solve the problem.
As discussed earlier, the likelihood of airborne infectious particles released by infectors causing
infection in susceptible individuals is extremely high if they reach the target infection site of
the host at a threshold level. However, some airborne infectious particles can be trapped in
the upper respiratory tract or be reflected to other parts of the body, where the probability of
causing infection is almost negligible. Let β be the total airborne infectious particle generation
rate (particles/s) released by an infector and µ be the mortality rate of generated airborne
infectious particles (particles/s) that do not reach the alveolar. Hence, airborne infectious
particles released by infectors that reach the target infection site of the susceptible individual
to cause infection, are generated with the rate β −µ (particles/s) as demonstrated in Figure
2.1.
Figure 2.1: Movement of airborne infectious particles
Thus, the average concentration of airborne infectious particles ( ¯N ), is equal to the average
volume fraction of rebreathed air by infectors ( I f̄n ) multiplied by the average concentration
of airborne infectious particles released by infectors in the space (β−µp ) that reach the target
infection site of the respiratory tract:
¯N =
I f̄ (β −µ)
np
, I ≥ 1 and (β −µ)≥ 1 (2.4.11)
where ¯N is the average concentration of airborne infectious particles (particles/m3), (β −µ)
is the survival rate of infectious particles (particles/s) that deposit in the alveolar, n is the
total number of individuals in the space and f̄ is the average volume fraction of exhaled air
that is obtained by integrating the volume fraction of exhaled air per time spent in the given
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space as discussed above.












if non− steady− state
I(β−µ)
Q if steady− state
(2.4.12)
which is the average concentration of airborne infectious particles that cause TB infection
when a threshold level is attained.
Since not all infectious particles can reach and deposit in the alveolar, let θ be a respiratory
deposition fraction of infectious particles that reach the target infection site of the host.
Hence, the average number of infectious particles (λ̄ ) breathed by a susceptible individual
that causes infection, is equal to the product of the volume of breathed air by susceptibles
(pt), respiratory deposition fraction of infectious particles, θ (0 < θ < 1) and the average
concentration of infectious particles ( ¯N ):
λ̄ = ptθ ¯N , t > 0 (2.4.13)
Substituting ¯N from Equation (2.4.12) into Equation (2.4.13), we obtain the average number













if non− steady− state
I(β−µ)θ pt
Q if steady− state
(2.4.14)
Therefore, Equation (2.4.14) denotes the average number of infectious particles inhaled by a
susceptible individual that reach the target infection site of the host to cause TB infection
under non-steady-state and stead-state conditions.
Computing an expected average number of airborne infectious particles in Equation (2.4.14),
the percentage of airborne infectious particles, γ , that cause airborne infectious diseases in





where CT is the sampled exhaled air in the given space (refer to Equation (4.3.1)).
Applying Wells’ (1995) assumption that the infected number of susceptible individuals in a
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confined space follows a Poisson distribution, the modified equation should be written as:
P(T ≤ t|I,β ,θ ,µ,Q, p) = 1− e−λ̄ (2.4.16)
Where P(T ≤ t|I,β ,θ ,µ,Q, p) is the probability of TB infection risk for susceptible individuals
under non-steady-state and steady-state conditions.
Substituting λ̄ from Equation (2.4.14) into Equation (2.4.16), we obtain an equation that
predicts the risk of TB transmission probability at non-steady-state and steady state conditions:











if non− steady− state
1− e−
I(β−µ)θ pt
Q if steady− state
(2.4.17)
Thus, Equation (4.4.1) demonstrates that both the Wells-Riley and Rudnick-Milton equations
can be modified to model the risk of infectious disease transmission under all conditions by
applying a carbon dioxide accumulation rate concept as a marker of exhaled air. In our
approach in the modification of these equations, we monitored carbon dioxide in the room as
a marker of rebreathed air by means of portable carbon dioxide monitors [100] and used it
to determine the average volume fraction of exhaled air ( f̄ ). This is because carbon dioxide
as a marker of exhaled air is one of the most diffusible gases, which reflect the dispersal of
airborne infectious particles that cause airborne infectious diseases in a confined space. From
a biological point of view, a susceptible individual can be infected by one or more infectious
particles depending on the virulence of the infecting pathogen strain and the threshold level
of the number and concentration of infectious particles which successfully reach the target
infection site to dominate the immunological state of the host [66]. However, we can’t directly
measure and determine the exact number of infectious particles that dominate the immune
system of the host and cause infectious disease, as postulated by Wells (1955). As stated
earlier, this is because the average number and deposition fraction of airborne infectious
particles are expected values rather than exact ones.














if non− steady− state
p
Q if steady− state
(2.4.18)
Hence, if we make a substitution of f̄n into Equation (4.4.1), we obtain the modified equation
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of the Wells-Riley and Rudnick-Milton equations that predicts the risk of TB transmission
under all conditions in terms of the average volume fraction of exhaled air:
P(T ≤ t|I,β ,θ ,µ,n, f̄ ) = 1− e−
I(β−µ)θ f̄ t
n (2.4.19)
Where P(T ≤ t|I,β ,θ ,µ,n, f̄ ) is the probability of TB transmission risk for susceptible indi-
viduals under any condition given the presence of infectious individuals in a confined space.
As mentioned earlier, in our approach we monitored the carbon dioxide concentration in the
room as a marker of rebreathed air and used the exhaled air accumulation rate concept to
directly compute the average volume fraction of exhaled air. An exponential term of this equa-
tion is equal to the average number of airborne infectious particles inhaled by each susceptible
individual to induce infection, and not quanta. This approach provides more information for
understanding the transmission of airborne infectious diseases.
2.4.1 New TB cases
From Equation (4.4.2), prevalence (Λ) is the ratio of infectious (I) and total number of





The general modified equation in terms of prevalence, can be written as:
P(T ≤ t|β ,θ ,µ,Λ, f̄ ) = 1− e−(β−µ)θ f̄ tΛ (2.4.21)
TB prevalence is the product of TB incidence rate (M) and infectiousness period (4). Thus,
in terms of incidence, Equation (2.4.21) can be written as
P(T ≤ t|β ,θ ,µ,Λ, f̄ ) = 1− e−(β−µ)θ f̄ tM4 (2.4.22)
Hence, Equation (2.4.21) is a general equation to determine the risk probability for TB trans-
mission in terms of TB prevalence that holds under all conditions by monitoring carbon diox-
ide in the room as a marker of rebreathed air. Furthermore, in terms of incidence, Equation
(2.4.22) can be used to determine the risk probability for TB transmission under all conditions.
With this equation that predicts the risk of TB transmission under all conditions, we can
determine the number of new TB cases (D) in terms of prevalence, which is the product of
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the probability in Equation (2.4.21) and the number of susceptible individuals:
D = S
[
1− e−(β−µ)θ f̄ tΛ
]
(2.4.23)
where S is the number of susceptible individuals.
In contrast to quanta, the exact number of inhaled airborne infectious particles required to
cause an infectious disease outbreak is unknown, but a susceptible individual becomes infected
if surviving airborne infectious particles in exhaled air by infectors attain a threshold level to
dominate the host immunological state [66]. Additionally, the respiratory deposition fraction
of airborne infectious particles on the host alveolar is an expected value and not an exact one.
Thus, the modified mathematical model in this study is unique and better reflects real life
in the community by matching both individuals and environment without limitations of well
mixed air and equilibrium conditions.
The mathematical model developed in this study by modifying the Wells-Riley and Rudnick-
Milton equations introduces both viable particles and successful deposition fraction into the
Wells-Riley and the prior modified Wells-Riley models. We modified these models because they
have limitations, which impact on the prediction of infectious disease risks, including uniformly
mixed air in the room and the theoretical construct of infectious quantum. The concept of
infectious quantum originated from animal infection experiments where it was noted that the
variable particle size of bacillary containing droplets resulted in differential infection rates.
The concept of infectious quantum was then expanded to quantify transmission of TB from
humans to guinea pigs (Wells and Riley) and has subsequently been used as a back calculated
measure of infectivity in TB outbreak investigation. However, infectious quantum includes
many significant parameters as discussed above and it’s not well understood in the context of
epidemiological studies.
Note that TB exposure is not the same as TB infection, which is subject to both host and
bacterial factors. In our model, bacterial survival is considered within the parameter (β −µ)
and the host factors by the successful deposition fraction (θ), which defines the infectious dose.
In this model, we do not address the probability of progression from infection to disease, which
is impacted by many other factors including age, gender, comorbidities etc. Rather, we have
the ordinate to reflect TB transmission probability. Model applications (numerical simulations)
with different factors and conditions correlated to TB transmission risks are demonstrated in
the following subsection.
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2.4.2 Simulation results
Figure 2.2a is a numerical simulation of Equation (4.4.2). In this figure, the horizontal dot-
ted line denotes the absence of infectors (I = 0) and the other lines denote the presence of
infectors (I = 1, I = 2 and I = 4) in the given space. This figure shows that TB transmission
probability becomes high in the given space as the number of airborne infectious particles gen-
erated by infectors increases with increasing number of infectors, and no infection occurrence
if there is no infectious individual(s) in the given space. Furthermore, a numerical simulation
of Equation (4.4.1) is illustrated in Figure 2.2b, with increasing duration of exposure from
t = 0 to t = 100 hours for different ventilation air changes per hour (ACH) of 1 ACH, 3 ACH,
8 ACH and 12 ACH. From this figure, we note that when ventilation rate decreases in the
given space, and duration of exposure increases, the probability of acquiring TB infection be-
comes extremely high given the presence of an infectious individual. The numerical simulation
of Equation (2.4.10) is demonstrated in Figure 2.2c, which shows that the average volume
fraction of exhaled air increases with increasing number of occupants(n), and decreases with
increasing ventilation rate in the given space. Figure 2.2d, a numerical simulation of Equation
(4.4.1) under non-steady state conditions, shows that as the room volume and ventilation
rate increases, TB transmission probability decreases. This implies that if ventilation can be
improved in buildings, the accumulation rate of airborne infectious particles can be reduced in
the community and airborne infectious diseases, such as TB can also be reduced [41, 117]. On
the other hand, the concentration of airborne infectious particles released by infectors in the
room increases with decreasing room volume and ventilation rate. The graphical illustration of
Equation (4.4.2) in Figure 2.2e shows that TB transmission probability increases in the given
space as the average volume fraction of exhaled air increases with increasing number of oc-
cupants. Furthermore, Equation (2.4.21) is demonstrated graphically in Figure 2.2f, showing
that when TB prevalence becomes high in the community, TB transmission probability that is
attributed to the increasing number of airborne infectious particles becomes extremely high.
In reality, TB transmission is directly correlated to TB prevalence, which accelerates the high
concentration of airborne infectious particles in the community.




Figure 2.2: Model simulation, showing TB transmission probability and attributable factors.
(a) TB transmission probability attributed to the increasing number of airborne infectious par-
ticles and number of infectors in the space (Equation (4.4.2) simulation). (b) TB transmission
probability increases with increasing duration of exposure and decreasing ventilation air change
per hour (Equation (4.4.1) simulation). (c) Average volume fraction of exhaled air increases
with increasing number of occupants and decreases with increasing per person ventilation
rate (Equation (2.4.10) simulation). (d) TB transmission probability decreases with increasing
room volume and ventilation rate per person (non-steady-state condition of Equation (4.4.1)).
(e) TB transmission probability attributed to the increasing average volume fraction of exhaled
air and number of occupants (Equation (4.4.2) simulation). (f) TB transmission probability
increases with increasing TB prevalence and production rate of airborne infectious particles
(Equation (2.4.21) simulation).
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2.5 Quantity of rebreathed air required to induce infec-
tion
Airborne infectious diseases, such as TB are transmitted in multiple congregate locations in the
presence of infectious individuals and with a low per person ventilation rate [3, 58, 73, 90, 113].
Carbon dioxide has been used as a measure of indoor air quality based on the concept that
people emit carbon dioxide at a rate dependent on body mass and physical activity and
that indoor carbon dioxide levels are determined by fresh air clearance [7, 46]. When the
concentration of exhaled air increases in the room with infectors present, the probability of
susceptible individuals acquiring airborne infectious diseases also increases [113].
Generally, high indoor carbon dioxide concentration is considered to be harmful [7, 46, 100].
This is because exhaled air from infectious individuals usually contains airborne infectious par-
ticles within droplet nuclei that may remain airborne for prolonged periods and when inhaled
may result in new infection of a susceptible individual [3]. The progression from infection to
TB disease depends on a number of different factors, including the state of the host immune
system, host genetics, and the virulence of the infecting pathogen strain [3, 11, 12]. We
make an assumption that the building, such as a class room of volume, V , starts the day with
environmental carbon dioxide concentration (CE), which is about 400 ppm and it becomes
occupied by a number of people (n). This implies that the level of exhaled air concentration
that might contain airborne infectious particles will start to increase in the room given the
presence of an infector, and depending on the ventilation rate (Q), room volume and number
of people in the room [7, 46, 68]. This is because people in the room contribute to the increase
in rebreathed air depending on their oxygen consumption, respiratory quotient and physical
activities [7, 46]. People in the room will contribute equally to the generation of carbon dioxide
as a marker of exhaled air and susceptible individuals may acquire airborne infectious disease
if they inhale rebreathed air from infectious individual(s) [66]. The fundamental equation for
exhaled air accumulation rate in the room with environmental carbon dioxide, which then be-
comes occupied, is equal to the rate of exhaled air generated by occupants plus environmental




= npCa +QCE −QC (2.5.1)
where C is the indoor exhaled air concentration (ppm), p is the breathing rate for each person
in the room (L/s) and Ca is the carbon dioxide fraction contained in breathed air (ppm).
To determine the quantity of exhaled air accumulated in the room with respect to elapsed
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time, we arrange Equation (2.5.1) and integrate from CE (which is the environmental carbon
dioxide in the room) to C(t) (which is the total exhaled air in the room) and elapsed time from










After integrating Equation (2.5.2) by application of integration rules (substitution method),
we obtain the following equation













Simplifying Equation (2.5.4) further by applying logarithmic and exponential rules, we ob-
tain the mathematical model for exhaled air accumulated (C(t)) in a room that started with










where t is the time spent in the room.
Equation (2.5.5) is demonstrated in Figure 2.3, which shows that when the room becomes
occupied the level of exhaled air increases as time elapses in the space. An experiment
was conducted in a room of 75 m3 while regulating ventilation from 3 L/s to 4 L/s and
measuring the quantity of carbon dioxide as a marker of rebreathed air. We noted that when
the ventilation rate decreases, the concentration of exhaled air increases depending on the
number of occupants and room ventilation rate.
Figure 2.3: The level of exhaled air in a room, which started a day with environmental carbon
dioxide, then became occupied by a number of people.
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We compute the total amount of exhaled air in the room, demonstrated in Figure 2.3, as
follows: Let QABCDA = Q1 and QCDEFC = Q2. The horizontal line indicates environmental
carbon dioxide (CE = 400 ppm), which was assumed to be in the room before the entrance
of occupants. If we take the summation integral of ABCDA and CDEFC, we obtain the total
quantity of exhaled air that was rebreathed by each person present in the room for one hour
when ventilation rates were Q1 = 3 L/s and Q2 = 4 L/s, respectively. If T denotes elapsed
time, the quantity of carbon dioxide as a marker of rebreathed air (C(T )), which is generated
in the room can be computed by taking the summation integral from TA to TD and TD to TE


















































Simplifying Equation (2.5.7) further, given that TA = 0, we obtain an equation for exhaled
air accumulated in the room that started with environmental carbon dioxide then became
occupied:





























where TD = 30 min and TE = 60 min as shown in Figure 2.3.
In our experiment we used CE = 400 ppm, p = 0.12 L/s, n = 50, Ca = 0.04, and V = 75 m3.
By substituting these values into Equation (2.5.8), we obtain the quantity of exhaled air that
is inhaled by each person in the room as C(T ) = 50,211 ppm.











We can obtain the quantity of exhaled air in the room with given ventilation by making a
schematic plot of this equation. Plotting Equation (2.5.9), produces the diagram in Figure
2.4.
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Figure 2.4: The level of exhaled air in a room, which started a day with no environmental
carbon dioxide then became occupied by a number of people.
In Figure 2.4, if we take the summation integral of ABCDA with time from TA to TD and
CDEFC with time from TD to TE , we obtain exhaled air accumulation in the room, which
















































Arranging Equation (2.5.11), and simplifying it further when TA = 0, we obtain an equation


























where TD = 30 min and TE = 60 min as shown in Figure 2.4.
Substituting the same values used in Equation (2.5.8) into Equation (2.5.12), we obtain the
quantity of exhaled air, which accumulated in the room as C(T ) = 26,211 ppm. If susceptible
individuals become exposed in an enclosed room with a high volume of exhaled air, as demon-
strated in this experiment, they get infected, given the presence of infectors. Infection for
human and animals has been documented at a minimum level of carbon dioxide as a marker
of exhaled air of about 10,000 ppm [7, 46]. This implies that carbon dioxide or exhaled air is
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harmful, especially in confined spaces with low per person ventilation rates.
Note that Equations (2.5.5) and (2.5.9) hold only under non-steady-state conditions. However,
as time, t approaches infinity, the concentration, C(t) approaches the steady-state value and
the time required to reach steady-state depends on the value of outdoor air change rate
(QV ), implying that the higher the value, the less the time required to reach the steady-state.
However, for constant carbon dioxide generation rate, constant ventilation rate and constant
outdoor concentration, the indoor concentration will attain steady-state conditions and these




Q if with environmental CO2
npCa
Q if with no environmental CO2
(2.5.13)
where C(s) is the concentration of carbon dioxide in the room under steady state conditions.
Equation (2.5.13) demonstrates that when the ventilation rate decreases in the buildings, the
concentration of exhaled air increases and vice versa. This implies that the accumulation and
concentration of airborne infectious particles from infectious individuals increases in the given
space with decreasing per person ventilation rate [41].
The increase in carbon dioxide as a marker of exhaled air in an indoor setting in the absence
of any other significant source of carbon dioxide reflects the quantity of exhaled breath, which
is available for inhalation. We assume that all occupants, including TB infectious and non-
infectious individuals, contribute to this exhaled air. Elevated carbon dioxide in inhaled air
therefore consists of exhaled air from (a) active TB cases and (b) uninfected individuals.
The proportion of that inhaled air derived from infectious cases (a/a+b) is determined by the
number of infectious cases and prevalence of active TB in the population being studied. When
the number of individuals in a space (room) is small then the Poisson distribution probability
of the presence of an infectious individual is used. Note that raised carbon dioxide as a marker
of exhaled air without the presence of an infectious source is only a measure of air exchange
between non-infectious individuals. The proportion of this air exchange, which is potentially
infectious, is therefore determined by the number of infectious individuals and prevalence of
active TB cases in the population under study.
Section 2.6. Discussion Page 52
2.6 Discussion
Mathematical modelling is one of the most powerful tools in the context of epidemiological
studies that is used to investigate, predict and demonstrate the transmission risks of infectious
diseases and highlight preventive measures for infection and disease control. The Rudnick-
Milton model is a non-steady state version of the Wells-Riley model that has been extensively
used to demonstrate the risk probability of acquiring airborne infectious diseases in confined
spaces. However, in the derivation of their equation, Rudnick and Milton used the same
approach and assumptions as the Wells-Riley model under steady state conditions, for example,
completely mixed air in the room and quanta of contagion as postulated by Wells (1955). This
causes limitations in understanding TB transmission scenarios by hiding useful parameters,
including particle size, deposition fraction, bacterial mortality and survival rates.
In this study, we used respiratory deposition fraction and airborne infectious particles in con-
trast to quanta to modify both the Wells-Riley and Rudnick-Milton models and obtained a
flexible mathematical model that predicts the transmission risks of airborne infectious diseases
in multiple environments without limitations of well mixed airspace and equilibrium conditions
(Section 2.4). In the modification of these equations, θ is used as the respiratory deposition
fraction that determine infectious particle threshold level, β is a measure of all airborne infec-
tious particles irrespective of the respiratory mechanism of production, µ denotes infectious
particle mortality rate and (β −µ) is the survival rate of airborne infectious particles with high
likelihood of inducing airborne infectious disease at a threshold level. We believe that this is
the first study to date to incorporate both respiratory deposition fraction and airborne infec-
tious particles in contrast to quanta to modify the Wells-Riley and prior modified Wells-Riley
equations under all conditions by monitoring carbon dioxide as a marker of exhaled air with-
out assuming well mixed airspace. Furthermore, we explored the application of the developed
model schematically considering different factors and conditions attributed to TB transmission
(Figure 2.2). The non-steady-state condition seems to be more practical than steady-state
since it demonstrates the real world schematically and mathematically as discussed in Sec-
tion 2.4. This means that the transmission of airborne infectious disease mostly occurs under
non-steady-state conditions. Furthermore, we noted that, in all conditions (steady-state and
non-steady-state), ventilation plays a key role in TB control by diluting the concentration of
polluted air, which accelerates the transmission of airborne infectious diseases in the room.
Hence, there are significant differences between our model and existing model approaches.
Firstly, our model addresses both steady state and non-steady state conditions and ventilation
is not required to be uniform. Second, the model introduces important parameters such as
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particle production, mortality, survival rates and successful deposition at the site of infection,
which determines infectious dose at a threshold level. Furthermore, the flexibility of inhaled
carbon dioxide allows summation of risk acquisition in multiple endemic environments. How-
ever, the current model does assume that successfully deposited viable bacteria in terminal
airways result in TB infection in susceptible individuals. Additionally, the model does not
capture the stochasticity associated with TB transmission.
Figures 2.3 and 2.4 and their corresponding calculated values of carbon dioxide as a marker of
exhaled air indicate that, when persons enter a confined space with the presence of an infectious
individual(s) and contribute equally to rebreathed air, then each person inhales a large quantity
of exhaled air, which might contain airborne infectious particles [66]. When the concentration
of exhaled air becomes very high in the room, the probability of acquiring airborne infectious
diseases such as TB also becomes high. When infectious particles are inhaled by susceptible
individuals and successfully reach a threshold level at the target infection site of the hosts,
they can cause TB infection. According to an experiment demonstrated in Figures 2.3 and
2.4, it was noted that when ventilation rate was 4 L/s, exhaled air declined in the room though
it was not diminished, but when the ventilation rate became 3 L/s, the level of exhaled air
started to rise implying that the generation rate of infectious particles also increased provided
the presence of infectious individual(s) in the room [66]. This implies that when ventilation
rate is very low, for example 1 L/s, the community becomes at high risk of acquiring airborne
infectious disease due to high social contact and indoor air pollution.
To our knowledge, there is no empirical evidence that demonstrate differences in carbon dioxide
levels in exhaled air between airborne infectious disease transmitting and non-transmitting
individuals. Carbon dioxide excretion as a surrogate for exhaled air is directly related to the
oxygen consumption required for metabolic activity. The ratio of exhaled carbon dioxide to the
oxygen consumption is defined by the respiratory quotient, which is somewhat diet dependent
but relatively constant at a value of 0.83. Our analysis assumes similar contribution of carbon
dioxide as a marker of exhaled air from all individuals (infectious and non-infectious individuals)
in the indoor space. However, infectious particles have been measured in TB patients, which
are capable of transmitting TB via the airborne rate to animal models.
Chapter 3
Seminal Mycobacterium tuberculosis in vivo
transmission studies: Reanalysis using
probabilistic modelling
Abstract
Much of our current knowledge of Mycobacterium tuberculosis (MTB) transmission origi-
nates from seminal human-to-guinea pig in vivo studies, carried out in the 1950’s. Similar
methodology has been used to investigate human immunodeficiency virus (HIV) co-infection
and multidrug resistant TB. However, all these studies have had to reconcile the need to use
high facility ventilation rates in order to decrease risks of human-to-human infection while
demonstrating human-to-guinea pig transmission. While these studies demonstrate tuberculo-
sis (TB) contagion can be airborne, they also estimated extremely low infectivity of TB cases.
However, calculated infectivity was based on a theoretical concept of quantal infection and
assumed that the guinea pig model was 100% sensitive for the remote detection of viable TB
organisms in highly diluted air exhausted from the facility. High facility ventilation markedly
decreases the probability of a successful guinea pig infection by both dilution of the exhaled
breathe and decreasing the proportion of air sampled by guinea pigs. In this study, we used a
new mathematical model based on Poisson distribution and previous guinea pig experimental
data to quantify more realistic estimates of the number of infective organisms required to
produce a successful infection for exposed guinea pigs in the in vivo studies. Furthermore, we
explored the probability of exposed guinea pigs acquiring infection in these studies. We found
that the in vivo studies to date were underestimated to demonstrate transmission derived from
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any but the most productive infectious cases. All four in vivo studies have remarkably low
probability of infection of exposed guinea pigs due to either high ventilation rates or insensitive
mathematical model used in these studies. Therefore, our analysis would suggest that the pro-
duction of infective organisms by TB cases might have been markedly underestimated. This
reassessment of the infectivity of guinea pigs is compatible with recent findings of very high
numbers of TB genomes present in health care environments and the very diverse distribution
of TB strains present in highly endemic settings which indicates a multiplicity of infective
sources.
3.1 Introduction
Our current knowledge of the nature of Mycobacterium tuberculosis (MTB) transmission
owes much to the in vivo guinea pig model of infection. In 1882 Koch, identified the causative
agent responsible for consumption and demonstrated tuberculosis (TB) transmission to guinea
pigs exposed to dried sputum from infected patients. Consequently, emphasis was placed on
avoidance of desiccated secretions in dust and fomites, which was then considered the principal
mode of transmission [5].
In the 1930′s Wells, expanding on the earlier work of Flugge et at (1897) [1], proposed that
TB transmission was the result of inhalation of infected droplet nuclei exhaled or coughed by
a TB case [38]. In the 1950′s, Riley and colleagues performed seminal experiments, which
confirmed airborne transmission from TB cases to guinea pigs, supporting Well’s theory [59].
Riley observed that guinea pig infections in his model occurred only as rare singleton lesions. He
postulated that guinea pig TB infection was quantal, lesions followed a Poisson distribution
(1− e−λ ) and that TB case quanta production was as low as 1− 2 per day. A Poisson
distribution following a quantum exposure (expected value λ = 1) would result in 36.8% with
no lesions and 63.2% with lesions (36.8% with a single lesion and 26.4% with multiple lesions).
However, the Poisson distribution of lesions remained theoretical, as multiple lesions were not
observed.
Riley et al (1962) [60], Escombe et al (2008) [93] and Dharmadhikari et al (2011) [106] sub-
sequently used similar guinea pig methodology to investigate differing infectiousness of human
clinical populations. High facility ventilation makes the back calculation of TB case infectious
quanta production very sensitive to sampling efficiency. However, quanta concentrations cal-
culated from individual guinea pigs exposed to as little as 2− 3 milliliters of patient-derived
air per hour were used for cross-study quanta production comparisons [93, 106].
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All four guinea pig studies A [59], B [60], C [93] and D [106] identified only a minority of
efficient transmitters or “super-spreaders”. While “super-spreaders” may be responsible for
explosive outbreaks of TB in low prevalence settings [39], in endemic settings, molecular epi-
demiology indicates more generalized TB transmission [56]. Additionally, variable human [89]
and guinea pig [106] immunological responses to TB infection that are predictive of subsequent
reversion and TB progression risk may be more compatible with quantitative rather than quan-
tal exposure. Recent advances in molecular technologies have enabled direct measurement of
airborne TB patient derived particles that are several orders of magnitude greater than those
estimated from guinea pig experiments [59, 76, 88]. However, protagonists of the in vivo
guinea pig model have questioned the clinical relevance of these large numbers of airborne TB
genomes [10] and newer viability assays are awaited.
In this study we hypothesized that the guinea pig sampling system may lack sensitivity to
identify any but the highest levels of infectivity. In order to re-explore the quantitative findings
from these in vivo transmission studies, we developed a steady state mathematical model to
estimate the likely source-patient airborne infectious particle (viable particles with potential
for TB infection) production. The model incorporated relevant parameters that likely decrease
guinea pig sampling efficiency including ventilation, sampling fraction and alveolar deposition
proportion.
3.2 In vivo study methodology
The data derived from four in vivo studies A [59], B [60], C [93] and D [106] is shown in Table
3.1. Patients (range 6−8) with untreated, treated, drug resistant TB disease or complications
of treated TB disease were housed in facilities with closed circuit ventilation systems which
were supplied with disease free ventilation at a rate Q (range 8.7×106 L/day to 57.6×106
L/day). Patient facilities were either communal wards, two bedded or single roomed facilities
with all exhausted air piped to a guinea pig exposure chamber. Within each exposure chamber
S number of guinea pigs (range 120− 362) were housed in communal cages through which
the exhaled air from the patient facility was passed. The guinea pig cages were designed such
that excreta fell through the floors in order to minimize chances of cross infection between
animals by means of contaminated bedding. The temperature and relative humidity of the
guinea pig cage environments were closely controlled. Each guinea pig was estimated to
breathe approximately p = 10 L/h. Regular tuberculosis skin testing identified G infections
(range 63−213) in the guinea pigs during time t (range 112−730 days) with TB diagnosis
confirmed by histology and or culture at subsequent autopsy. Uninfected substitute guinea pigs
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constantly replaced infected or euthanized animals in order to maintain an average number
S of susceptible animals. Most newly infected animals had evidence of only one infectious
focus in their lungs, supporting the study hypothesis that TB entered the body through a
single invasive site in the respiratory system and the assumption that the number of infections
reflected the number of airborne infectious particles inhaled.
Two studies A [59] and B [60] used proportionality to estimate the concentration of airborne
infectious particles in the exhausted ward air from the number of infected guinea pigs G divided
by the total air volume V (range 3.8×106 L to 27.3×106 L) breathed by all susceptible guinea
pigs during the period of t days of the study. The total airborne infectious particles produced by
I TB patients were calculated from the total facility ventilation Q divided by calculated volume
per infected guinea pig V/G containing a single airborne infectious particle. The calculated
number of airborne infectious particles causing infection was considered to be identical to the
number of airborne infectious particles inhaled by the guinea pigs and the concentration of
such particles in the patient ward was identical to that of the inhaled guinea pig air.
One study, C [93], incorporated calculation of airborne infectious particles using a Poisson
probability, but similar to studies A and B, assumed that the inhaled number of airborne
infectious particles by guinea pigs was identical to the number of airborne infectious particles
causing infection, and that there were no losses between exhalation from patients and inhalation
by guinea pigs. The fourth study, D [106], focused predominantly on a new finding that some
guinea pigs were observed to revert their tuberculin reactions after infection with drug resistant
TB. This observation led to a proposal that drug resistant strains were less virulent than the
drug sensitive strains reported in the prior studies A [59], B [60] and C [93]. However, the
number of susceptible guinea pigs (S) exposed and the number infected or dying of tuberculosis
(G) after exposure to TB cases (I) was reported. Facility ventilation was reported only as 12
air changes per hour, which, in conjunction with published facility dimensions [77], allowed
facility ventilation (Q) to be calculated.
For each of the studies A to D we estimated the probability of finding the published infection
rates using the Poisson distribution approach with sensitivity analysis of TB infectious doses
of between 10 to 50 colony forming units as reported in a review of the guinea pig as an
infectious model [52]. We then went on to estimate the mean patient production rate of
airborne infectious particles necessary to reproduce the reported guinea pig infection rates of
each study as discussed in Section 3.3. Note: Study A = Wells-Riley et al (1959), study B =
Riley et al (1962), study C = Escombe et al (2008), study D = Dharmadhikari et al (2011).
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A [59] 730 6(88∗) 8,685 156 71 35.3 0.0041
B [60] 730 6(130∗∗) 9,379 120 63 27.2 0.0029
C [93] 505 8(97†) 39,675 292 129 66.1 0.0017
D [106] 112 6(26‡) 57,600†† 362 213 82.0 0.0014
I = maximum patient occupancy at any time, total = total number of patients in each study.
Patient characteristics: ∗ treatment-näıve and treatment failures, ∗∗ untreated, treatment-
näıve and drug resistant, † All HIV-infected, suspected tuberculosis, treatment-näıve, and with
treatment complication, ‡ multi-drug resistant tuberculosis and ††12 ACH estimated volume
rate.
3.3 Mathematical modelling and simulation results
Using guinea pig experimental data in the four in vivo studies A [59], B [60], C [93] and D
[106] (Table 3.1), we explore the probability of exposed guinea pigs acquiring infection in these
studies by application of the mathematical model developed in Issarow et al (2015) [66] under
steady state conditions. Furthermore, we quantify the number of surviving airborne infectious
particles (infective organisms) required to reach the alveolar to induce infection for exposed
guinea pigs in these in vivo studies. The mathematical model used in this study for the in vivo
studies reanalysis is demonstrated as:
P(ψ|I,F ,θ , p,Q, t) = 1− e−
IFθ pt
Q (3.3.1)
where P(ψ|I,F ,θ , p,Q, t) denotes the probability of infection of exposed guinea pigs, ψ is
whether or not infection occurred given that TB infection conditions are fulfilled, Q is the
ventilation rate (L/h), p is the guinea pig breathing rate (L/h), I is the number of infectious
individuals in the space, θ is the alveolar deposition fraction, t is the duration of exposure (h)
and F (βtotal − µloss) is the number of surviving airborne infectious particles per unit time
(particles/h) that reach the alveolar to establish infection. βtotal is the total airborne infectious
particle production rate and µloss is the mortality rate of airborne infectious particles before
reaching the host infection site.
This mathematical model (Equation (3.3.1)) was preferred over others as it incorporates all
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significant parameters in the prediction of airborne infectious disease risks, without assumption
of well mixed airspace and equilibrium conditions [66, 67] (see Chapter 2, Section 2.4). The
in vivo studies claimed that they used a Poisson distribution approach (Wells-Riley model) to
predict the number of infective organisms required to induce infection and the probability of
exposed guinea pigs acquiring infection. However, they didn’t demonstrate mathematically or
schematically how they used the Wells-Riley model in their studies to estimate the number
of infective organisms and the probability of exposed guinea pigs acquiring infection. Using
Equation (3.3.1), in this study, we estimate the number of surviving airborne infectious par-
ticles required to reach the alveolar to induce infection and the probability of exposed guinea
pigs acquiring TB infection in the four in vivo studies. Since the in vivo studies used a steady
state mathematical model (Wells-Riley model), Equation (3.3.1) should provide a more accu-
rate prediction of the probability of exposed guinea pigs acquiring infection in these studies.
Furthermore, this equation should estimate a more accurate number of surviving airborne
infectious particles required to reach the alveolar to induce infection in exposed guinea pigs.
In the application of Equation (3.3.1) to guinea pig experimental data, we made the following
assumptions: first, there is no immune control of infection i.e. a single or more than one
airborne infectious particle arriving at the alveolus will result in a guinea pig infection if the
probability of exposed guinea pigs acquiring infection is attained; second, the experimental
conditions were such that there was no cross infection between guinea pigs; and third, the
infective TB dose required to establish infection in guinea pigs varies between 10 and 50 colony
forming units resulting in alveolar deposition fractions between 0.02 and 0.1 [52].
Here, we explore the probability of infection of exposed guinea pigs by applying in vivo ex-
perimental data in studies A [59], B [60], C [93] and D [106] (Tables 3.1 for I, t,Q, p and
3.2 for F ) to Equation (3.3.1), while varying alveolar deposition fraction (θ = 0.02,0.1). We
use 0.9(0.8−1) as the probability of exposed guinea pigs acquiring infection, with the proba-
bility of 1 being the saturation point (threshold level) where infection will occur. Simulating
Equation (3.3.1) numerically, we found that the maximum probability of exposed guinea pigs
acquiring infection in the four in vivo studies A [59], B [60], C [93] and D [106] was 0.054,
0.074, 0.08 and 0.00062, respectively, with deposition fraction of 0.02. Furthermore, with de-
position fraction of 0.1, the maximum probability of exposed guinea pigs to acquire infection
in these studies was 0.24, 0.32, 0.35 and 0.0031, respectively (Figures 3.1a, 3.1b, 3.1c and
3.1d). All four in vivo studies A [59], B [60], C [93] and D [106] seem to have remarkably low
probability of infection of exposed guinea pigs due to high ventilation rates in their studies,
which dilute the concentration of airborne infectious particles. It shows that of all four in vivo
studies, study D [106] (Figure 3.1d) had the lowest infection probability of exposed guinea
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pigs, perhaps because of shorter duration of exposure and higher ventilation rate than the
other studies (Table 3.1). The findings in this study show that the expected probability of
exposed guinea pigs to acquire infection was not attained in all four in vivo studies, implying
that their observations may be inaccurate or underestimated [67].
The four in vivo studies seem to have several issues, including high ventilation rates, which led
to remarkably low probability of exposed guinea pigs to acquire infection. Alveolar deposition
fraction and surviving airborne infectious particles also seem to have a significant impact on the
prediction of exposed guinea pigs acquiring TB infection. Here, we quantify and demonstrate
the number of surviving airborne infectious particles required to attain the threshold level to
establish infection for exposed guinea pigs in the four in vivo studies by simulating Equation
(3.3.1) numerically using in vivo experimental data (Table 3.1), varying airborne infectious
particles (F = 10,100,1000 particles/h) and alveolar deposition fraction (θ = 0.02,0.1). We
chose these values of airborne infectious particles because the number of surviving particles
that reach the host infection site to induce infection is an expected value and not an exact
one [66]. By simulating Equation (3.3.1) numerically using in vivo experimental data, varying
airborne infectious particles and alveolar deposition fraction, we determined the threshold level
of surviving airborne infectious particles (F ) required for exposed guinea pigs to acquire TB
infection in each in vivo study as follows: For study A, the threshold level of surviving airborne
infectious particles was reached when F ≥ 69 particles/h with deposition fraction of 0.02
and F ≥ 14 particles/h with deposition fraction of 0.1 (Figures 3.2a and 3.2b); for study B,
the threshold level was attained when F ≥ 75 particles/h with deposition fraction of 0.02
and F ≥ 15 particles/h with deposition fraction of 0.1 (Figures 3.2c and 3.2d); for study C,
the threshold level was reached when F ≥ 341 particles/h with deposition fraction of 0.02
and F ≥ 69 with deposition fraction of 0.1 (Figures 3.3a and 3.3b); and for study D, the
threshold level was reached when F > 1000 particles/h with deposition fraction of 0.02 and
F ≥ 596 particles/h with deposition fraction of = 0.1 (Figures 3.3c and 3.3d). It shows that
none of the four in vivo studies reached the threshold level for exposed guinea pigs to acquire
TB infection when F ≤ 10 particles/h with deposition fraction of 0.02≤ 0.1. Unfortunately,
all four in vivo studies estimated that exposed guinea pigs were infected with less than 10
particles/h [59, 60, 93, 106] and concluded that TB infection is induced by a single organism
[59]. This implies that their observations may be inaccurate and they lacked sensitivity in their
experimental studies, perhaps due to using a mathematical model with implausible assumptions
and some limitations [67].
Because of shorter duration of exposure and higher ventilation rate than other in vivo studies,
study D failed to reach the threshold level at the maximum number of airborne infectious
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particles (1000 particles/h) with deposition fraction of 0.02 (Figure 3.3c). Furthermore, we
noted that studies C and D (Figure 3.3) seem to require larger numbers of airborne infectious
particles to reach the threshold level for exposed guinea pigs to acquire infection than studies A
and B (Figure 3.2), perhaps because of high ventilation rates and short durations of exposure
in the former studies (Table 3.1). Studies A and B are very similar schematically (Figure 3.2),
probably because of the same number of infectious individuals and duration of exposure in
the two in vivo experiments (Table 3.1). However, due to higher ventilation rate in study B
than that of study A, we show that study B requires a larger number of airborne infectious
particles to attain the threshold level than study A. It shows that high ventilation rates in these
studies is one the key factors which led to remarkably low probability of exposed guinea pigs to
acquire infection. Since ventilation dilutes the concentration of airborne infectious particles,
duration of exposure needs to be higher with high ventilation rate to attain the threshold level
for exposed guinea pigs to acquire infection. As mentioned earlier, due to high ventilation
rates in all four in vivo studies, our findings suggest that the minimum number of airborne
infectious particles required to reach the threshold level for infection in each study was greater
than 11 particles/h per person with deposition fraction of 0.02 and greater than 2 particles/h
per person with deposition fraction of 0.1 (Table 3.2). However, none of the four in vivo
studies quantified these values, implying that their observation may be highly underestimated
or false-negative. It shows that the likelihood of TB infection is directly correlated with alveolar
deposition fraction, which determines the number of surviving airborne infectious particles that
reach the alveolar to establish infection (Figures 3.2 and 3.3). Table 3.2 compares the number
of surviving airborne infectious particles/h per person, which are required to reach the target
infection site of the host to induce infection in the four in vivo studies and our study.
Table 3.2: Comparison of the number of airborne infectious particles per hour per person in
our study and the in vivo studies that required to reach the alveolar to establish infection.
Airborne infectious particles/person in our study.
Study Airborne infectious
particles/person in





A [59] 0.167∗ 11.5 2.333
B [60] 0.25∗ 12.5 2.5
C [93] 1.025∗ 42.625 8.625
D [106] 0.083∗∗ > 166.667 99.333
∗ Airborne infectious particles per person from in vivo studies, ∗∗ Calculated airborne infectious
particles per person from in vivo study experimental data.
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Figure 3.1: Exploration of the probability of exposed guinea pigs to acquire TB infection
in studies A, B, C and D using in vivo experimental data (Tables 3.1 and 3.2) and varying
deposition fraction in Equation (3.3.1) (numerical simulation) in each study.
(a) Probability of infection of exposed guinea pigs in study A with deposition fraction of 0.02
and 0.1. (b) Probability of infection of exposed guinea pigs in study B with deposition fraction
of 0.02 and 0.1. (c) Probability of infection of exposed guinea pigs in study C with deposition
fraction of 0.02 and 0.1. (d) Probability of infection of exposed guinea pigs in study D with
deposition fraction of 0.02 and 0.1. Note: gp = guinea pig, df = θ = alveolar deposition
fraction.
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Figure 3.2: Numerical simulation of Equation (3.3.1) using in vivo experimental data in
studies A and B (Table 3.1) with varying alveolar deposition fraction to quantify the number
of surviving airborne infectious particles required to reach the threshold level for exposed guinea
pigs to acquire TB infection. Note: gp = guinea pig, df = θ = alveolar deposition fraction.
(a) The number of surviving particles required to reach the alveolar to induce infection in
exposed guinea pigs in study A with deposition fraction of 0.02. (b) The number of surviving
particles required to reach the alveolar to induce infection in exposed guinea pigs in study A
with deposition fraction of 0.1. (c) The number of surviving particles required to reach the
alveolar to induce infection in exposed guinea pigs in study B with deposition fraction of 0.02.
(d) The number of surviving particles required to reach the alveolar to induce infection in
exposed guinea pigs in study B with deposition fraction of 0.1.
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Figure 3.3: Numerical simulation of Equation (3.3.1) using in vivo experimental data in
studies C and D (Table 3.1) with varying alveolar deposition fraction to quantify the number
of surviving airborne infectious particles required to reach the threshold level for exposed guinea
pigs to acquire TB infection. Note: gp = guinea pig, df = θ = alveolar deposition fraction.
(a) The number of surviving particles required to reach the alveolar to induce infection for
exposed guinea pigs in study C with deposition fraction of 0.02. (b) The number of surviving
particles required to reach the alveolar to induce infection for exposed guinea pigs in study
C with deposition fraction of 0.1. (c) The number of surviving particles required to reach
the alveolar to induce infection for exposed guinea pigs in study D with deposition fraction of
0.02. (d) The number of surviving particles required to reach the alveolar to induce infection
for exposed guinea pigs in study D with deposition fraction of 0.1.
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3.4 Discussion
Guinea pig is a suitable model of human TB because of its susceptibility to the infection, similar
symptoms and pathophysiology. Our reanalysis of in vivo experiments of human to guinea pig
MTB transmission shows that they lacked sensitivity and suggests that the production of in-
fectious particles by TB cases reported in these studies may have been greatly underestimated.
The guinea pig facilities used in each study lack sensitivity due to the fundamental conflict
between the need for enhancing transmission from human to animals while being constrained
by the need to reduce human to human cross infection. The ventilation of the patient wards
increased with each successive study, such that patient exhaled air was diluted by 125-fold,
135-fold, 530-fold and 833-fold in studies A [59], B [60], C [93] and D [106], respectively.
Concurrently, with the increasing dilution of the ward vented air, the sampling proportion
determined by the number of guinea pigs used in each study decreased progressively from
0.0041, 0.0029, 0017 and 0.0014 in studies A [59], B [60], C [93] and D [106], respectively.
Furthermore, we have questioned the assumption that because only a single bacterium was the
source of a single granuloma at the site of infection within a guinea pig that the infective dose
for a guinea pig is a single airborne infectious particle. The respiratory anatomy of mammals
has evolved to filter environmental threats in order to limit access to the vulnerable alveolar
bed. The infective TB dose required to establish infection in guinea pigs varies between 10
and 50 colony forming units, resulting in deposition fractions between 0.02 and 0.1 [52].
The deposition of inhaled particles in the lung is determined by breathing patterns and lung
geometry in conjunction with attributes of particles affecting physical processes, such as inertial
impaction, gravitational sedimentation and Brownian diffusion [23]. The proportion of small-
respired particles in the 1-2 microns range capable of transporting one or more MTB organisms
capable of deposition in the human alveolar has been estimated at around 10% [16].
There are some important consequences of our findings. Cross study comparisons of the
relative infectivity of different types of TB infected individuals may lead to false conclusions
because the sensitivity of each study differed markedly, as did the methodology for calcula-
tion of airborne infectious particle production. For example, the conclusion that HIV infected
patients in study C were more infectious than non HIV-infected patients in studies A and B
should be viewed in light of the above limitations [93]. The use of calculated airborne infec-
tious particle production from in vivo animal studies may also be inaccurate for mathematical
modelling of human-to-human transmission [21, 42, 51, 96]. If TB airborne infectious parti-
cles are much more frequent than previously estimated there should be a greater emphasis on
environmental searching for airborne TB.
Chapter 4
Modelling TB transmission in
congregate settings
Abstract
Tuberculosis (TB) transmission in congregate settings, such as schools, households, public
transport, health care settings and prisons has been noted to be remarkably high due to nu-
merous factors. In this study, we explore the contribution of biological, socio-economic and
environmental factors attributable to TB prevalence in these locations using mathematical
modelling approach. Furthermore, we describe preventive measures for TB control in these
crucial locations. We noted that high interaction and duration of exposure to infectious individ-
uals are among the factors accelerating TB transmission in congregate settings. Furthermore,
the study shows that increasing number of infectious individuals, overcrowding and insufficient
ventilation are another key contributing factors to the increasing TB incidence in congregate
settings. Identification and treatment of TB cases may have a greater impact on TB control
in these locations.
4.1 Introduction
Tuberculosis (TB) transmission in congregate settings, such as schools, households, public
transport, health care settings and prisons is estimated to be high. Increasing TB incidence in
these locations is contributed by several factors, including interaction, contacts, social mixing
and duration of exposure to infectious individuals [11]. Undoubtedly, exhaled air is the carrier
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of airborne infectious particles viable with potential for TB infection in confined spaces with
the presence of infectious individuals [46, 113, 117]. Overcrowding and insufficient ventilation
are some of the factors, which accelerate accumulation of exhaled air in confined spaces, and
susceptible individuals become infected given the presence of infectious individual(s) [24, 113].
As mentioned earlier (Chapter 1), in most of the schools, households and public transport
in South Africa, are highly overcrowded with high interaction and social contacts between
infectious and susceptible individuals, which create reasonable proximity for TB transmission.
Furthermore, insufficient ventilation, increasing number of infectious individuals and high du-
ration of exposure to infectious individuals in health care settings and prisons are assumed to
be among the factors contributing to the increasing TB incidence in these locations.
In this study, we demonstrate social and environmental factors attributable to TB transmission
in congregate settings using mathematical modelling approach. Furthermore, we describe
preventive measures for TB control in these locations.
4.2 Integrated model for TB transmission in transport,
schools and households
4.2.1 Group interaction model
If we want to determine the risk probability for TB transmission among students who enter the
classroom or passengers who enter the vehicle at the same time and sit as a group, we need to
develop a specific mathematical model for people who contribute re-breathed air equally, such
that susceptible individuals can easily be infected. In this study we developed a mathematical
model that predicts the risk of TB transmission probability when people are in a group (group
interaction model), such as students in the classroom or passengers in the vehicle.
Let us consider an enclosed space (classroom or vehicle) of n susceptible individuals (students
or passengers) and the probability that at least one individual might be smear-positive is r. The
number of infectious individuals (i) in the given space can be expressed as i = nr. Thus, for
the probability of having new infected individuals in the space, we should consider a binomial
distribution as follows:






where P(I = i) denotes the probability of having new infected individuals in the space, for i =
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0, 1,..., n.
In order to determine the probability of infection risk outbreak and spread for susceptible
individuals (n) in a group in a given period of exposure t, we should take the product of





P(I = i)P(n|I = i) (4.2.2)
Where
P(n|I = i) = 1− e−
i(β−µ)θ f̄ t
n ,
which is the probability of acquiring infection for n susceptible individuals given the presence
of infectious individuals. Where I = i is the number of infectious individuals, (β − µ) is the
surviving airborne infection particles that reach the alveolar (particle/s), θ is the respiratory





























If we further simplify Equation (4.2.4), we obtain the probability, P(g), of TB transmission








Equation (4.2.5), implies that when n persons enter the room at the same time, they contribute
equally to the re-breathed air, such that susceptible individuals can easily be infected, given
the probability of having at least one smear-positive individual (r) in the room. This equation
is valid for a group of people, for instance, when students enter the classroom and sit as a
group or when passengers enter an enclosed vehicle and share re-breathed air for a long period
of time, but it does not account for random entrance and exit of students in the classroom or
passengers exiting the vehicle randomly because the time spent by the smear-positive individual
in the space is the same as the duration of exposure for susceptible individuals. Therefore,
we need to develop a general equation which can hold for all manners of interactions in the
community either in groups or with random interactions, where duration of exposure should
not necessarily be the same as the time spent by the smear-positive in the given space as
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discussed below.
4.2.2 Random interaction model
Here, we develop a general mathematical model that determines the risk probability of TB
transmission in all manners of interaction in the community (random interaction model). The
difference between random and group interaction models, is the manner of interaction between
smear-positive and susceptible individuals. This means that the random interaction model
holds under all conditions of the TB transmission environment regardless of group formation
since duration of exposure for susceptible individuals is not necessarily the same as the time
spent by the smear-positive individual in the given space as discussed below.
Let us consider a classroom or vehicle of n individuals who enter the space and leave randomly
such that i individuals might be smear-positive with the probability r. Thus, the number of
susceptible individuals is n− i. For new infections (x) to occur, the time spent by susceptible
individuals in the space should be greater than or equal to the time spent by a smear-positive
individual, and the time spent by the smear-positive should be less than or equal to the time






where k is the total number of new infected individuals and x j is the new infection for a person
j.
x j =
1 i f τ 6 t j,τ 6 t0 otherwise
x j = 1 denotes an occurrence of a new TB infection and x j = 0 if there is no occurrence of
new infection, where t j is the time for a person j to be infected, τ is the time spent by the
smear-positive individual, and t is the time spent by susceptibles in the space.








where P(krandom) is the probability of having k new infected individuals in the space with
random interaction, k = 0,1, ...,(n− i).
Thus, infection risk probability, P(m) that susceptible students or passengers will be randomly
infected given that there are i smear-positives in the space, is equal to the probability of infec-
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tion spreading given that there are i infectious individuals in the space, P(n|I = i) multiplied






P(krandom)P(n|I = i) (4.2.8)
Where



































where P(m) is the probability of TB infection risk occurrence in enclosed spaces in random
interaction.
Note that the difference between group and random models is that duration of exposure for
susceptible individuals for a group model is the same as the time spent by a smear-positive
individual in a confined space, while for a random model, duration of exposure may be greater
than or equal to the time spent there by the smear-positive. In the random model, the number
of susceptible individuals is more flexible since the model adopts a random condition compared
to the group model.
Equation (4.2.10) implies that students can enter the classroom and leave randomly but the
total time spent in the room is still t as the duration of exposure. According to this equation
it means that students who were previously in the classroom and left before entrance of
the smear-positive should not be infected, while those who entered together with or after the
smear-positive could be infected. Moreover, even students who remained in the classroom after
exit of the smear-positive could be infected since this equation is valid for random movement
at any time of exposure which is counted as duration of exposure. In addition, this equation
is applicable to passengers who enter and exit the vehicle provided that the environment is
conducive to TB transmission and given the presence of a smear-positive individual in that
environment.
Therefore, Equation (4.2.10) is regarded as a random interaction model that can be applied
for modelling TB transmission in confined spaces in a given population, as a sample in a
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large community, in all manners of interaction under all conditions. This implies that people
can either enter or leave individually or in a group such that students can enter or exit the
classroom in any way but if there is at least one infectious individual, then susceptible students
can also be infected. Furthermore, in public transport where commuters (elders and students)
enter and exit randomly, while all windows are fully or half closed, susceptible individuals can
easily be infected as demonstrated by this random interaction model. In the case of the annual
risk of TB infection, we should consider a Poisson distribution as it is applicable in rare events
as discussed below.
4.2.3 Measures for TB control in schools, households and transport
Factors contributing to TB transmission in schools, households and public transport are closely
related [92]. For example, interactions, social contacts and environmental exposure in these
locations are similar and are highly correlated with TB transmission. Due to random interaction
and social contacts between infectious and susceptible individuals in confined spaces, TB
prevalence in one location may act as a reservoir for TB transmission in another [92]. For
example, TB prevalence in schools is highly dependent on public transport and the households.
Furthermore, TB transmission in the households is dependent on that in public transport and
schools, and the TB burden in public transport is linked to TB prevalence in schools and
households. Of all three congregate locations discussed in this section, public transport has
the highest TB prevalence followed by schools because of high interactions and duration of
exposure in confined spaces, especially during winter. TB transmission can be reduced in these
locations if interactions, social contacts and duration of exposure can be reduced between
infectious and susceptible individuals [11, 92].
Controlling the spread of airborne infectious particles in the air is one of the more efficient in-
terventions for TB control in schools, households and public transport. For example, if airborne
infectious particles can be reduced then (β −µ) in Equations (4.2.5) and (4.2.10) approaches
or becomes zero, implying that TB transmission probability becomes approximately zero. Fur-
thermore, reducing duration of exposure, TB transmission probability in these equations also
approaches zero. Therefore, early diagnosis and case detection is one of the most important
interventions for TB control in the community [79]. The big challenge is that some TB cases
are not yet identified in the community due to either lack of health care or poor diagnostic
tools, which provide false-negative results.
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4.3 Modelling TB transmission in health care settings
Since carbon dioxide is one of the most diffusible tracer gas, it is usually used to measure the
quality of airspace [66, 99]. We therefore monitor carbon dioxide as a surrogate for exhaled re-
breathed air to demonstrate the risk of airborne infectious diseases. Let us consider a hospital
with a TB ward as illustrated in Figure 4.1 and use carbon dioxide as a surrogate for exhaled
air to demonstrate TB transmission and control in health care settings by monitoring exhaled
air by infectious individuals in the TB ward as follows:
Figure 4.1: TB transmission in hospitals, a schematic of a ward.
Mathematically, accumulated exhaled air in the TB ward of volume V , is equal to the rate of
exhaled air generated by TB patients (I pCa) plus ambient air in the room (QCe) minus indoor




= I pCa +Q(Ce−Ci), I ≥ 1 (4.3.1)
where Ci denotes indoor carbon dioxide concentration (ppm), Q is the ventilation rate (L/s),
Ce is the outdoor carbon dioxide concentration (ppm), p is the breathing rate of the patients
in the TB ward (L/s), Ca is the carbon dioxide fraction contained in breathed air and I is a
number of TB patients in the TB ward.
Arranging Equation (4.3.1) and integrating with respect to time for CO2 = Co when time,
t = 0 to CO2 =CT when time, t = T , we obtain the concentration of the sampled exhaled air
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Simplifying Equation (4.3.3) further, gives:
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which can be written as
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Applying logarithmic and exponential rules in Equation (4.3.5) and simplifying it further
by making CT the subject, we obtain an expression that describes the sampled exhaled air
concentration-time curves:















where Co is the indoor carbon dioxide at time, t = 0, which is greater than Ce.
Simulation of Equation (4.3.6) in Figures 4.2a and 4.2b demonstrate factors associated with
TB transmission in health care settings.
a b
Figure 4.2: Risk factors correlated with tuberculosis transmission in health care settings.
(a) Concentration of exhaled air increases in the ward with increasing number of infectors and
duration of exposure. (b) Exhaled air from infectors increases in the ward with decreasing
ventilation rate and increasing duration of exposure.
Figures 4.2a and 4.2b (simulation of Equation (4.3.6)) show risk factors correlated with TB
transmission in health care settings with increasing duration of exposure. Results show that
the concentration of exhaled air increases in the space with increasing number of infectious
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individuals and duration of exposure (Figure 4.2a)). Figure 4.2b shows that the concentration
of carbon dioxide as a surrogate of exhaled air increases in space with decreasing ventilation
rate and increasing duration of exposure.
Equation (4.3.6) that is illustrated in Figure 4.2a, shows that when the number of TB patients
increases in the TB ward, the concentration of exhaled air that may contain airborne infec-
tious particles becomes high and a large number of exposed susceptible individuals may be
infected. However, if the number of TB patients in the TB ward can be treated with effective
chemotherapy and cured then I pCa→ 0 and Equation (4.3.6) becomes:







which describes the decay exponential curve [99] as demonstrated in Figure 4.3.
Figure 4.3: Exhaled air from infectors decreases in the TB ward with decreasing number of
TB patients per given period of time.
Figure 4.3 shows that if the number of TB cases can be reduced/cured, a TB control strategy
in health care settings is likely to be achieved. We further discuss TB control interventions in
health care settings in the following section.
4.3.1 TB control interventions in health care settings
As mentioned earlier, although it is not the most effective intervention for TB control, natural
or mechanical ventilation plays a key role in TB control by reducing (diluting) the concentration
of airborne infectious particles expelled by infectors. The WHO recommend a ventilation rate of
12 ACH for health care settings, which includes TB isolation wards. However, in exceptionally
hazardous areas, such as autopsy rooms, airflow rates should be increased to 15−25 ACH [58].
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Mechanical air disinfections, such as negative pressure ionisation and ultraviolet germicidal
irradiation in hospital wards can act as TB control interventions and may replace ventilation
if installed properly [58, 94]. Negative pressure ionisation removes polluted air from the room
and replaces it with fresh air, such that airborne infectious particles are not able to settle
in the given space to induce infection. It has been noted that large-scale negative ionizers
reduce airborne infectious particles by up to approximately 99% [94]. However, installation
and maintenance of mechanical air disinfectors is very expensive for some health care centres
to afford and requires experts to provide this service, though ultraviolet germicidal irradiation
is still cheaper than mechanical ventilation [94].
High efficiency particulate air (HEPA) filters have been demonstrated to provide a minimum
efficiency of 99.97% by trapping small particles with diameter ≥ 0.3 µm [58]. Although they
may have aerodynamic diameter of less than 1 µm, airborne infectious particles viable with
potential for TB infection have a critical diameter of approximately 1− 5 µm [58], implying
that if HEPA filters can be implemented and used properly, they should be one of the most
effective interventions for TB control among health care workers. Furthermore, if multi-drug
resistant and extensive-drug resistant patients can be supplied with and encouraged to wear
HEPA filters, the concentration of airborne infectious particles expelled by TB patients can
be reduced in the atmosphere and TB transmission probability in health care settings may be
reduced.
Surgical masks have been demonstrated to reduce the transmission of multi-drug resistant TB
by 56% if worn by multi-drug resistant TB patients [105]. The efficacy of surgical masks seems
to be lower than that of HEPA, implying that its face-seal leakage is high and a large number
of susceptible individuals may be infected despite the use of this device. For an effective
respiratory protective device against airborne infectious disease, its face-seal leakage should
not exceed 10% [58]. Thus, though they have been used in different health care settings,
perhaps because of their affordable price, surgical masks are not recommended for TB control.
Although the efficacy and face-seal leakage of mist/dust respirators are not clearly specified,
they have been demonstrated to be cheap, and provide comfort and protection against airborne
infectious diseases [6]. However, since none of the air disinfection devices provide 100%
protection against airborne infectious disease, rather than depending on one disinfection device,
they should be combined. For example, HEPA filters should be used together with ultraviolet
germicidal irradiation to provide high protection against airborne infectious diseases [58].
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4.4 Modelling TB transmission in prisons
Many studies apply the Wells-Riley model, which assumes steady-state ventilation conditions
and well mixed airspace to estimate the probabilities of TB transmission in confined spaces
[113]. Since airborne infectious diseases, such as TB, mostly occur in congregate locations
with low per person ventilation either under non-steady-state or steady-state conditions, here,
we apply a mathematical model developed in this project (Chapter 2, Section 2.4) by mon-
itoring carbon dioxide as a marker of exhaled air to demonstrate factors attributable to TB
transmission in prisons as follows:











if non− steady− state
1− e−
I(β−µ)θ pt
Q if steady− state
(4.4.1)
combined, the two equations give
P(T ≤ t|I,β ,θ ,µ, f̄ ,n) = 1− e−
I(β−µ)θ f̄ t
n (4.4.2)
Where P(T ≤ t|I,β ,θ ,µ, f̄ ,n) is the probability of TB transmission risk for susceptible individ-
uals under non-steady-state and steady-state conditions, T ≤ t denotes duration of exposure up
to the point of infection (s). I is the number of infectious individuals, (β −µ) is the surviving
airborne infection particles that reach the alveolar (particle/s), θ is the respiratory deposition
fraction, Q is the ventilation rate (L/s), V is the room volume (m3), f̄ is the average volume
fraction and n is the total number of individuals in the given space.
Through application of these equations, we explored TB transmission in prisons by considering
numerous factors and conditions attributable to TB transmission probability in this congregate
location as illustrated in Figure 4.4. Graphically, Equation (4.4.1) (under non-steady-state con-
ditions), is illustrated in Figure 4.4a, which shows that TB transmission probability increases
with increasing number of infectious individuals and decreases as the room volume increases.
This implies that small area per person communal cells with the presence of infectious indi-
viduals in prisons accelerates the risk of acquiring infectious diseases. Application of Equation
(4.4.2) is demonstrated in Figure 4.4b. From this figure we note that as the number of inmates
increases in prisons with increasing number of infectious individuals, TB transmission proba-
bility becomes extremely high, implying that TB transmission probability in prisons is highly
correlated with overcrowding and increasing number of infectious individuals. By application
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of Equation (4.4.1), we explored the impact of ventilation air change per hour (ACH) under
non-steady state and steady state conditions from the minimum (Q = 3 ACH), intermediate
(Q = 8 ACH) to the maximum (Q = 12 ACH), which is recommended by the WHO for
health care settings. It was noted that the probability of acquiring TB infection increases
as ventilation rate decreases and the number of infectious individuals increases in the given
space (refer to Figure 4.4c). This implies that low per person ventilation rate in prisons is one
of the factors attributed to TB transmission. Figure 4.4d (generalized numerical simulation
of Equations (4.4.1) and (4.4.2)), shows that increasing number of infectious individuals and
duration of exposure are among the factors which accelerate TB transmission probability in
prisons. The fact that a large number of inmates stay in prisons for a long time, some of
whom have already been infected, leads to the increasing risk of TB transmission probability
in prisons and the community at large.
a b
c d
Figure 4.4: Mathematical model simulation, showing TB transmission probability in prisons.
(a) TB transmission probability decreases with increasing room volumes and increases with
increasing number of infectious individuals. (b) TB transmission probability increases with
increasing number of inmates some of whom are infectious individuals. (c) TB transmission
probability increases with increasing number of infectious individuals and decreasing room
ventilation. (d) TB transmission probability increases with increasing number of infectious
individuals and duration of exposure.
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4.4.1 Strategies for TB control in prisons
Identification and isolation of infected from non-infected individuals might be among the best
strategies of reducing TB transmission in prisons. Infected individuals should be identified and
be given a specific living area while undergoing TB treatment. As mentioned earlier, proximity
to infectors and high concentration of airborne infectious particles per air volume are among
the factors attributable to TB transmission. If isolation can be implemented and maintained
in prisons, it can play a vital role in TB control.
Though the value of air change per hour is not well specified for prison environments, natural
ventilation is one of the cheapest effective TB control interventions if implemented properly.
The accumulation and retention of airborne infectious particles in communal cells can be
reduced if natural ventilation can be improved in prisons. Communal cells are highly confined
with a small area per inmate, which is one of the best environments for transmission of
airborne infectious disease, due to high concentration of airborne infectious particles per air
volume and reasonable proximity to infectors. If communal cells can be expanded with large
secured windows, which allow air circulation it can have a greater impact on TB control in
prisons. It has been noted that if communal cells can be expanded to a minimum floor space
of about 5.4 m2 per inmate (International recommendation), TB transmission in prisons can
be reduced by over 50%, and if they can be expanded to a minimum floor space of 3.34 m2
per inmate (South African recommendation), TB transmission can be reduced by 30% [109].
However, since most of the world’s prisons are still highly confined with a high concentration
of polluted air and high rates of transmission of airborne infectious diseases, it means that
these recommendations can not be implemented practically.
As mentioned earlier, overcrowding is one of the problematic factors that leads to high TB
prevalence in prisons. The key question is, what can be done to reduce overcrowding in prisons?
Though it is convincing that prisons are reserved for punishing and reshaping the criminals,
overcrowding and explosion of infectious diseases are threatening the lives of the inmates.
Furthermore, prisoners are acting as a source of TB transmission in the civilian community
after their release, implying that TB burden in prisons affects the civilian community indirectly.
Generally, prison environmental conditions are not conducive to a healthy life, which is why
the prevalence and incidence of airborne infectious diseases are remarkably high. Reducing
overcrowding in prisons can play an important role in TB control, and can be implemented
if the period of those either awaiting sentencing or awaiting trials can be reduced in prisons.
Furthermore, the time spent in confined communal cells for 23 hours per day should be reduced
to either 8 hours or 12 hours per day [109]. This can reduce the prolonged period of exposure
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to infectors and contribute to TB control in prisons.
4.5 Discussion
Using mathematical modelling approach, we demonstrated factors attributable to TB trans-
mission in congregate settings, including schools, households, public transport, health care
settings and prisons. The study suggests that identification, isolation and successful treat-
ment of TB cases in congregate settings is one of the most effective interventions for TB
control in these crucial locations [58]. If identified TB cases can be treated with effective
chemotherapy, it will significantly impact TB control strategies by reducing the number of
airborne infectious particles viable with potential for TB infection.
Insufficient ventilation plays an important role in the transmission of airborne infectious diseases
and if ventilation can be improved, this might be an important intervention for TB control in
congregate settings. However, though ventilation plays a key role in reducing TB transmission,
it does not ensure 100% air disinfection [21, 58], it dilutes the concentration of airborne
infectious particles or moves them from one space of high concentration to another, and it
does not destroy them. Destruction of airborne infectious particles in exhaled air from infectors
should be the most effective intervention for TB control and other airborne diseases.
Ultraviolet germicidal irradiation damages the DNA of airborne pathogens, destroys their repli-
cation ability and makes them non-infectious [21, 58]. Furthermore, ultraviolet germicidal
irradiation has the ability to kill airborne infectious particles in the given space [21, 47, 58]. If
ultraviolet germicidal irradiation can be applied with precautions in different congregate loca-
tions with high likelihood of airborne infectious disease transmission, such as schools, health
care settings and prisons it may have a greater impact on disease prevention and control.
Furtheemore, all modes of public transport should be sterilised after a given number of routes
using ultraviolet germicidal irradiation. Substantial research show that if general ventilation
can be considered together with application of ultraviolet germicidal irradiation, a disinfection
rate of 45 ACH can be achieved if properly installed [58], which may have a greater impact
on TB control. However, the correlation between ventilation and ultraviolet germicidal irra-
diation is not clearly understood, but high rates of ventilation hamper the killing of airborne
infectious particles [58], perhaps because of high dilution. We suggest that both ventilation
and ultraviolet germicidal irradiation should be applied in congregate locations for airborne
infectious disease prevention and control.
Chapter 5
Impact of effective contact rate and
post treatment immune status on
population TB infection and disease
states using a mathematical model
Abstract
Tuberculosis (TB) is transmitted by Mycobacterium tuberculosis (MTB) in an environment
allowing interaction between infectious and susceptible individuals, usually in indoors. Pro-
gression from TB infection to disease depends on the interaction between the immunological
state of the host and the virulence of the pathogen strain. Recent studies of TB vaccines
are investigating high risk individuals who have had active TB and successfully completed a
full course of combination TB chemotherapy. In this study, we explore the population impact
of effective contact rate (β ) and post-treatment immune status on TB epidemiology using a
mathematical model we developed that consists of five states of susceptible, newly infected,
reinfected, active TB and treated individuals. The study explores the population impact of
effective contact rate on TB epidemiology by comparing the number of newly infected and
reinfected individuals at stability point of a TB epidemic with increasing effective contact rate
(ranging from 5 to 30 yr−1). Furthermore, we examine the impact of post-treatment immune
status by comparing the number of active TB cases when all treated individuals move to either
a susceptible, newly infected or reinfected state at stability point of a TB epidemic. This is an
important study population as the incidence of TB can be higher in people recently cured of
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the disease. We found that the number of newly infected cases increases when β = 5 to β = 10
yr−1 then decreases with increasing effective contact rate, while that of reinfected individuals
increases in all values of effective contact rate, implying that TB prevalence might be driven
by reinfection, especially in high burden settings. Furthermore, we noted that the number of
active TB becomes higher when all treated individuals move to a susceptible state than when
they move to either a newly infected or reinfected state, probably because of immunological
factors. Results show that post-treatment immunological memory reduces the risk of active
disease by 7−16% compared to susceptible individuals.
5.1 Introduction
Tuberculosis (TB) is caused and thus transmitted by Mycobacterium tuberculosis (MTB) in
an infective environment with the presence of infectious and susceptible individuals. Effective
contact rate is assumed to be one of the factors correlated with the force of infection, which
fosters TB transmission in a community. For example, TB transmission in congregate settings,
such as households, public transport, schools, and work places is associated with high effective
contact rate between infectious and susceptible individuals [92, 100]. The effective contact rate
between infectious and susceptible individuals varies in different locations depending on the
interactions and environmental exposure. Progression from TB infection to disease depends on
the interaction between the immunological state of the host and the virulence of the pathogen
strain [36]. TB disease may arise either early or late following a new infection and also from
reinfection of previously infected cases. Empirical evidence suggests that reinfection is among
the factors hampering successful TB control [34, 64, 112]. It is unclear what leads to a
remarkably high number of reinfected individuals in the community, but since effective contact
rate is directly correlated with the force of infection, it might be the main driving factor.
Recent studies of TB vaccines are investigating high risk individuals who have had active TB
and successfully completed a full course of combination TB chemotherapy [19, 91]. This
chapter describes a mathematical model we developed that incorporates susceptible, newly
infected, reinfected, active TB and treated individuals to study the population impact of
effective contact rate and post-treatment immune status on TB epidemiology. An infectious
individual with varying effective contact rate (ranging from 5 to 30 yr−1) was introduced
among 100,000 fully susceptible individuals and we observed the number of individuals in
all five states at stability point of a TB epidemic. This range of effective contact rate was
selected because β = 5− 10 yr−1 is related to TB transmission in the United Kingdom in
1900−1950 [34], β = 15 yr−1 is related to TB transmission in schools in South Africa [100],
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and β = 30 yr−1 is related to TB transmission in prisons in South Africa [109]. Here, we
explore the population impact of effective contact rate by comparing the number of newly
infected and that of reinfected individuals at stability point of a TB epidemic, with increasing
effective contact rate. Furthermore, we examine the population impact of post-treatment
immune status by comparing the number of active TB cases when all treated individuals move
to either a susceptible, newly infected or reinfected state with increasing effective contact
rate. This is an important study population as the incidence of TB can be higher in people
recently cured of the disease. The study was divided into three parts and simulated the model
numerically when all treated individuals move to: (i) susceptible (ii) newly infected or (iii)
reinfected state, and we observed the number of individuals in all five states. We compute
the basic reproduction number and eigenvalues from the model when treated individuals move
to all three states of susceptible, newly infected and reinfected to examine the stability of the
disease free equilibrium.
5.2 Methods
5.2.1 Model design and development
The model consists of five states of susceptible individuals (S) who are not yet infected but at
a high risk of acquiring TB infection or disease if become exposed to infectious individual(s),
newly infected individuals (L1) who have been infected once in lifetime with MTB and they can
move to either reinfected or active TB state if become exposed, reinfected individuals (L2)
who have been infected multiple times with MTB and remain latently infected or move to
active TB state through endogenous reactivation, active TB individuals (I) who are infectious
and they can transmit TB, and treated individuals (T ) who were previously infectious and
become cured by chemotherapy and some are still on treatment. Note that the difference
between newly infected and reinfected individuals is that newly infected individuals are latently
infected individuals who have been infected once with MTB and they can develop active
disease through either exogenous reinfection or endogenous reactivation depending on the
virulence of the pathogen strain and immune response of the host, while reinfected individuals
are repeatedly exposed latent TB individuals who can only develop active disease through
endogenous reactivation.
The design and development of the model was based on an actual population in Cape Town,
South Africa, where many already infected individuals are repeatedly exposed to different
infectious sources and become reinfected, and start treatment after acquiring TB disease.
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Furthermore, since natural MTB infection and chemotherapy induce an immune response that
reduces TB susceptibility [65], we take into consideration the fact that treated individuals
move to either a newly infected or reinfected state if they maintain immunological memory
after successful treatment, and if they become susceptible due to waning of the immune
response, they move to a susceptible state. This is because the average duration for the waning
of induced immune response by MTB and chemotherapy is not well understood. However,
if treatment fails or is not completed, they can move back to active disease and become
infectious. As it has been reported that TB disease incidence in TB treated individuals is
several-fold higher than in latently infected [110], we explored post-treatment cases returning
to either the susceptible, newly infected or reinfected immunological state. This approach
makes our model more unique and different from the prior studies, which apply infection force
for treated individuals moving to latent TB states without considering immunological memory
of the host. In order to explore the population impact of effective contact rate and post-
treatment immune status on TB epidemiology, the model does not incorporate the following
states: (i) multi-drug resistance TB (MDR-TB) (ii) vaccination (iii) human immunodeficiency
virus (HIV) infection or (iv) age stratification.
5.2.2 Model description and assumptions
In the development of the model, we assume that the population consists of fully susceptible
individuals, hence, the number of births or recruitment individuals become susceptibles at a
rate π yr−1. When susceptible individuals become infected with MTB, a proportion p in this
group develop active TB very fast and it’s complement proportion 1− p, which constitute
the majority become latently infected and move to a newly infected state depending on the
virulence of the pathogen strain and host immunological factors. Newly infected individuals
are at a high risk of developing active disease through either endogenous reactivation or
exogenous reinfection. Here, we take into consideration that one group of newly infected
individuals develop active TB slowly through endogenous reactivation at a rate c yr−1, and
a fraction q of the second group of newly infected individuals develop active TB very fast
after infection through exogenous reinfection, while a remaining fraction 1-q of this group
move to a reinfected state. Reinfected individuals develop active TB through endogenous
reactivation either fast or slowly at a rate y yr−1, depending on the immunological state of
the host and the virulence of the pathogen strain. Individuals with active TB receive medical
treatment and move to a treated state at a rate k, while some die of active TB at a rate
µt yr−1. Treated and successfully cured individuals may become susceptible and move to a
susceptible state at a rate r or retain immunological memory and move to either a newly
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infected at a rate g or a reinfected state at a rate z yr−1, without exposure to the force of
infection. This is because latently infected and treated individuals acquire an immune response
that reduces TB susceptibility though it may wane and individuals become susceptible. As
mentioned earlier, we only implement treatment for active TB cases because in the real world,
many TB patients only start treatment after active disease development. However, if TB
cases are not well treated, treatment fails or chemotherapy is incomplete, they incubate the
infection and relapse back to active TB at a rate α yr−1. As stated earlier. it has been noted
that latently infected individuals acquire immunity that reduces TB susceptibility [64, 86],
though they can be (re)infected and develop active disease if they become frequently exposed
to infectious individuals in confined spaces. Thus, ω(0 < ω < 1) is the preventive factor due
to prior natural MTB infection, which partially prevents latently infected individuals from TB
susceptibility [64]. In each of the five states, there is a natural mortality rate µ yr−1 as
demonstrated in Figure 5.1.
Figure 5.1: TB transmission model to study the impact of effective contact rate and post-
treatment immune status on TB epidemiology. Parameters are described in Table 5.1.
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From the model (Figure 5.1), we developed a mathematical model as follows:
Ṡ = πN− (θ +µ)S+ rT
L̇1 = (1− p)θS− (c+ωθ +µ)L1 +gT
L̇2 = ω(1−q)θL1− (y+µ)L2 + zT
İ = pθS+(c+ωqθ)L1 + yL2− (k+µ +µt)I +αT
Ṫ = kI− (r+g+ z+α +µ)T

(5.2.1)
where θ = β IN , which is the force of infection, β is the effective contact rate,
I
N is the
prevalence, I is the number of infectious individuals and N is the total number of individuals
in the population. Other parameters are described in Table 5.1.
Table 5.1: Description of parameters used in Figure 5.1. The values of parameters used in
this study were estimated from published literature and computed others by matching infection
and incidence data in South Africa.
Parameters Description Values Reference
β Effective contact rate 5−30 yr−1 estimated
p Probability of fast progression from susceptible to active
TB after infection
0.05 [22, 62]
c Rate of progression from newly infected to active TB
through endogenous reactivation
0.0053 yr−1 [22, 62]
q Probability of moving from newly infected to active TB
through exogenous reinfection
0.03 [112]
y Rate of endogenous reactivation from reinfected to active TB 0.0026 yr−1 [22, 62]
r Rate of moving from treated to susceptible state Variable Depends on the im-
munological status
π Birth or recruitment rate 0.02 yr−1 [17]
g Rate of moving from treated to a newly infected state Variable Depends on the im-
munological status
ω Preventive factor that reduces TB susceptibility due to prior nat-
ural MTB infection
0.21 [91]
z Rate of moving from treated to a reinfected state Variable Depends on the im-
munological status
k Case detection rate from active TB to treated state 0.68 yr−1 [84]
α Rate of treatment failure and move to active TB 0.01 yr−1 [62]
µ Natural mortality rate 0.02 yr−1 [112]
µt Active TB mortality rate 0.075 yr−1 [84]
Computed values: In the design of the model, we take into consideration that treated and
successfully cured individuals may become either susceptible or immune due to immunological
memory. Thus, successful treatment = 1 - relapse (α), such that Q = 1−α . Where Q = r,g
or z. Or r = g = z = 0, depending on immunological status.
Disease free equilibrium is defined as the point at which there is no existence of the dis-
ease in the population. By computing S, L1, L2, I and T at disease free equilibrium (i.e.,
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L1 = L2 = I = T = 0) and assuming that birth rate is equal to death rate, we obtain dis-
ease free equilibrium point as (So,Lo1,L
o
2, I
o,T o) = (N,0,0,0,0). This implies that at dis-
ease free equilibrium, the total number of population is equal to that of susceptible individ-
uals, such that N = S. However, during epidemic active disease at any time, t, we have
N(t) = S(t) + L1(t) + L2(t) + I(t) + T(t), implying that the population is comprised of all five
states and disease free equilibrium might be unstable. The model is epidemiologically bal-
anced. From the mathematical model (Equation 5.2.1), we compute the basic reproduction
number to determine the stability of the disease free equilibrium as discussed below.
5.2.3 Basic reproduction number
Basic reproduction number (Ro) is the average number of secondary cases generated by a
single case connected with the fully susceptible population [31, 62, 75]. We use the next
generation method to determine the basic reproduction number, which is an important figure
in the epidemiology of infectious diseases. It is among the most frequently estimated quantities
to predict the outbreak of infectious diseases, and its value provides information for designing
control interventions for the infectious disease burden [62, 75]. Ro thus plays an important
role in the analysis of infectious disease models, such as TB [22]. If Ro < 1, the disease free
equilibrium is asymptotically stable, and it is unstable if Ro > 1 [31, 62, 75].
The next generation method is used extensively to compute the basic reproduction number,
though numerous other methods are discussed in the literature [75]. It generates a next
generation matrix, and the basic reproduction number is the spectral radius of this matrix.
The next generation matrix is defined as a matrix that relates the numbers of newly infected
individuals in the various states in consecutive generations [75]. The dominant eigenvalue in a
next generation matrix is referred to as the basic reproduction number. The next generation















o,T o) are the transmission and transition matrices (n×n matrix) at disease

















for i, j = 1, · · · ,n
where xo is the disease free equilibrium, fi is the rate of appearance of the new infection in
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classes, vi is the transfer of the infection from one class to another and n is the number of
infective classes.
However, prior to the formation of the next generation matrix, we generate the transmission
( f ) and transition (v) subsystems from Equation (5.2.1). We then linearise subsystems f and v
by applying the Jacobian (Jc) and obtain matrices F(S,L1,L2, I,T ) and V (S,L1,L2, I,T ), which
are n×n transmission and transition matrices, respectively. The transmission subsystem is an
infected subsystem that describes the production of newly infected individuals and changes
in the states of existing infected individuals. The transition subsystem is the transfer of the
infection from one class to another. On the other hand, the transmission matrix describes the
production of new infections, and the transition matrix describes changes of infected states,
such as the immunity acquisition or removal by death [75]. Considering Equation (5.2.1), the



































































−πN +(β IN +µ)S− rT
(c+ωβ IN +µ)L1−gT
(y+µ)L2− zT
−cL1− yL2 +(k+µ +µt)I−αT
−kI +(r+ z+g+α +µ)T

In Figure 5.1, there are three infected states, which are L1, L2 and I, giving a 3× 3 matrix.
Hence, we form the transmission matrix, F(S,L1,L2, I,T ), by applying Jacobian (see Equation
(5.2.2)) in f with respect to L1, L2 and I as
F(S,L1,L2, I,T ) =

0 0 (1− p)β SN
ω(1−q)β IN 0 ω(1−q)β
L1
N
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0 0 (1− p)β0 0 0
0 0 pβ
 (5.2.4)
By applying the Jacobian with respect to L1, L2 and I in v above, we obtain the transition
matrix, V (S,L1,L2, I,T ), as
V (S,L1,L2, I,T ) =
c+ωβ
I




−c −y k+µ +µt
 (5.2.5)
Substituting disease free equilibrium point into Equation (5.2.5), we obtain the transition








c+µ 0 00 y+µ 0
−c −y k+µ +µt
 (5.2.6)
Since the transition matrix consists of many variables, to be consistent we used a com-
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As mentioned earlier, the basic reproduction number is a spectral radius of the next generation
matrix. Thus, the basic reproduction number, which is also defined as the dominant eigenvalue
in the next generation matrix, was obtained from Equation (5.2.8) as
Ro =
β (µ p+ c)
(k+µ +µt)(µ + c)
The computed basic reproduction number has a positive real part, implying that it might be
greater than 1. As mentioned earlier, if Ro < 1 it means that the risk of TB transmission
is decreasing and it might be controlled by chemotherapy, and if Ro = 1, the risk of TB
transmission is endemic. If Ro > 1, the TB burden is increasing and it cannot be controlled
by the implementation of chemotherapy only, particularly in high TB burden settings, such as
South Africa. We further examined the stability of the disease free equilibrium by computing
eigenvalues as discussed below.
5.2.4 Stability analysis of the disease free equilibrium
Since the basic reproduction number computed in this study has a positive real part, it is likely
to be greater than 1, implying that TB transmission is increasing, regardless of the implemen-
tation of medical treatment. Here, we explore the stability of the disease free equilibrium by
computing eigenvalues in Equation (5.2.1). Disease free equilibrium is stable if all eigenvalues
have negative real parts, and unstable if any of the eigenvalues is positive [31]. Hence, applying
the Jacobian in Equation (5.2.1), gives
J =

−(β IN +µ) 0 0 −β
S
N r
(1− p)β IN −(c+ωβ
I










N y H α
0 0 0 k Q
 (5.2.9)
where H = pβ SN +ωβ
L1
N − (k+µ +µt) and Q =−(r+α + z+g+µ)
The characteristic equation of the model at disease free equilibrium is expressed as
[J0−λ I] = 0
where J0 is the Jacobian matrix (from the model) at disease free equilibrium, λ is the eigenvalue
and I is the identity matrix.
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Substituting disease free equilibrium point (So,Lo1,L
o
2, I
o,T o) = (N,0,0,0,0) into Equation
(5.2.9), minus the product of eigenvalue and identity matrix diagonally, we obtain the model
matrix at disease free equilibrium as follows:
(J0−λ I) =

−µ−λ 0 0 −β r
0 −c−µ−λ 0 (1− p)β g
0 0 −y−µ−λ 0 z
0 c y pβ − (k+µ +µt)−λ α
0 0 0 k R
 (5.2.10)
where R =−(r+α + z+g+µ)−λ
From Equation (5.2.10), we form the characteristic equation, [J0−λ I] = 0, as
(−µ−λ )[(−c−µ−λ )(−y−µ−λ )(pβ − k−µ−µt−λ )(−r−α− z−g−µ−λ )]
−c[(−y−µ−λ )(pβ − k−µ−µt−λ )(−r−α− z−g−µ−λ )] = 0
Simplifying the characteristic equation further, gives
(−y−µ−λ )(pβ−k−µ−µt−λ )(−r−α−z−g−µ−λ )[µ(c+µ)+λ (2µ +c+λ )−c] = 0
From the simplified characteristic equation, we form the following four equations:
− (y+µ)−λ = 0 (5.2.11)
pβ − (k+µ +µt)−λ = 0 (5.2.12)
− (r+α + z+g+µ)−λ = 0 (5.2.13)
λ
2 +(2µ + c)λ +µ2 + cµ− c = 0 (5.2.14)
Using Equations (6.2.7) to (6.2.8), we can determine the eigenvalues that predict the stability
of the disease free equilibrium. As mentioned earlier, disease free equilibrium is stable if
all eigenvalues have negative real parts, and unstable if any of the eigenvalues is positive.
Additionally, if one of the eigenvalues is zero then we cannot tell from stability analysis whether
the disease free equilibrium is stable or unstable. Thus, considering Equations (6.2.7) to
(6.2.8), the eigenvalues are:
λ1 =−(y+µ)< 0
λ2 = pβ − (k+µ +µt)
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(2µ + c)2−4(µ2 + cµ− c)
2
Here, we noted that λ1 and λ3 have negative real parts, and λ2 has a positive real part if pβ >
(k+µ +µt). For stability of the disease free equilibrium, we assume that λ4,5 have negative
real parts (i.e., λ4 < 0 and λ5 < 0). Disease free equilibrium is stable if pβ < (k+µ +µt) and
unstable if pβ > (k+µ +µt), where pβ is the effective contact rate for susceptible individuals
moving direct to active disease. On the other hand, disease free equilibrium is stable if the
effective contact rate for susceptible individuals moving direct to active disease is less than the
summation of case detection, natural death and disease death rates. Otherwise disease free
equilibrium is unstable.
5.2.5 Sensitivity analysis
We conducted sensitivity analysis of the model for all parameters to explore TB progression
influencing factors. We observed the impact of each parameter on the model output and its
sensitivity. Since TB infection and disease progression depends on the host immunological
status and virulence of the pathogen strain, our sensitivity analysis based on TB progression
rate and immune response induced by natural MTB infection and post-treatment immune
status.
5.3 Simulation results
Using data estimated from published literature, varying effective contact rate (ranging from
5 to 30 yr−1) and computed or estimated values by matching infection and incidence data in
South Africa (Table 5.1), we simulated Equation (5.2.1) numerically to explore the population
impact of effective contact rate and post-treatment immune status on TB epidemiology. As
mentioned earlier, the study was divided into three parts where we simulated the model when
all treated individuals move to: (i) susceptible (i.e., z = g = 0,r = 0.99 yr−1) (ii) reinfected
(i.e., r = g = 0,z = 0.99 yr−1) or (iii) newly infected state (i.e., r = z = 0,g = 0.99 yr−1). To
be We performed the sensitivity analysis of these parameters and β In the model simulation,
we used the initial assumption that S = 100,000, L1 = L2 = T = 0 and I = 1, implying that an
infectious individual was introduced among 100,000 fully susceptible individuals. The epidemic
was observed for 700 years when β = 5 yr−1 and 200 years when β ≥ 10 yr−1 so that the TB
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epidemic stability point could be attained.
Here, we observed the number of individuals in all five states at stability point of a TB epidemic
with increasing effective contact rate, and compared the number of newly infected and that of
reinfected individuals. We also compared the number of active TB cases schematically when
all treated individuals move to a susceptible, newly infected or reinfected state at stability point
of a TB epidemic. We found that the number of newly infected cases increases when β = 5
to β = 10 yr−1 then decreases with increasing effective contact rate, while that of reinfected
individuals increases in all values of effective contact rate (Tables 5.2, 5.3 and 5.4), implying
that a large number of active TB cases might be contributed by repeatedly exposed individuals.
The number of active TB individuals was increasing with increasing effective contact rate, but
lower than that of newly infected and reinfected individuals. Of all five states, the number of
treated individuals was noted to be the lowest, probably because treated individuals become
either susceptible and move to a susceptible state or retain immunological memory and move
to either a newly infected or reinfected state. We noted that as the effective contact rate
increases, the number of susceptible individuals decreases dramatically with a steep slope until
a stability point is attained, implying that effective contact rate is an important factor, which
determines the likelihood of TB infection and disease in the community.
Observing the number of active TB cases when treated individuals move to a susceptible,
newly infected or reinfected state, we noted the highest number of active TB cases when
all treated individuals move to a susceptible state (Tables 5.2, 5.3 and 5.4). We went on
to compare the number of active TB cases schematically when treated individuals move to
a susceptible, newly infected or reinfected state and found that when all treated individuals
become susceptible, the number of active TB cases becomes higher than moving to either
a newly infected or reinfected state (Figure 5.5), perhaps because individuals moving to a
newly infected or reinfected state have more protection due to immunological memory than
susceptible individuals. These findings imply that treated individuals are at high risk of active
disease acquisition if they become susceptible, probably because of immunological factors.
The time taken for a TB epidemic to reach the peak and stability points was noted to decrease
with increasing effective contact rate in all cases, implying that effective contact rate is directly
correlated with the force of infection. Here, we show that the number of active TB cases in the
community is contributed by both newly infected and reinfected after developing TB disease,
though TB prevalence might be driven by reinfection force, because the number of reinfected
individuals becomes higher than that of newly infected individuals at stability point of a TB
epidemic when β ≥ 20 yr−1. Tables 5.2, 5.3 and 5.4 summarise results in Figures 5.2, 5.3 and
5.4, while Figure 5.5 compares TB cases as the impact of post-treatment immune status.




Figure 5.2: Numerical simulation of a mathematical model (Equation (5.2.1)) to explore the
impact of effective contact rate when all treated individuals move to a susceptible state.
(a) T moving to S when β = 5 yr−1. (b) T moving to S when β = 10 yr−1. (c) T moving to
S when β = 15 yr−1. (d) T moving to S when β = 20 yr−1. (e) T moving to S when β = 25
yr−1. (f) T moving to S when β = 30 yr−1. Note: S = susceptible, L1 = newly infected, L2
= reinfected, I = active TB, T = treated.




Figure 5.3: Numerical simulation of a mathematical model (Equation (5.2.1)) to explore the
impact of effective contact rate when all treated individuals move to a newly infected state.
(a) T moving to L1 when β = 5 yr−1. (b) T moving to L1 when β = 10 yr−1. (c) T moving
to L1 when β = 15 yr−1. (d) T moving to L1 when β = 20 yr−1. (e) T moving L1 when
β = 25 yr−1. (f) T moving to L1 when β = 30 yr−1. Note: S = susceptible, L1 = newly
infected, L2 = reinfected, I = active TB, T = treated.




Figure 5.4: Numerical simulation of a mathematical model (Equation (5.2.1)) to explore the
impact of effective contact rate when all treated individuals move to a reinfected state.
(a) T moving to L2 when β = 5 yr−1. (b) T moving to L2 when β = 10 yr−1. (c) T moving
to L2 when β = 15 yr−1. (d) T moving to L2 when β = 20 yr−1. (e) T moving to L2 when
β = 25 yr−1. (f) T moving to L2 when β = 30 yr−1. Note: S = susceptible, L1 = newly
infected, L2 = reinfected, I = active TB, T = treated.
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Table 5.2: Comparison of the number of individuals in all five states at stability point of a
TB epidemic, when all treated individuals move to a susceptible state (Figure 5.2).
Effective contact rate Susceptible Newly infected Reinfected Treated Active TB
5 62678 29732 2646 212 311
10 32142 43660 19017 330 484
15 21964 41517 30800 357 525
20 16607 37767 39375 371 545
25 13392 34821 45803 379 556
30 11250 31607 50892 382 561
Table 5.3: Comparison of the number of individuals in all five states at stability point of a
TB epidemic, when all treated individuals move to a newly infected state (Figure 5.3).
Effective contact rate Susceptible Newly infected Reinfected Treated Active TB
5 52232 37767 5089 197 289
10 27053 46607 20625 319 469
15 18482 43392 32142 351 515
20 14196 39375 40714 364 535
25 11250 35625 46607 371 545
30 9642 32946 51428 375 550
Table 5.4: Comparison of the number of individuals in all five states at stability point of a
TB epidemic, when all treated individuals move to a reinfected state (Figure 5.4).
Effective contact rate Susceptible Newly infected Reinfected Treated Active TB
5 56517 27589 11517 177 260
10 28928 37232 28392 298 438
15 19821 35089 39107 330 484
20 15000 32678 46607 344 505
25 12053 30000 52500 351 515
30 9910 27053 56785 354 520
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Figure 5.5: Active TB cases when all treated individuals move to either a susceptible, newly
infected or reinfected state at stability point of a TB epidemic (Tables 5.2, 5.3 and 5.4).
TB becomes higher when treated individuals become susceptible than moving to either newly
infected or reinfected. S = susceptible, L1 = newly infected, L2 = reinfected, T = treated.
5.4 Discussion
Using a mathematical model developed in this study, we investigated the impact of effective
contact rate and post-treatment immune status on TB epidemiology, with the caveat that this
is a simple model assuming a homogeneous population without age stratification and HIV.
However, the model has major findings: Susceptible (S), newly infected (L1), reinfected (L2),
active TB (I), and treated (T ) individuals are all affected in a non-linear relationship with
effective contact rate. While it is intuitive that the number of susceptible individuals declines
with increasing effective contact rate the other states are more complex. When β < 20 then
L1 > L2 if T move to either S or L1 and when β ≥ 20 then L2 > L1. Treatment and active
TB rates are also non-linear, if effective contact rate decreases from 30 to 25 yr−1 then the
decline in TB cases is 5/100,000 but a reduction of 10 to 5 yr−1 produces a decline of
177(range,173− 180)/100,000. This may explain the empiric finding that TB notification
rates are relatively insensitive to moderate improvements in case finding in high burden settings.
E.g. the Zamstar study and the Word Health Organisation (WHO) observation of very little
data on the impact of enhanced case finding in high burdened settings [53]. This is also
compatible with the modelling of TB transmission in South African prisons [109]. At high
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effective contact rate (i.e., β ≥ 20) there is a high proportion of cases from L2 rather than L1.
This is compatible with the observation that 20−25% of TB cases are re-treatment cases in
high TB burden settings, such as Cape Town. Active TB can decline by 16% when individuals
are multiply infected in low transmission settings with effective contact rate of 5 yr−1, and 7%
in high transmission transmission settings with effective contact rate of 30 yr−1 compared to
susceptible individuals (Figure 5.5). This implies that post-treatment immunological memory
reduces the risk of active disease by 7−16% compared to susceptible individuals.
The early peak values in TB rates demonstrate that there may be temporary peaks followed by
apparent improvements in notifications when TB disease is introduced into a new susceptible
population e.g. Eskimo epidemics [116]. The time course of TB epidemiology is long, and
the status of the post-treatment state is something that prior models have ignored. Loss
of protective factor of newly infected following treatment (or prophylaxis which is a form of
treatment) could have major negative epidemiological consequences.
The findings in this study suggest that TB prevalence is driven by reinfection force, particularly
in high TB burden settings. Though chemotherapy and prior natural MTB infection induce an
immune response that reduces TB susceptibility [65], the number of reinfected individuals con-
tinues increasing dramatically. The source of reinfection strains is not clearly understood but
the increasing number of reinfected individuals might be accelerated by the force of infection
due to high effective contact rate and duration of exposure in congregate areas in particular.
In conclusion, TB control strategies cannot only depend on medical recovery, extra effort is
required, for example, reducing effective contact rates between infectious and susceptible in-
dividuals in the community. If post-treatment immune status can be improved by vaccination,
it may significantly empower medical treatment.
Chapter 6
Impact of vaccination on TB control
Abstract
Despite the fact that a tuberculosis (TB) vaccine has been implemented globally, TB remains
a public health concern that causes morbidity and mortality in the community. Here, we
designed an age-structured mathematical model that incorporates vaccination for susceptible
individuals (young age groups [0−5) and [5−15) years) to explore the impact of the vaccine
on TB control in high TB burden settings, such as Cape Town. In order to explore the impact
of the vaccine, the study was divided into two parts: (i) without vaccination and (ii) with
vaccination, and we observed TB notification rates in different age groups. We schematically
compared TB notification rates in the first case with the observed TB notification rates in
Cape Town in 2009 so that to show if TB is decreasing or increasing. We found that in the
first case, high rates of active TB were detected for the age groups [0−5), [15−25), [35−45)
and [45− 55) years with notification rates 592, 546, 531 and 569 per 100,000 population,
respectively. In the second case, when the vaccine was introduced in the population, active
TB decreased for the age groups [0−5), [5−15) and [15−25) years by 43.92%, 60.20% and
71.61%, respectively. The lowest TB notification rate was detected in the age group [5−15)
years in both cases. However, active TB remains high for the age groups [25− 35) to ≥ 75
years in both cases, suggesting that these age groups are at excessively high risk of developing
TB disease. Results in the first case show that TB has increased for the age groups [0−5),
[15− 25), [25− 35), [55− 65), [65− 75) and ≥ 75 years, and decreased for the age groups
[35−45) and [45−55) years, compared to the 2009 study. The findings in this study suggest
that active disease progression depends on age and average duration of the waning of the
vaccine effect.
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6.1 Introduction
The Bacille Calmette Guerin (BCG) vaccine has been noted to induce immune protection
against tuberculosis (TB) for about 0−80% of individuals [65], whilst other studies demon-
strated that vaccinated individuals are 70−80% protected from TB disease [26, 50]. Further-
more, though there is no empirical data about BCG vaccine protection against TB infection, it
is assumed that only 77% of the vaccinated individuals might be protected against TB disease
[34]. Since they are not 100% protected, vaccinated susceptible individuals may acquire TB
infection and develop active disease.
Prior infected individuals have greater defence mechanisms against TB than uninfected ones
because the previous Mycobacterium tuberculosis (MTB) infection induces an immune re-
sponse that reduces TB susceptibility [34, 65, 86]. For example, a study conducted in Norway
in 1927 on the BCG vaccine, noted that vaccinated-uninfected and prior infected student nurses
had a significantly lower risk of acquiring TB than unvaccinated and uninfected individuals
[12]. Additionally, a study conducted by Vynnycky and Fine (1997) using an age-structured
model and data from England and Wales, demonstrated that natural MTB infection confers
a minimum protection of 16% and 41% against TB disease in a respective age group of 15
and over 20 years [34], which is a lower level of protection than that noted in the BCG vac-
cine (0− 80%) [12, 65]. Furthermore, Andrews et al (2012) [91] estimated that the risk of
developing active disease for the latently infected is 79% lower than uninfected individuals,
implying that the immune protection induced by natural MTB infection is approximately equal
to that of the BCG vaccine. The cause of greater diversity of the BCG vaccine and natural
MTB induced immunity is not clearly understood, and more research is needed.
Despite the fact that vaccinated and medically recovered individuals acquire immunity that
reduces TB susceptibility [86], they can be (re)infected and develop active disease if they
become frequently exposed to infectious individuals in confined spaces and inhale airborne
infectious particles, which are viable with potential for TB infection and disease. Furthermore,
though latently infected individuals acquire immunity that prevents TB progression, they can
develop active TB through either endogenous reactivation or exogenous reinfection if they
interact with infectious individuals in confined spaces for long periods of exposure [65]. Since
more than 60% of children become infected by the age of 16 years, there are only two ways
that a vaccine can be useful in adolescents: first, if the vaccines provide superior immunity to
natural MTB infection, perhaps through better cross-strain immunity, and second, if immunity
conferred by natural MTB infection wanes. Though, natural MTB infection and the BCG
vaccine induce an immune response that reduces TB susceptibility, it is not well understood
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if the immunity conferred by natural MTB infection wanes, and there is no empirical study
comparing the average duration of the waning of the immunity induced by natural MTB
infection and that of the BCG vaccine.
Although it is not known if the BCG vaccine confers a superior immune response to natural
MTB infection, the frequency of exposure to MTB reduces the efficacy of the BCG vaccine
and airborne infectious particles dominate the immunological state of the host when they reach
the threshold level [65]. The BCG vaccine improves natural immunity but does not reduce or
improve immune response induced by the prior natural MTB infection. However, as mentioned
earlier, natural MTB infection reduces BCG vaccine efficacy if vaccinated susceptible individual
become frequently exposed to infectious individual(s) [65]. This reflects the fact that BCG
vaccine efficacy becomes poor in high TB burden settings due to a high level of reinfection,
and TB burden continues, regardless of vaccination. The BCG vaccine is thus more effective in
low TB burden settings. The key question is, does the BCG vaccine induce a superior immune
response that reduces active TB progression in all age groups?
Here, we use an age-structured mathematical model that incorporates vaccination for sus-
ceptible individuals (young age groups [0− 5) and [5− 15) years) to explore the impact of
the vaccine on TB control in high TB burden settings, such as Cape Town. The study was
divided into two parts: (i) without vaccination and (ii) with vaccination, and we observed TB
notification rates in different age groups. We compared TB notification rates in this study
with that observed in Cape Town in 2009 [102] to show if TB is increasing, decreasing or
endemic in different age groups.
6.2 Methods
6.2.1 Model description and assumptions
For our study we preferred an age-structured model because, in reality, infection and disease
rates vary in different populations depending on age and host immunological factors [34]. In
order to explore the impact of the vaccine in different age groups, human immunodeficiency
virus (HIV) infection and multi-drug resistant TB (MDR-TB) contributions are not incorpo-
rated in the design of the model. In the development of the model, we make an assumption
that the BCG vaccine and prior MTB infection have the same protective factor, which reduces
TB susceptibility. Furthermore, we assume that susceptible or vaccinated individuals develop
active TB after latent TB acquisition, and treatment starts if the test indicates active disease.
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The model is comprised of six states of susceptible individuals, S(a, t) who are not yet infected
but are at a high risk of acquiring infection; vaccinated individuals, V (a, t) who are partially
protected against TB disease; early latent TB, E(a, t) who are primarily infected by MTB and
are at high risk of developing TB disease after few years (< 5 years); late latent TB individuals,
L(a, t) with latent TB infection who take a long time (≥ 5 years) to develop TB disease through
endogenous reactivation or revert to early latent TB through exogenous reinfection; active TB
individuals, I(a, t) with active disease who can transmit TB to susceptible individuals; and
treated individuals, T (a, t) who are cured by chemotherapy, and others are still on treatment.
6.2.2 Model design and development
Considering a and t as the variables denoting respectively age and time, we design the age-
structured model as follows: New born individuals at a rate λ (t), attain susceptibility and
move to a susceptible state, where they get vaccinated with BCG vaccine at a rate θ(a).
However, the vaccine wanes at a rate ψ(a) after vaccination, let’s say after a′ years (usually
10− 15 years), and an individual becomes susceptible to TB [36]. In other words, for a
vaccinated individual at age a, the vaccine wanes at age a+ a′ and this individual again
becomes susceptible to TB. When susceptible individuals come into contact with infectious
individuals with the force of infection (FOI), Λ(t) = β I(t), they acquire early latent TB, where
β is the effective contact rate between infectious and susceptible individuals, and I(t) is the
number of infectious individuals. The vaccinated individuals become infected and move to
either an early or late latent TB state depending on the infecting pathogen strain and the
host acquired immune response. Early latent TB individuals progress to active TB at a rate
k(a) within few years after infection (< 5 years), and others move to late latent TB at a
rate δ (a), depending on the host immune response and infecting pathogen strain. Late latent
TB individuals move to active TB at a rate p(a) through endogenous reactivation, and some
become reinfected and revert to early latent TB. As mentioned earlier, the BCG vaccine and
prior MTB infection induce an immune response, which reduces TB susceptibility. Thus,
y(a)(0 < y(a)< 1) is the protection by BCG vaccine and z(a)(0 < z(a)< 1) is the protection
by natural MTB infection from TB susceptibility. However, the protection factor from the
vaccine is assumed to be approximately equal to that of natural MTB infection, such that
y(a)≈ z(a) [91]. Active TB individuals detected at a rate c(a) move to a treated state, while
some die from active disease at a rate µT . Furthermore, some active TB individuals recover
naturally at a rate f (a) and move to late latent TB due to immune retention. They are not
infectious. Treated and successfully cured individuals may either become susceptible and move
to a susceptible state at a rate d(a) if the immune response wanes or become immune if they
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retain immunological memory and move to a late latent TB state at a rate r(a). However, due
to incomplete treatment, treatment failure or immunological factors, some treated individuals
retain infection and revert to active TB at a rate ω(a). We assume that in each state, there is
a natural mortality rate of µ(a) as demonstrated in Figure 6.1. Note that rates are per year.
Figure 6.1: Age-structured model that incorporates vaccination, showing TB transmission.
S(a, t) = susceptible, V (a, t) = vaccinated, E(a, t) = early latent TB, L(a, t) = late latent TB,
I(a, t) = active TB and T (a, t) = treated individuals. Parameters are described in Table 6.1
Section 6.2. Methods Page 104


























L(a, t) = qΛ(t)y(a)V (a, t)+δ (a)E(a, t)− [Λ(t)z(a)+ p(a)






I(a, t) = k(a)E(a, t)− [c(a)+ f (a)+µ(a)+µT (a)]I(a, t)






T (a, t) = c(a)I(a, t)− [d(a)+ω(a)+ r(a)+µ(a)]T (a, t)

(6.2.1)
where Λ(t) = β I(t), which is the force of infection, β is an effective contact rate and I(t) is
the number of infectious individuals at any time t. Other parameters are described in Table
6.1, and corresponding values in Table
Table 6.1: Description of parameters used in Figure 6.1. Parameter values are demonstrated
in Table 6.2.
Parameters Description Units
λ (t) Birth rate at time t yr−1
β Effective contact rate between infectious and susceptible individuals yr−1
y(a) Protective factor due to vaccination
z(a) Protective factor due to prior natural MTB infection
θ(a) Vaccination rate of age a from susceptible to vaccinated state yr−1
ψ(a) Vaccine waning rate of age a from vaccinated to susceptible state yr−1
q Probability of moving from vaccinated to late latent TB state
k(a) Progression rate of age a from early latent TB to active TB yr−1
p(a) Endogenous reactivation rate of age a from late latent TB to active TB yr−1
r(a) Rate of moving from treated to late latent TB state yr−1
f (a) Rate of natural recovery from active TB yr−1
δ (a) Rate of moving from early latent TB to late latent TB as a function of age yr−1
c(a) Case detection rate of age a from active TB to treated state yr−1
ω(a) Rate of treatment failure or relapse from treated to active TB yr−1
d(a) Rate of moving from treated to susceptible state yr−1
µ(a) Natural mortality rate as a function of age yr−1
µT (a) TB mortality rate as a function of age yr−1
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Table 6.2: Values of parameters described in Table 6.1. These values were estimated from
published literature and South African statistics.
age (years)
parameters [0−5) [5−15) [15−25) [25−35) [35−45) [45−55) [55−65) [65−75) ≥ 75 reference
λ 0.0189 0 0 0 0 0 0 0 0 [17]
β 20.0 20.0 20.0 20.0 20.0 20.0 20.0 20.0 20.0 estimated
y 0.80 0.80 0.80 0.80 0.79 0.79 0.79 0.79 0.79 [65, 91]
θ 0.713 0.380 0 0 0 0 0 0 0 [36]
ψ 0.06 0.06 0.13 0.13 0.13 0.13 0.20 0.20 0.20 [27]
q 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 [65]
k 0.240 0.02 0.150 0.150 0.20 0.220 0.20 0.175 0.175 [71]
p 0.0002 0.0002 0.0002 0.0002 0.0002 0.0002 0.0002 0.0002 0.0002 [65]
r 2.0 2.0 2.0 2.0 2.0 2.0 2.0 2.0 2.0 computed
f 0.20 0.20 0.25 0.25 0.25 0.20 0.20 0.15 0.15 [27]
δ 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 estimated
c 0.61 0.61 0.61 0.61 0.61 0.61 0.61 0.61 0.61 [84]
ω 0.015 0.015 0.01 0.01 0.01 0.015 0.01 0.015 0.015 [63]
d 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 computed
µ 0.039 0.007 0.024 0.061 0.07 0.069 0.072 0.067 0.058 [18]
µT 0.075 0.075 0.075 0.075 0.075 0.075 0.2 0.5 0.5 [84]
Data computation and assumptions: Average duration of infectiousness (ρ) was assumed to
be 6 months in all age groups, such that ρ = 0.5 yr. Thus, the rates of moving from treated to
late latent TB (immune), r(a), and susceptible, d(a), in Table 6.2 were computed as follows:
r(a) = 1
ρ
, and d(a) = r(a)(1−ρ). Note: the square bracket indicates that the age is included,
while the round bracket means it is not included.
6.2.3 Initial and boundary conditions




Thus, at age a = 0 and time t, initial conditions are set as follows:
S(0, t) = λ (t),V (0, t) = E(0, t) = L(0, t) = I(0, t) = T (0, t) = 0
This implies that at age 0 and time t, disease free equilibrium is stable without vaccination,
infection, active disease and treatment. Thus, the number of births corresponds to the small
variation or change in the total number of individuals in the population aged 0 at time t, such





implying that at age 0 and any time t, the number of susceptible individuals is equal to the
total population as:
N(0, t) = S(0, t)
However, at age a and time t = 0, the following initial condition is fulfilled:
S(a,0)= S0(a),V (a,0)=V0(a),E(a,0)=E0(a),L(a,0)=L0(a), I(a,0)= I0(a),T (a,0)=T0(a)
At age a and time t, disease free equilibrium is unstable and the population is comprised of all
six states, such that:
N(a, t) = S(a, t)+V (a, t)+E(a, t)+L(a, t)+ I(a, t)+T (a, t),
implying that at any time t and age a, there are different age groups in the population from







N(a, t) = λ (t)−µ(a)N(a, t)−µT (a)I(a, t)







N(a, t) = λ (t)−µ(a)N(a, t),
showing that the model is epidemiologically balanced.
6.2.4 Finite difference scheme and solution existence
In order to analyse the dynamics and different states of the system (6.2.1), we can explicitly
express the time dependent solution, under the assumption that age depends on time, i.e.,













Letting dadt = 1, we get:









Thus, for the system (6.2.1), the time dependent solution (S(t), V (t), E(t), L(t), I(t), T (t))
satisfies:
d
dt S(t) = λ (t)− [Λ(t)+θa(t)+µa(t)]S(t)+ψa(t)V (t)+da(t)T (t)
d
dtV (t) = θa(t)S(t)− [ψa(t)+Λ(t)ya(t)+µa(t)]V (t)
d
dt E(t) = Λ(t)S(t)+(1−q)Λ(t)ya(t)V (t)− [ka(t)+δa(t)+µa(t)]E(t)
+Λ(t)za(t)L(t)
d
dt L(t) = qΛ(t)ya(t)V (t)+δa(t)E(t)− [Λ(t)za(t)+ pa(t)+µa(t)]L(t)
+ fa(t)I(t)+ ra(t)T (t)
d
dt I(t) = ka(t)E(t)+ pa(t)L(t)− [ca(t)+ fa(t)+µa(t)+µTa(t)]I(t)
+ωa(t)T (t)
d
dt T (t) = ca(t)I(t)− [da(t)+ωa(t)+ ra(t)+µa(t)]T (t)

(6.2.2)
with sa(t) = s(a) for a given parameter s(a) and initial conditions given by S(0) = S0(a),
V (0) = V0(a), E(0) = E0(a), L(0) = L0(a), I(0) = I0(a) and T (0) = T0(a). Therefore, from
the well known the Picard’s existence theorem, the solution exists.
Here, we approximate the solution of the system of the partial differential equations in Sys-
tem (6.2.1) by estimating the partial derivative functions ∂S
∂ t and
∂S
∂a . In System (6.2.1), a and
t are two independent variables denoting respectively age and time in a grid of equal intervals
such that 4a =4t = h, where h is a forward step interval and −h indicates the backward step
interval. We use Taylor series and apply truncation to form the backward-difference for partial
derivatives. We prefer backward-difference rather than forward-difference because it projects
the exact age and time in real life. Let us consider a grid as a function of age and time with
equal intervals and use Taylor series in backward-difference as follows:




which can be written as
S(a−h, t) = S(a, t)−S′(a, t)h+O(h2) (6.2.4)
Solving for S′(a, t) = ∂S(a,t)
∂a in Equation (6.2.4) and dividing by h both sides, we obtain:







For an error, O(h) being very small (i.e., O(h)≈ 0), Equation (6.2.5) becomes:
∂S(a, t)
∂a
≈ S(a, t)−S(a−h, t)
h
(6.2.6)
In numerical schemes for solving partial differential equations we assume a grid with discrete
value a j = jh for j = 1,2, . . . ,M and tn = nh for n = 1,2, . . . ,N. Assuming a grid with constant
spacing as stated before, we take into account that a j − h = a j−1 and tn− h = tn−1 then




S(a j, tn)−S(a j−h, tn)
h
=
S(a j, tn)−S(a j−1, tn)
h
(6.2.7)
using the same procedure and solving for ∂S(a,t)
∂ t , we obtain:
∂ (a j, tn)
∂ t
≈
S(a j, tn)−S(a j, tn−h)
h
=
S(a j, tn)−S(a j, tn−1)
h
(6.2.8)

































We can now design a numerical scheme to approximate the solution of System (6.2.1) of
partial differential equations or better the initial boundary value of System (6.2.1). This
scheme consists of solving the following system of linear equations:















h = θ jS
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h = c jI
n
j − (d j +ω j + r j +µ j)T nj

(6.2.11)
Multiplying by h both sides in System (6.2.11) and simplify further by making the previous
known initial condition the subject at right hand side, we obtain:
(2+h(Λn +θ j +µ j))Snj −h(ψ jV nj +d jT nj ) = hλ n +Snj−1 +S
n−1
j
(2+h(ψ j +Λny j +µ j))V nj −hθ jSnj =V nj−1 +V
n−1
j
(2+h(k j +δ j +µ j))Enj −h(ΛnSnj +(1−q)Λny jV nj +Λnz jLnj) = Enj−1 +E
n−1
j
(2+h(p j +Λnz j +µ j))Lnj −h(qΛny jV nj +δ jEnj + f jInj + r jT nj ) = Lnj−1 +L
n−1
j
(2+h(c j + f j +µ j +µT j))I
n
j −h(k jEnj + p jLnj +ω jT nj ) = Inj−1 + I
n−1
j





System (6.2.12), is a system of linear equations written in matrix form as
Ax = b (6.2.13)
where A is a coefficient matrix, x is the variable matrix and b is a vector in System (6.2.12).
Hence, System (6.2.12) can be written in matrix form as follows:

G −hψ j 0 0 0 −hd j
−hθ j K 0 0 0 0
−hΛn h(q−1)Λny j M −hΛnz j 0 0
0 −hqΛny j −hδ j Q −h f j −hr j
0 0 −hk j −hp j R −hω j
































where G = 2+ h(Λn + θ j + µ j), K = 2+ h(ψ j +Λny j + µ j), M = 2+ h(k j + δ j + µ j), Q =
2+h(Λnz j + p j +µ j), R = 2+h(c j + f j +µ j +µT ) and W = 2+h(d j +ω j + r j +µ j).
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System (6.2.14) can be solved using any known solver of systems of linear equations. Thus,
using a Python package by applying data in Table 6.2 into System (6.2.14), we explored the
impact of vaccination on TB control numerically as discussed in Section 6.3. In our simulation,
we used step interval, h = 0.05.
6.3 Simulation results
We simulated the model numerically, while taking into consideration that each age group
has its own parameters, which monitor TB dynamics. Furthermore, we consider that all
age groups show an increasing TB notification rates over time. We therefore discretised the
model to match the data and simplified it further into matrix form (Equation (6.2.14)) for
easier coding and numerical simulation. Applying data estimated from published literature
and computed values by matching infection and incidence data in South Africa (Table 6.2)
in Equation (6.2.14), we simulated 100,000 fully susceptible individuals in two different ways:
(i) without vaccination (i.e., θ = 0 for all age groups) and (ii) with vaccination (i.e., θ 6= 0 for
the age groups [0−5) and [5−15) years). We schematically compared TB notification rates
in this study with the observed TB notification rates in Cape Town in 2009 [102] to determine
whether TB is decreasing, increasing or endemic in different age groups.
The model detected TB notification rates in different age groups with different peaks in
both cases (Figures 6.2a and 6.3a). In the first case (without vaccination), the highest TB
notification rate peaked for the age group [0−5) years with notification rate 592 per 100,000
population because of immature immunity and higher TB progression rate than any other
group. The second peak was observed for the age group [45−55) years with notification rate
569 per 100,000 population, followed by age groups [15−25), [25−35) and [35−45) years
with notification rates 546, 454 and 531 per 100,000 population, respectively (Figure 6.2a).
Comparing TB notification rates in the first part in this study with that observed in the 2009
study, we found that the shapes of the produced models in the two studies are the same, and
TB notification rates are the same in the age group [15−25) years. However, in this study, we
noted higher TB notification rates for the age groups [0−5), [5−15) and [25−35) years, and
lower TB notification rates for the age groups [35−45) and [45−55) years than that reported
in the 2009 study. Furthermore, we noted the difference in the two studies for the age groups
[55−65) to ≥ 75 years, where the 2009 study observed the decline of TB notification rates in
these age groups, while the findings in this study show that TB notification rates remain high,
probably because of different immunological memories and mortality rates in the two studies.
On the other hand, the findings in this study suggest that TB has increased for the age groups
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[0−5), [15−25), [25−35), [55−65), [65−75) and ≥ 75 years, and decreased for the age
groups [35−45) and [45−55) years, compared to the 2009 study (Figure 6.2b). This implies
that TB mortality rate might be higher for some age groups in the 2009 study than the current
study, probably because of treatment improvement. Furthermore, TB notification rates seem
to be low in the 2009 for young age groups (age groups [0−5) and [5−15) years) because
of vaccination impact compared to the model prediction in the first part in this study.
In the second case, when the vaccine was introduced in the population, active TB decreased for
the age groups [0−5) years by 43.92% (from 592 to 332), [5−15) years by 60.20% (from 108
to 43) and [15−25) years by 71.61% (from 546 to 155 per 100,000 population) compared to
non-vaccination prediction. However, regardless of vaccination, active TB remains remarkably
high for the age groups [25− 35), [35− 45), [45− 55), [55− 65), [65− 75) and ≥ 75 years
with notification rates 454, 531, 569, 471, 352 and 369 per 100,000 population, respectively
(Figure 6.3a), implying that the current vaccine may not have an impact on these age groups.
Furthermore, these age groups are at excessively high risk of developing TB disease, probably
because of the short average duration of the vaccine efficacy and some immunological factors.
Comparing TB notification rates in the second part in this study with that observed in the
2009 study, we show that the model predicted lower TB notification rates for the age groups
[0−5), [5−15) and [15−25) years than the 2009 study (Figure 6.3b). We noted that TB
notification rates for other age groups remain the same as predicted in the first part in this
study.
We noted remarkably low TB notification rate in the age group [5−15) years in both cases
(with a notification rate of 108 if not vaccinated and 43 per 100,000 population if vaccinated).
However, low TB progression rate in this age group is not well understood, perhaps it is because
of an active immune response that may fight against infectious particles. Furthermore, though
there is no molecular empirical evidence, natural immunity and acquired immunity (from either
the vaccine or MTB infection) may be stronger in this age group than any other age group.
We noted lower active TB notification rate for old age groups [65− 75) and ≥ 75 years
(with notification rates 352 and 369 per 100,000 population, respectively) than productive
age groups (Figures 6.2a and 6.2b). This is probably because effective contact rate and
interactions, which are directly correlated with the force of infection are higher in productive
age groups than in old age. Since TB cannot exist if individuals die, TB seems to be higher
in young age groups than old age because of higher mortality rate in old age than young age
groups. Furthermore, since MTB induce an immune response that reduces TB progression,
old age group might have higher protection against active disease due to multiple infection
than young age groups.
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Figure 6.2: Model prediction TB notification rates without vaccination and the 2009 study.
(a) Active TB notification rate per 100,000 population without vaccination. (b) Comparison
of TB notification rates observed in this study (model simulation without vaccination) and
that observed in Cape Town in 2009.
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Figure 6.3: Model prediction TB notification rates with vaccination and the 2009 study.
(a) Active TB notification rate per 100,000 population with vaccination for the age groups
[0− 5) and [5− 15) years. (b) Comparison of TB notification rates observed in this study
(model simulation with vaccination) and that observed in Cape Town in 2009.
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6.4 Discussion
We performed sensitivity analysis for all parameters of the model to explore factors influencing
TB progression in different age groups. Since TB infection and disease progression depends
on age and immunological memory status, our sensitivity analysis focused on TB progression
rates and immune response induced by natural MTB infection and BCG vaccine.
Using an age-structured mathematical model developed in this study, we explored the impact
of the vaccine on TB control in different age groups. Our findings suggest that active disease
progression is different in different age groups. It is unclear what causes diversity of disease
progression in different age groups, though immunity and average duration of the waning of the
vaccine might be among the contributing factors. Since the BCG vaccine wanes after a limited
range of years and individuals become susceptible to TB, it is plausible that a large number
of TB cases among adults might be attributable to reinfection and reactivation [34, 65].
Since MTB hampers the effort of TB control, particularly in high TB burden settings by
reducing the efficacy of the vaccine, the complement way is earlier diagnosis of TB cases
in the community and treatment. However, due to poor diagnostic tools, which may give
false-negative or positive results, in developing countries in particular, the most efficient form
of control is the implementation of an efficacious TB vaccine, which combats MTB infection
and prevents TB disease. Though the BCG vaccine and prior natural MTB infection confer
almost the same immune protection against TB, the average duration of the waning of natural
MTB induced immunity is not well understood, which makes the situation uncertain. Latently
infected individuals are at higher risk of developing active disease through either endogenous
reactivation or exogenous reinfection than vaccinated individuals. Thus, latently infected
individuals should be vaccinated, especially in high TB burden settings.
Here, we show that TB progression is age dependent, perhaps because the strength of immunity
and waning of the vaccine’s efficacy are age dependent. To have a greater impact on TB
control and achieve the WHO target of eliminating TB [80], the new vaccine should target
age groups at high risk of TB infection and disease progression. Furthermore, in the control of
endogenous reactivation in productive age, the average duration of the waning of the vaccine
efficacy should be longer than that of the current vaccines. The findings in this study show that
the current TB vaccine reduces disease progression in specific targeted age groups, but it does
not control active disease progression 100%. This reiterates the need for early identification
and treatment of TB cases to avoid new cases. We suggest that the new vaccine should be




Tuberculosis (TB) incidence is still increasing worldwide, regardless of numerous TB interven-
tions applied in different locations. Because of the high concentration of exhaled breath some
of which is derived from infective sources, TB transmission in congregate locations, includ-
ing households, schools, public transport, prisons and health care settings is remarkably high
[32, 100, 109], especially in developing countries where poverty and HIV infection act as driv-
ing forces. The main reservoir of TB strains is not well understood but susceptible individuals
usually become infected in these locations when they interact with infectious individuals and
inhale airborne infectious particles for a prolonged period of exposure. Since unidentified TB
cases and multi-drug resistant individuals expectorate massive numbers of airborne infectious
particles, they are assumed to be one of the TB transmitting sources in the community.
Exhaled air contains a mixture of nitrogen, oxygen, carbon dioxide and water vapor. Carbon
dioxide excretion as a surrogate for exhaled air is directly related to the oxygen consumption
required for metabolic activity. The ratio of exhaled carbon dioxide to the oxygen consumption
is defined by the respiratory quotient which is somewhat diet dependent but relatively constant
at a value of 0.83 [7, 46]. The concentration of exhaled carbon dioxide is determined by the
respiratory rate, which for an adult at rest is 8−10 liters per minute. Therefore, for a normal
adult at rest the carbon dioxide exhaled is 8− 10 liters of 4% (40,000 ppm) [7, 46]. Here,
using carbon dioxide as a surrogate for exhaled air, we modified the Wells-Riley and the prior
modified Wells-Riley models and obtained a more flexible mathematical model that predicts
the risks of airborne infectious diseases, such as TB in multiple environments. We used this
mathematical model to demonstrate TB transmission in some congregate settings, such as
schools and prisons. Furthermore, we applied the model to guinea pig experimental data from
previous in vivo studies to predict the probability of exposed guinea pigs acquiring infection in
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these studies and quantified the number of infective organisms required to reach the alveolar to
induce infection [67]. We believe that this is the first study to date to modify both the Wells-
Riley and prior modified well-Riley models, and to apply the resulting model to the prediction
of TB transmission and quantification of the number of infective organisms required to induce
infection.
In contrast to the prior studies, including guinea pig experiment reports by Wells-Riley and
others, we noted that susceptible individuals are not usually infected by a single airborne
infectious particle [66]. This shows that TB infection is a somewhat complex scenario that
incorporates respiratory deposition fraction, which determines the threshold level of airborne
infectious particles needed at the host infective site. In other words, respiratory deposition
fraction is correlated with airborne infectious particles, such that susceptible individuals usually
become infected if surviving airborne infectious particles reach a threshold level to reach the
relevant site and dominate the immunological state of the host [66].
Most studies show that ventilation plays a key role in the prevention of TB transmission but
they don’t quantify a specific value of air change per hour in each location or other depen-
dent factors. To our knowledge, ventilation depends on various factors, including location,
window(s) size, weather conditions, number of occupants and their physical activities in the
given space. We believe that if these factors can be addressed and specific values of air change
per hour can be quantified in each location, then improved ventilation can be among the best
interventions for TB control. Furthermore, though some protective respirators have been used
in some health care settings, their face-seal leakage, which is not specified hampers TB con-
trol efforts. Since HEPA filters are somewhat expensive, this means that the most affordable
respirators are ineffective for TB control, which is why TB transmission is remarkably high in
health care settings and other congregated areas.
Using a compartmental model developed in this study, we investigated the population impact
of effective contact rate (β ) and post-treatment on TB epidemiology. An infectious individual
with varying effective contact rate (ranging from 5 to 30 yr−1) was introduced among 100,000
fully susceptible individuals and we observed the number of individuals in all five states at
stability point of a TB epidemic. We found that the number of newly infected cases increases
when β = 5 to β = 10 yr−1 then decreases with increasing effective contact rate, while that
of reinfected individuals increases with increasing effective contact rate, implying that a large
number of active TB cases might be repeatedly exposed individuals. We noted that the number
of active TB becomes higher when all treated individuals move to a susceptible state than when
they move to either a newly infected or reinfected state, probably because of immunological
factors. The study shows that post-treatment immunological memory reduces the risk of TB
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disease by 7− 16% compared to susceptible individuals. Using an age-structured model we
developed that incorporates vaccination, we examined the impact of the vaccine on TB control
in high TB burden settings, such as Cape Town. The model detected TB notification rates in
different age groups with different peaks. We noted that the vaccine reduces TB progression
for the age groups [0−5) to [15−25) years, and TB remains remarkably high for other age
groups. This implies that TB progression depends on age and average duration of the waning
of the efficacy of the vaccine.
In this study, we managed to explore TB transmission in the above outlined locations, showing
that TB remains high in congregate settings. However, because of limited time, we didn’t
manage to visit other congregated areas, such as refugee camps and mining industries where
TB prevalence might be remarkably high because of high population density, interaction, poor
infrastructure, unidentified TB cases and TB co-infection with HIV. In our future work, we
shall visit these locations and quantify environmental, biological and socio-economic factors
correlated with TB prevalence and highlight preventive measures for TB control. Furthermore,
we shall design and develop an age-structured mathematical model that incorporates TB and
HIV co-infection for further investigation about TB transmission in high TB burden settings.
Rebreathed air volume from infectious individuals is an important factor that contributes to TB
transmission in a community [100, 113]. The quantity of rebreathed air volume inhaled from
others in enclosed spaces, such as prisons, health care settings and work places is remarkably
high, which accelerates the fuel of airborne infectious diseases. Effective contact number is
directly correlated with rebreathed air volume and has non-linear relationship with the period of
infectiousness. Furthermore, airborne infectious particles viable with potential for TB infection
have a complex relationship with the period of infectiousness and rebrethed air volume. The
effective contact number and airborne infectious particles seem to have unidentified boundary
values, which maintain a TB epidemic. In our future work, we shall use the derived equations in
this study with addition of others to further identify and define boundary conditions required to
maintain a TB epidemic within specific communities. The boundary conditions may be defined
as the number of secondary cases infected by an index case in order to maintain a TB epidemic.
The boundary conditions will vary by age and also between susceptible and previously infected
individuals. The aim of this future work is to bring a TB epidemic under control by decreasing
TB transmission in a community. Furthermore, the determination of boundary conditions
required to maintain a TB epidemic will enable quantification of the targeted values of drivers
of transmission, which will be required to break community transmission.
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elecki J., and Zwolska Z. (2012). Transmission of tuberculosis within family-households.
Journal of Infection 64(6): 596-608.
REFERENCES Page 121
[33] Brooks-Pollock E., Cohen T., and Murray M. (2010). The impact of realistic age
structure in simple models of tuberculosis transmission. Plos One 5(1): e8479.
[34] Vynnycky E. and Fine P. E. M. (1997). The natural history of tuberculosis: the impli-
cations of age-dependent risks of disease and the role of reinfection. Epidemiol. Infect
119: 183-201.
[35] Paul J. Edelson and Phypers M. (2010). TB transmission on public transportation: A
review of published studies and recommendations for contact tracing. Travel Medicine
and Infectious Disease 9: 27e31.
[36] Nyabadza F. and Winkler D. (2013). A simulation age-specific tuberculosis model for
the cape town metropole. South African Journal of Science 109(910): 1-7.
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